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Executive Summary 
 
Purpose and scope of the evaluation 
This final report presents the outcome of the 
“Thematic evaluation of EC support to the health 
sector”. It was commissioned by the Evaluation 
Unit of DG DEVCO1 and implemented between 
January 2011 and May 2012. 
The evaluation provides an independent assess-
ment of the European Commission’s (EC’s) past 
and current support to the health sector by looking 
at the relevance, efficiency, effectiveness, impact 
and sustainability of the EC support provided. It 
also assesses the coherence of EC health support 
with other EC/European Union (EU) and donor 
policies and activities, as well as the specific EC 
added value within the health sector. The evalua-
tion ultimately aims at identifying relevant key 
lessons, in order to provide recommendations for 
future EC support. 
The evaluation covers EC aid delivery over the 
period 2002 to 2010, including all geographical 
programmes (EDF, DCI, ENPI and predeces-
sors2) and thematic budget lines. It comprises all 
countries under the mandate of DG DEVCO
3
 and 
assesses every aid modality used in the health 
sector, including Sector Budget Support (SBS) 
and General Budget Support (GBS), as well as 
funds channelled through multilateral organisa-
tions or global initiatives, such as the Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GFATM) 
or the Global Alliance for Vaccines and Immunisa-
tion (GAVI).  
Methodology 
The evaluation follows the methodology devel-
oped by DG DEVCO’s Evaluation Unit and is di-
vided into three main phases: structuring phase, 
desk research and synthesis phase. The design 
chosen was a multiple case study approach. 
However, no field visits were carried out.  
A Reference Group consisting of representatives 
of DG DEVCO and the European External Action 
Service (EEAS) accompanied the evaluation pro-
cess. In close collaboration with the group, the 
                                                     
1
 EC Directorate on Development and Co-operation – 
EuropeAid 
2
 European Development Fund, Development Co-
operation Instrument, European Neighbourhood Part-
nership Instrument 
3
 This excludes countries under the mandate of DG 
Enlargement as well as EC support provided through 
the EC Directorate on Humanitarian Aid & Civil Protec-
tion (DG ECHO). 
evaluation team formulated seven Evaluation 
Questions (EQs). The questions and the related 
Judgement Criteria (JC) and indicators were 
based on analysis of the EC policy framework and 
activities in the health sector, which was summa-
rised by the reconstructed intervention logic. 
Moreover, an inventory of the whole EC financial 
support to the health sector was carried out.  
Further data collection was based on a sample of 
25 country case studies, of which 12 were select-
ed for in-depth research. The sample countries 
were selected to reflect, as far as possible, the 
diversity of EC partner countries and EC pro-
grammes and approaches. Furthermore, three 
thematic case studies illustrated a selection of 
regional or thematic specificities of EC support 
more in depth.  
The evaluation used a combination of tools and 
techniques for primary and secondary data collec-
tion, such as: online-survey to EU Delegations 
(EUDs) and ministries of health; analysis of Coun-
try Strategy Papers (CSPs); literature review and 
meta-analysis of evaluations or audits, such as 
EC country strategy evaluations or European 
Court of Auditors’ reports; as well as (phone) in-
terviews with stakeholders at the EC Headquar-
ters (HQ) and in the sample countries. 
Main findings of the evaluation 
During the evaluation period, the EC supported 
the health sector with direct support amounting to 
EUR 4.1 billion. This represents 6% of total EC 
support to all sectors during the period. Moreover, 
EUR 5 billion of indirect support, i.e. GBS, with a 
link to the health sector was provided by the EC 
during the same period.  
Within the direct support, the basic health sub-
sector as defined by DAC received most of the 
funds, 73% of the total (this category includes 
interventions aiming at basic health care, infra-
structure, or the fight against PRDs). Other sub-
sectors are ‘Health general’, comprising mainly 
policy and administrative management (22%) and 
sexual and reproductive health (5%). 
The main beneficiary of direct support was the 
ACP region (46%), followed by Asia (18%) and 
the ENP South region4 (13%). Most direct EC 
support to the health sector was channelled 
through the individual project modality (45% of 
                                                     
4
 European Neighbourhood Policy-South 
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total support), followed by ‘Support to sector pro-
grammes, excluding sector budget support’ (18%) 
and SBS (16%). 21% of EC funds were chan-
nelled through global trust funds, the main recipi-
ent being GFATM. Over the evaluation period, 
funds allocated to the health sector tended to 
increase.  
Although actual attribution of impact is difficult, the 
EC has contributed to progress in the health sec-
tor. Three key themes that emerge from the eval-
uation have limited its impact: (i) the persistent 
under-resourcing of the health sector by benefi-
ciary governments, (ii) the human resource (HR) 
crisis in health, and (iii) the need for better health 
technical capacity in EUDs. 
EQ1- Quality of health care: EC support has con-
tributed to an improved quality of health care in 
beneficiary countries. The modalities were varied, 
including direct provision of basic health care in 
troubled settings to supporting ministry of health 
reform designs in more stable environments. In all 
three main areas examined – essential medicines, 
infrastructure and HR – the evaluation team has 
recognised that, while the EC’s impact may have 
been high at a micro level, the total amount of 
money in play for pharmaceuticals, infrastructure 
and health worker salaries dwarfs the EC’s re-
sources. 
EQ2- Affordability of health care: Increasing ac-
cess and utilisation by reducing cost has been a 
central concern of all EC interventions in the field 
of health. Overall, the EC made some contribution 
to reducing the cost of basic health services to 
households in the countries where it provided 
support, e.g. through the direct financing of health 
care services. The EC has contributed in a range 
of settings to cost reduction of health care to 
those with special needs, such as children, the 
elderly, persons living with HIV/AIDS and the dis-
abled. In most countries, the EC provided at least 
some Technical Assistance (TA) and participated 
in policy dialogue related to health care finance. 
However, there appear to be few success stories 
in the area of health care finance.  
EQ3- Availability of health infrastructure especially 
for the poor: EC contribution to infrastructure is 
moderate, especially in comparison to other do-
nors, such as the World Bank. EC interventions 
aimed at expanding, reconstructing and equipping 
the network of primary health facilities, especially 
in disadvantaged and remote areas and/or post-
conflict areas. The sustainability of interventions, 
together with lasting inequities between rural and 
urban populations, remains a challenge.  
EQ4- Improved health service utilisation related to 
Maternal, Neonatal and Child Health (MNCH): 
The EC has financed basic health care provision 
programmes (e.g. in Egypt, Afghanistan and 
South Africa), GBS programmes with indicators 
related to maternal health, (e.g. Millennium De-
velopment Goals (MDG) contracts), and has also 
contributed to global initiatives (e.g. GFATM, 
GAVI, polio eradication). These efforts have been 
successful in improving maternal health and, to a 
lesser extent, in increasing the utilisation of health 
facilities by children. This resulted in higher im-
munisation rates and better monitoring of the 
growth and nutrition status. Considerable gaps 
remain between rural and urban areas related to 
MNCH, and the EC approach to prioritise under-
privileged areas and communities can be seen as 
relevant.  
EQ5- Strengthening the management and gov-
ernance of the health sector: The majority of the 
EC’s work addressed public financial manage-
ment (PFM). Most of this support has been in the 
form of TA to support the drafting of health sector 
plans, Medium-Term Expenditure Frameworks 
(MTEFs) and development of indicators; while 
EUDs have been active in establishing health co-
ordination mechanisms. Evidence also indicates 
that there has been a good level of dialogue in 
health sector forums related to PFM, accountabil-
ity and capacity building measures in most coun-
tries. However, it is not always clear to what ex-
tent this dialogue has resulted in strengthened 
capacity in these areas. The EC has undertaken 
limited work on decentralised capacity building to 
strengthen health policy capabilities, which is an 
issue as capacity at provincial and district level 
remains low. Procurement is the governance area 
which has seen the least EC contribution and 
there appears to be little focus in EC health pro-
grammes on this aspect. 
EQ6- Co-ordination, complementarity, synergy 
with donors and partner governments: Overall 
donor co-ordination in the health sector has im-
proved over the period and can be judged as 
good in 2010. Specifically related to EU Member 
States (MS) co-ordination, the EC has played a 
key role, has usually chaired these groups, and 
has thus provided added value. A number of Joint 
Assistance Strategies (JAS) were developed dur-
ing the evaluation period. However, they are not 
necessarily complete nor applied in all areas of 
support. The increasing role of partner govern-
ments in donor-government coordination mecha-
nisms demonstrates a step towards closer align-
ment, as set down in the Paris Declaration. How-
ever, there is little evidence on EC support in the 
health sector affecting government’s capacity to 
steer and co-ordinate donor assistance. Progress 
has been made in increasing the number of joint 
donor field missions and analytical work shared 
between them. The EC has provided financial 
contributions to global trust funds (GAVI, 
GFATM), as well as trust funds at country level. 
While complementarity of these funds with other 
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EC support at country level can be assessed as 
good, problems remain related to heavy adminis-
trative procedures or incoherence of strategic 
goals.  
EQ7- Appropriate use of financial modalities and 
channels to deliver health support: EC aid delivery 
modalities were increasingly well adapted to recip-
ient countries' national contexts over the evalua-
tion period. This was accompanied by an increas-
ingly thorough analysis of the different dimensions 
of the health sector in partner countries. This 
trend corresponded to greater use being made of 
budget support, especially SBS, although its use 
is still at a relatively low level compared to other 
sectors. In most countries analysed, the EC has 
had reasonably ambitious health-related indica-
tors for both SBS and GBS programmes, although 
there are exceptions. Most programmes used 
outcome indicators linked to the health MDGs. 
Evidence suggests that the achievement of indica-
tor targets used by the EC varies, indicating that 
not all have been easily achievable. In particular, 
the GBS health performance indicators have 
tended to be overambitious compared to those of 
other donors, leading to low rates of disburse-
ment. The EC, both on its own and in conjunction 
with other donors, has made a contribution 
through GBS and SBS to inclusive objectives in 
the health sector. SBS has resulted in increased 
levels of capacity building support for health. 
However, this does not seem to have been trans-
lated into improved policy-based resource alloca-
tions. Transaction costs have been decreasing for 
recipient governments through the move to 
SBS/GBS, reduction of Project Implementation 
Units (PIUs) and increasing use of joint missions. 
In contrast, for some EUDs the move to budget 
support increased transaction costs, particularly 
as sufficient health PFM expertise was not always 
available in-house. High transaction costs are also 
generated by EC projects implemented by other 
agencies or donors. 
Overall assessment of EC support 
Relevance: EC co-operation in health was rele-
vant to needs and coherent with EC development 
policy. In general, the poverty focus of health co-
operation was well maintained over the evaluation 
period. The theme of access to quality health care 
cuts across all EC interventions. EC assistance in 
health was also in line with the observation that 
many countries are off track on the health MDGs. 
In covering health care finance, HR for health and 
improved governance in health, the EC has been 
in line with the pillars of universal health care ac-
cess. However, a few caveats apply:  
(a) Few concrete interventions sought to directly 
alleviate the HR crisis. What was accomplished, 
by contrast, was the strengthening of HR plan-
ning, improved data and analysis and the sharing 
of regional experiences.  
(b) While the concentration of projects on rural, 
geographically remote and disadvantaged areas 
was appropriate for the focus on poverty, growing 
urbanisation was scarcely taken into account.  
(c) TA and policy dialogue regarding finance were 
highly relevant and in line with the goal of univer-
sal access, even if impact was limited.  
(d) EC support in fragile states was relevant, but 
the small portion of EC funding allocated to fragile 
states is not in line with its recent policy commit-
ment. 
EC participation in various initiatives related to 
provision of global public goods for health, some 
related to pharmaceuticals and implemented un-
der DG Research framework programmes, was 
relevant to needs and coherent with the EC’s role 
as a supranational organisation. 
Efficiency: Overall, EC support to the health sec-
tor was no more or less efficient than support in 
comparable sectors such as education. The effi-
ciency of EC interventions providing infrastructure 
and equipment was impaired by an inadequate 
attention to maintenance and operating costs. In 
answering EQ4, it was found that in almost all 
regional interventions (implemented by partner 
organisations such as United Nations (UN) agen-
cies and international Non-Governmental Organi-
sation (iNGOs)), co-ordination weaknesses and 
differences in procedure limited efficiency. In gen-
eral, the EC has made progress in aligning with 
national systems, which is e.g. exemplified by the 
decreasing use of parallel PIUs. However, the EC 
has been slower to move to SBS than in compa-
rable sectors, such as education. The HR crisis, 
leading to high staff turnover and shortages, im-
paired the efficiency of interventions across the 
board, from capacity building to direct provision of 
services. 
Effectiveness: EC co-operation in the health 
sector has been generally effective. However, in a 
few areas, such as health finance reform and HR, 
results have been found to be small compared to 
the scope of the challenges. A factor limiting ef-
fectiveness throughout has been the chronic 
shortage of technical expertise in EUDs. 
Impact: Impact is difficult to assess, but there is 
no doubt that overall, EC health assistance con-
tributed to progress towards health MDGs, not 
only in the particular areas of maternal and child 
health and HIV/AIDS, but also more broadly in 
terms of promoting better health outcomes, espe-
cially among the poor. By contrast, EC impact in 
health care finance and in HR has been modest. 
Health care finance is ultimately the responsibility 
of governments and all the EC can do is to pro-
vide TA and, through policy dialogue, encourage-
ment. With a few exceptions, it is difficult to see 
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hard evidence that EC SBS and GBS resulted in 
increased resources for the health sector. Regard-
ing the closely-related area of health sector PFM, 
there is evidence of EC capacity building, but less 
evidence of tangible improvements. 
In the area of HR, the basic problem is the gap 
between salaries and working conditions in the 
public health sector and those available by emi-
gration or by working in the private sector or a 
donor-financed project. Under such circumstanc-
es, a significant share of capacity built is lost due 
to attrition. Some EC programmes and policies 
have sought to address this issue, but the scope 
of the problem has been too large for substantial 
mitigation. 
Most governments have schemes in place to im-
prove health care access for the very poor or 
those with special needs. In some cases, the EC 
had a significant impact. In other cases, general 
EC support may have had some impact. 
With a few exceptions, the share of out-of-pocket 
expenses in total health spending remained high 
or increased. This reflects a combination of limited 
impact on health sector finance and, closely relat-
ed, the continuing low quality of public health ser-
vice in many countries. EC programmes directly 
providing health services, such as in Afghanistan 
and DRC, have had a major impact, even if their 
sustainability questionable. In several settings, EC 
support for improved MNCH has contributed to 
significant progress, even if the related MDGs are 
proving elusive. 
Apart from projects in disadvantaged areas, infra-
structure supply is not a focus of EC assistance. 
However, in interventions that were geographical-
ly targeted, the EC had significant impact on ac-
cess to health via infrastructure and equipment. 
Nevertheless, the problem of operations and 
maintenance remains unresolved. 
There is mixed evidence on the degree to which 
EC assistance has contributed to strengthening 
the management and governance of health sys-
tems. In some areas there has been a clear con-
tribution such as in strengthening health policy 
strategy, planning and processes. There is, how-
ever, little evidence as to how successful EC sup-
port was in strengthening health systems them-
selves - a priority goal of the recent EC health 
strategy. 
The EC's selection of aid modalities and channels 
was made on the basis of a sound analysis of the 
health sector and of partner country needs and 
capacities, although this analysis was weaker in 
the early period of the evaluation. However, the 
indicators themselves have not always been 
achieved, while problems have been experienced 
finding sufficient data to assess whether indicators 
have been met. In most countries analysed, the 
EC has had reasonably ambitious health-related 
indicators for both SBS and GBS programmes. 
Regional instruments and regional applications of 
thematic instruments were used when cross-
border and regional aspects were prominent. 
There is no strong evidence of a significant posi-
tive impact of budget support on national health 
expenditures and on budget processes at both 
central and decentralised levels. There is, howev-
er, evidence that SBS has resulted in increased 
levels of capacity building support for health, in-
cluding all EC financed SBS and in some instanc-
es GBS. 
Sustainability: The sustainability of EC health 
impacts has remained limited. A major theme is 
the persistent and continuing under-resourcing of 
health sectors by beneficiary governments. If the 
economic growth, good governance, sound public 
financial management and stability required for 
solid fiscal accounts are not present and com-
bined with a policy commitment to providing ade-
quate health care, the current situation will prevail. 
EC assistance, like all donor assistance, can seek 
to break countries out of this low-level equilibrium 
trap, but this evaluation has found no clear exam-
ples of national health sector-wide success sto-
ries. While the evaluation has found some clear 
evidence of successful impacts, it is unclear 
whether many of these will persist once donor 
support is withdrawn. 
EU added value: One way of approaching the 
question of added valued is to ask what the EC 
was able to provide that other donors would have 
been incapable or less capable of providing. The 
EC, with its wide range of health policy styles in its 
Member States and its close linguistic and histori-
cal ties with some developing regions, has a com-
parative advantage in TA and it provided a great 
deal in the health sector. Another area in which 
the EC clearly added value was in promoting 
global public goods for health, an area in which , 
nation-states under-provide and joint action is 
required. In most other areas, it is hard to define a 
unique EC contribution, which is, of course, not to 
downplay the massive financial resources that it 
has supplied. 
Co-ordination, complementarity and coher-
ence: The Paris Declaration of 2005 and health-
sector specific initiatives such as the International 
Health Partnership Initiative (IHP+) and Joint As-
sessments of National Health Strategies (JANS) 
have strengthened joint efforts between donors 
and governments. The EC has played a key role 
especially in MS co-ordination as well as in co-
ordination mechanisms including partner govern-
ments. While, the role of partner governments in 
donor-government co-ordination mechanisms has 
increased, weak capacity and low government 
leadership continue to be bottlenecks. The persis-
tence of projects is testimony to governments’ 
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continuing tendency, widely reported although not 
established by any specific findings in this evalua-
tion, to accept whatever interventions are offered. 
There could be better co-ordination and comple-
mentarity between the multiple interventions that 
are supported by the EC through multiple instru-
ments, modalities and channels. The strategic 
relationship between thematic budget lines pro-
jects (managed from Brussels and not tailored to 
country strategies), GFATM projects and bilateral 
geographical programmes was often not clear. 
There was no sign of co-ordination between re-
gional and bilateral programmes. Under such 
circumstances, there were overlap and lack of 
coherence. 
Main conclusions of the evaluation 
For analytical clarity we have grouped the conclu-
sion into three clusters. 
Cluster 1: Strategic focus 
Conclusion 1: The EC still lacks a clearly ar-
ticulated and implemented global strategy for 
health co-operation with developing countries 
The EC was involved in almost every aspect of 
health, using a wide range of financing instru-
ments, modalities and aid channels. While a 
strong anti-poverty focus was successfully main-
tained, it is difficult to identify any single, coherent 
and focused strategy in health with clearly defined 
priorities. At field level, CSPs were aligned with 
national health priorities for the most part, but 
coherence with an overall EC vision was lacking. 
The absence of sufficient technical expertise in 
many EUDs worsened the situation. 
Conclusion 2: EC health strategies have tend-
ed to focus on the present, not the longer term 
over which health sector development takes 
place (such as urbanisation and the demo-
graphic and epidemiological transitions) 
Because of its development co-operation cycle, 
the EC is in a weak position to take long-term 
trends into account. Some health challenges are 
immediate, and EC co-operation has effectively 
addressed many of these (as detailed below in 
Cluster 2). Yet, others are closely linked to demo-
graphic, economic and social development, so 
they emerge and evolve over the long term. The 
EC’s global health strategy, to the extent that it 
can be identified, focused primarily on near-term 
problems and solutions, paying insufficient atten-
tion to the longer time frame over which health 
sector development occurs (one, if not several, 
decades). 
Conclusion 3: The magnitude and sustainabil-
ity of impacts of EC support to health system 
strengthening are limited  
Despite the clear link with poverty, its prominent 
role in the MDGs, and donor (including EC) pres-
sure to pay more attention to the social sectors, 
health remains a low budgetary priority sector in 
most co-operation partner countries. In some of 
the poorest, the share of total health expenditure 
that is donor-financed is unsustainably high. Long-
term progress towards better health in poor coun-
tries, which requires durable health sector reform, 
is dependent on increasing national resource allo-
cations to the sector. This requires economic 
growth, better governance, stability and absence 
of conflict, in addition to shifts in policy attitudes 
and priorities. 
Cluster 2: EC support to specific thematic is-
sues 
Conclusion 4: EC direct support to infrastruc-
ture / equipment has had limited impact and 
sustainability 
EC direct support to infrastructure and equipment 
provision has increased access to health care in 
specific geographical areas (disadvantaged areas 
in some countries), but has been limited overall. 
While policy dialogue through SBS improved poli-
cy making, planning and management related to 
infra-structure and equipment, issues of mainte-
nance and operating cost were neglected. These 
are most closely tied to the under-resourcing of 
public health systems, and there is little evidence 
that the EC made progress in addressing this 
problem. 
Conclusion 5: EC commitment to addressing 
the HR crisis in health has not much concrete 
impact at country level 
Through its 2006 Communication, the EC has 
pledged to take actions to tackle the HR crisis in 
health and EC project documents and SBS / GBS 
policy matrices regularly cite the HR crisis, as 
called for by policy. However, the shortage and 
attrition of trained health personnel remain serious 
in most countries and EC actions have been lim-
ited. 
Conclusion 6: The EC’s support to health care 
finance only yielded mixed success in reduc-
ing out-of-pocket payments as a share of total 
health care spending 
In a number of countries, EC TA has supported 
overall health sector financial reform. Unsustaina-
ble financing policies have been addressed (e.g. 
in Moldova), new strategies have been proposed 
and piloted (e.g. in Egypt and Lao PDR), and ex-
isting health insurance schemes have been re-
formed (e.g. in the Philippines). In many cases, 
despite policy changes, the key indicator of out-of-
pocket payments as a share of total health ex-
penditure has remained high or has increased. 
Overall evidence for SBS / GBS contribution to 
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increased public budgetary resources in health is 
thin. Nevertheless, some countries that received 
GBS did experience significant declines in out-of-
pocket payments. 
Conclusion 7: Geographically targeted inter-
ventions improved access to health care for 
the poorest populations 
When it was geographically targeted, EC assis-
tance concentrated on rural regions where health 
was poorest and access to quality health care was 
lowest. The EC scored some successes in worst-
off regions. However, in concentrating its re-
sources on rural areas – a strategy that responds 
to the broad-urban-rural gap in health – the EC 
did not take into account the fact that health chal-
lenges are gradually shifting from urban to rural 
areas because of urbanisation. 
Conclusion 8: EC support to MNCH resulted in 
significant progress in many settings 
The EC provided support to improved MNCH, 
mostly through its support to primary health care 
(the number of interventions exclusively devoted 
to MNCH has been low). In a wide range of set-
tings, there has been progress against maternal 
mortality and under-five mortality - the two MDGs 
directly related to MNCH. However, progress to-
wards these MDGs has been disappointing due to 
the problem's complex nature. In addition, the 
goals set were unrealistically ambitious. 
Conclusion 9: EC contribution to health im-
provements has remained modest in the case 
of fragile states 
One of the largest EC health programmes was 
that in Afghanistan, with a well-documented im-
pact on health status. Support to other fragile 
states, however, has remained much more mod-
est. In such settings, the EC was also more bound 
by procedural constraints than other donors, and 
would need to be more innovative to contribute 
significantly to progress. 
Conclusion 10: Although the EC has contrib-
uted to improved health sector policy and 
management, impact on resource availability 
has been modest 
In most countries where the EC has been involved 
in health co-operation, EC support, especially 
SBS, has led to improved health sector policy 
making capacities and improved management 
practices. While capacity for better PFM has been 
increased, the ultimate impact on health sector 
PFM has often not been seen. Not only PFM ca-
pacity, but also increased national resource allo-
cations to the health sector are needed. 
Conclusion 11: The EC significantly contribut-
ed to the production of global and regional 
public goods for health 
Through support to research, infectious disease 
control (much of it through the Global Fund, GAVI 
and the initiative to eliminate polio, but also in 
emerging areas such as cross-border veterinary 
health and pandemic influenza), the EC contribut-
ed to the production of global and regional public 
goods for health. This is appropriate in view of its 
status as a supranational organisation. In the case 
of GFATM and GAVI, the significant role of EC 
HQ stands in contrast to the limited role played by 
most EUDs, meaning that co-ordination with other 
EC programmes was lacking. 
Cluster 3: EC interaction with donors and 
partner governments in the health sector  
Conclusions 12 & 13: While increasingly hon-
ouring Paris Declaration commitments, the 
lack of technical expertise in EUDs has limited 
the EC's potential co-ordination role  
The EC has exploited its role as a supranational 
organisation and its special relationship with the 
EU MS. However, the shortage of technical exper-
tise in EUDs placed it at a comparative disad-
vantage relative to other donors and govern-
ments.  
The EC contributed to reducing health co-
operation transaction costs for recipient govern-
ments through a reduction in PIUs and, despite 
the persistence of the project approach, moved 
towards sector support through SBS and GBS. 
However, one of the most recent instruments for 
this, Delegated Co-operation, was little utilised as 
of the end of the evaluation period. Moreover, EC 
effectiveness and impact were weakened by un-
der-staffing in EUDs. 
Conclusions 14 - 16: While participation in 
policy dialogue in the context of sector-wide 
approach (SWAp) / SBS / GBS has contributed 
to better health sector policies and manage-
ment, concrete increases in resources allocat-
ed to health were rare 
Despite capacity shortages, EUD policy dialogue 
as part of the wider donor dialogue related to GBS 
and sector support has contributed to improved 
capacity. However, strong evidence was not found 
that this has resulted in higher budget allocations 
for health. 
The indicators chosen to form the SBS and GBS 
performance assessment frameworks were in 
most cases reasonably well specified and ad-
dressed the core health sector issues. In some 
instances, however, a lack of data made it difficult 
to track progress of chosen indicators. 
In many settings (e.g. the Philippines, Vietnam), 
EC participation in multi-donor trust funds at coun-
try level has proven effective. The main factors of 
success in the implementation of such funds were 
a regular and transparent dialogue between do-
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nors and partner governments, and the active 
participation of EUDs in the steering and co-
ordination committees. Once more, however, lim-
ited technical capacity of Delegations has been a 
constraining factor. 
Conclusion 17: The mix of EC aid modalities 
could be more coherent and strategic 
In the health sector, the EC uses a wide range of 
aid modalities, which are increasingly aligned with 
recipient government systems. However, it is of-
ten not clear why alternative aid modalities and 
funding channels were not chosen and how those 
chosen were meant to be complementary. This 
has led to a lack of coherence and consistency 
between programmes. 
Main recommendations of the evaluation 
Eleven recommendations have been derived from 
the established conclusions. They are presented 
under the headings: strategic recommendations 
and operational recommendations. Recommenda-
tions 1, 5, 6 and 8 are considered both most im-
portant and most urgent. 
Strategic level 
Recommendation 1: Consolidate various 
global policy statements and approaches into 
a comprehensive health co-operation strategy 
that can be effectively operationalised at the 
field level in conformity with national sector 
development plans 
Conclusion 1 found that the EC’s global health 
strategy, which seeks to cover all fronts at once, 
does not result in sound country-level strategies, 
especially since thinly staffed EUDs lack the ca-
pacity to absorb the potential workload. In order to 
rise above the current activity-driven approach, 
the EU should review, consolidate and synthesise 
its health co-operation strategies, possibly in the 
form of a White Paper. Major dimensions of a 
comprehensive approach should be identified, 
including an anti-poverty focus, primary health 
care (PHC), health systems strengthening, health 
care finance, global public goods, HR, etc. The 
goal should not be a one-size-fits-all approach. 
Instead, the approach should be sufficiently broad 
and well-articulated to allow individual compo-
nents to be matched to country priorities and other 
donors’ activities, and to identify priority interven-
tions while ensuring that major issues are cov-
ered. In this way, capacity building, for instance, 
will need to be matched with HR policy; infrastruc-
ture and equipment needs with health care fi-
nance via maintenance and operating budgets; 
support for vertical programmes with health sys-
tems strengthening; etc. 
The persistent fragmentation of health aid and the 
need for improved co-ordination with national 
health sector plans and budget cycles argues for 
a continued strong role for both SBS and GBS. In 
providing budget support, account must be taken 
of countries’ policy commitments and resource 
allocation decisions related to social sector re-
form. Governments should be asked to make a 
credible case for how budget support has contrib-
uted to making available additional resources for 
inclusive and equitable health sector develop-
ment, including health finance and social protec-
tion reform, where needed. This will serve EU 
accountability and increase country ownership. 
The hallmarks of the approach should be (i) identi-
fication, prioritisation and choice of interventions 
while maintaining enough breadth to allow con-
sistency with national programmes; and (ii) avoid-
ance of overlaps with other agencies such as 
GFATM, UNFOPA and UNICEF. It would translate 
overarching policy commitments into a menu of 
choices from which to choose in line with individu-
al national strategic priorities. 
Recommendation 2: When defining the focus 
of support, take the shifting burden of disease 
and structural shifts such as urbanisation 
more carefully into account 
Little notice has been taken of the challenges 
associated with urbanisation and non-
communicable diseases. The EC should take 
these into account when formulating global and 
country health strategies. The impact of climate 
change on health is another area in need of con-
sideration. The health-poverty focus has rightly 
led the EC to concentrate on rural areas, but pov-
erty is increasingly an urban phenomenon and the 
EC’s health strategy should be pro-active along 
this dimension. 
With its emphasis on primary health care and 
poverty focus, the EC is perhaps not in a strong 
position to directly address chronic conditions and 
non-communicable diseases, which often require 
secondary-and tertiary-level care. There are, 
however, several areas where the EC can never-
theless intervene. One is encouraging health 
planners to squarely address road trauma and 
mental disease. Integrated PHC programmes - a 
clear and continuing focus of the EC - can be 
adapted to play an important role in doing so (e.g. 
through health promotion, blood pressure monitor-
ing, routine screening procedures, etc.). Address-
ing non-communicable diseases does not com-
pete with primary health care, but leverages it. 
Recommendation 3: While continuing to sup-
port global initiatives such as GFATM and 
GAVI, the EC should use its influence to en-
courage further moves towards the health 
system's strengthening components of such 
vertical programmes and in particular address 
HR consequences 
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The EC should continue supporting global initia-
tives such as the Global Fund and GAVI. Howev-
er, the Health System Strengthening (HSS) com-
ponents of the GFATM and GAVI proposals (since 
Round 8) provide an entry point for HSS support 
and should therefore be prioritised. The EC’s con-
siderable role in financing these initiatives gives it 
a strong say in pushing them in the direction of 
systems strengthening. In addition to aligning 
more closely with country priorities, this will help 
address the HR crisis, which is significant, partly 
due to health professionals having been absorbed 
by vertical programmes. The HSS approach is 
crosscutting and horizontal in addressing the 
weakest aspects of health systems, including 
service delivery, and more in line with the goal to 
create a strong PHC framework. 
Recommendation 4: In order to improve co-
herence, the EC should be more strategic re-
garding the choice of instruments  
The EC needs to be more strategic regarding 
which aid instruments to use in which contexts. 
Thematic programmes need to be coherent with 
geographic programmes, while consideration 
needs to be given as to how GBS, SBS and other 
sector support and projects can be complemen-
tary. GBS is the modality most likely to succeed in 
raising key health sector issues to a higher level 
of dialogue, with the achievement of objectives 
supported through a coherent series of interven-
tions through sector support programmes and 
projects aimed at improving service delivery. SBS 
and other sector support can support dialogue 
aimed at better health sector management and 
related strategic interventions. A greater use of 
SBS should also be considered, with capacity 
building support given prior to SBS to ensure that 
the EC pre-requisites can be met.  
Fragile states present a special challenge. 
Though relatively little EC assistance has gone to 
such countries, impacts have been substantial. In 
fragile states, emphasis should be put on 
strengthening basic service provision as a means 
of confidence building and, in situations of conflict 
or near-conflict, building bridges. Operations in 
fragile states should be innovative, flexible and 
adaptable, as situations may change rapidly. 
Recommendation 5: The EC should strengthen 
the technical health capacity of EUDs or, in 
countries where this is impossible, consider 
either reducing its direct participation in the 
health sector, delegating to others by partici-
pating in pooled funding, or drawing on exper-
tise in EU MS embassies 
Most EUDs, even in countries with significant 
health engagement, are short of technical capaci-
ty. In order for policy dialogue related to sector 
SPSP and budget support to be effective, EUDs 
must have sufficient in-house expertise in health 
and PFM. EUD participation in co-ordination exer-
cises and multi-donor trust funds, input into policy 
dialogue and EC visibility suffer if credible exper-
tise is lacking. The planned tightening of focus on 
only three focal areas per country is an opportuni-
ty for doing an inventory of HR needs and formu-
lating a staffing plan. Where needed, if technical 
expertise cannot be mobilised, delegated co-
operation may be employed to access the skilled 
staff of EU MS embassies. 
Recommendation 6: More explicit actions are 
called for in favour of HR for health 
In many developing countries, ministries of health 
struggle to attract and retain sufficient numbers 
and types of health personnel to provide quality 
services, especially in rural and remote areas. 
The EC should pay more attention to this issue, 
e.g. through HR planning in consultation with key 
stakeholders to provide a framework and strategic 
directions to guide the development of an effective 
workforce that can meet the challenges facing in 
countries’ health systems. One of the key pillars of 
the strategy should be to ensure appropriate in-
centives for health workers based on national 
policy and legislation. 
Moreover, the EC should ensure that human re-
sources for health (HRH) are taken into account in 
SBS / GBS policy matrices. It should act in con-
cert with other donors and government to reduce 
HR "poaching" from the public health system.  
The EC should also explore the links between 
problems experienced in Third Countries and the 
burgeoning demand for health worker immigrants 
in EU MS. In so doing, co-ordination and liaison 
with the MS and WHO would be especially valua-
ble. 
Operational recommendations, specific 
themes 
Recommendation 7: Take greater account of 
complementarities, synergies and inter-
sectoral links 
The EC’s country programmes should take into 
greater account the synergies, complementarities 
and cost-efficiency potentials that exist between 
different sectors such as health, rural develop-
ment, food security, water and sanitation, and 
transport. In many settings, seemingly separate 
policies can in reality be closely tied, such as the 
provision of effective community-level health care, 
a referral system based on mobile telephony and 
emergency transport availability, deserve consid-
eration. Particularly in MNCH and in dealing with 
remote regions, integrated approaches may be 
important in accelerating progress. In addition, 
EUDs should ensure that, in aligning with national 
sector development plans, co-operation is also 
aligned with EU policies on climate change, mi-
gration and environment. 
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
Final Report – Volume I August 2012 xv 
As education, health and social protection are 
priority sectors and since the new approach is to 
limit assistance in three priority sectors, if one of 
these is selected, then aspects of the other two 
should be mainstreamed into the support pack-
age. 
Recommendation 8: The EC should undertake 
a systematic review of its health system fi-
nance support to identify lessons learned and 
directions for further action 
In view of the EC's (and other donors') generally 
weak record in effectively, sustainably and equita-
bly reforming health system finance and the cru-
cial importance of increasing resources available 
to the health sector, the EC should conduct a 
thematic review specifically devoted to this area, 
in order to identify lessons learned and new stra-
tegic directions. The EU MS, having succeeded in 
delivering reasonably affordable health care in a 
financially sustainable manner in their own coun-
tries, are in a unique position to provide policy 
advice in this central area. The role of the private 
sector – which accounts for more than half of 
health spending in many developing countries – 
should be given more attention than in the past. 
Where out-of-pocket payments remain high de-
spite health system finance reform, causes should 
be identified and shared with partners and stake-
holders. The actuarial sustainability of mandatory 
public health insurance should be analysed in a 
selection of partner countries and income distribu-
tion and poverty consequences of health system 
finance should be assessed. 
Recommendation 9: Regardless of the modali-
ty chosen, EC support to health infrastructure 
should more realistically assess operations 
and maintenance requirements 
While infrastructure and equipment are not and 
should not be EC priorities, in those cases where 
the EC does provide these, it should more careful-
ly assess the operations and maintenance re-
quirements that arise. Whenever the EC is in-
volved in support to infrastructure and equipment 
(e.g. vehicles, medical equipment, cold chain 
technologies) an amount of the pro-
ject/programme budget should be allocated to a 
simple ad hoc maintenance strategy and plan. 
From the effectiveness, efficiency and sustainabil-
ity perspectives, the EC needs to tighten the link 
between facilities and health system finance. The 
EC clearly cannot itself finance operations and 
maintenance. However, through sector support 
and, to the extent possible, GBS, it should support 
the strengthening of ad hoc maintenance strate-
gies following WHO guidelines on performance 
inspections, preventive maintenance and correc-
tive maintenance. Monitoring and data collection 
regarding the state of infrastructure and equip-
ment need to be improved. 
Recommendation 10: Pay greater attention to 
innovative approaches to target remote, iso-
lated and vulnerable population and minorities 
The worst health outcomes are increasingly con-
centrated in remote areas, often populated by 
ethnic minorities and affected by conflict. These 
are difficult areas to work in, incurring high opera-
tional costs. Therefore, the EC should help to 
develop comprehensive strategies at country level 
that are tailored to local circumstances. Where 
needed, the EC should support data gathering 
and mapping exercises in MoHs. In some cases, 
traditional provision of infrastructure and equip-
ment, typically through NGO projects, will be ap-
propriate. In others, supporting government in 
putting in place an HR policy that relieves staff 
shortages will be more effective. In addition, inno-
vative approaches involving mobile telephony and 
community health workers, bush ambulance ser-
vices, medical evacuation, etc. may be more cost 
effective. Improving health system performance in 
remote and disadvantaged regions could be add-
ed to SBS / GBS policy matrices. Moreover, in 
these regions, the EC should consider the role of 
health in other sectors such as rural development, 
roads and water and sanitation. Geographical 
division of labour may be called for in some coun-
tries. 
Recommendation 11: Pay increased attention 
to data needs, particularly in designing sector 
and GBS interventions 
There exists almost everywhere a solid core of 
data regarding key indicators such as mortality 
and vaccination. However, data needed to guide 
government policy, donor policy dialogue and 
resource allocation now include a much wider 
range of issues: e.g. infrastructure, budgets and 
health outcomes and expenditure data disaggre-
gated by income, poverty status, household struc-
ture, sex, age, etc., as well as geographical dis-
aggregation. In the context of its sector support, 
the EC should continue to strengthen data collec-
tion, stressing not only disaggregation, but timeli-
ness, as data five or more years old are of little 
use. This may require co-operation with statistical 
agencies as well as the EC’s traditional MoH part-
ners. 
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1 Introduction 
This final report presents the outcome of the “Thematic evaluation of the European Commission support to 
the health sector”. The evaluation was commissioned by DG DEVCO’s Evaluation Unit5 and was implement-
ed between January 2011 and July 2012.  
1.1 Overall objective and scope of the evaluation 
The EC recognises the health of individuals and populations as one of the major determinants of economic 
growth and social development and acknowledges that ill health is both a cause and effect of poverty. Its 
support to health related sectors is thus an integral part of its development policies and programmes, which 
is consistent with the development efforts of the larger international community.  
Systematic and timely evaluation of its expenditure programmes is an established priority for the EC as a 
mean of accounting for the management of allocated funds and as a way of promoting a lesson-learning 
culture throughout the organisation. To be in line with its priorities, the EC has commissioned the evaluation 
of EC support to the health sector.  
According to the Terms of References (ToR) of this evaluation, the purpose of the evaluation is to assess to 
what extent the EC assistance: 
 has been relevant, effective, efficient and sustainable in providing the expected impacts in the 
health sector; 
 is co-ordinated and complementary with other donors activities, other relevant EC policies, the 
partner governments' priorities and activities and with international legal commitments in health; 
 provides specific EU added-value. 
In answering these questions, the evaluation will mainly inform the implementation of the EC health policy 
and shall give indication of bottlenecks and challenges to be addressed in the future support to the health 
sector and could – as foreseen in the ToR – be used as a baseline for future EC support to the health sector.  
The main objectives of this evaluation thus are: 
 to provide the users of the evaluation with an overall independent assessment of EC’s past and cur-
rent support to the health sector policy development; 
 to identify key lessons and to provide recommendations for policy decision-making and project man-
agement purposes, in order to improve current and future strategies for continued support to the 
health sector policy development in partner countries. 
In terms of temporal scope, the evaluation covers aid implementation over the period 2002-2010. The geo-
graphical scope of the evaluation covers all countries benefitting from EC co-operating support, excluding 
the countries under the mandate of DG Enlargement as well as the activities financed under DG ECHO. 
The evaluation takes into account all aid modalities that are used in the health sector, including sector and 
general budget support as well as funds channelled through multilateral organisations or global initiatives, 
such as GFATM or GAVI. Furthermore, all bilateral health support is taken into account, covering geograph-
ical budget lines (financed by the EDF and the geographical DCI) and all relevant thematic budget lines.  
The evaluation focuses on health policy development and the choice was made to explicitly exclude EC 
support to poverty related diseases (PRDs), namely Malaria, Tuberculosis and HIV/AIDS from the scope 
of this evaluation. This choice is grounded on the need to keep the evaluation focused in order to be able to 
achieve meaningful results, taking into account time and resource constraints. 
1.2 Structure of the final report 
Volume 1 of the Final Report is structured as follows: 
 Chapter 1 - Introduction: this chapter presents a brief overview of the evaluation purpose and scope, 
as well as background and context information. 
 Chapter 2 - Methodology: this chapter includes the final EQs and details the methodological ap-
proach, the tools and the sources of information used during the evaluation. 
                                                     
5
 Former Joint Evaluation Unit common to Directorates General of External Relations (RELEX), of Development (DEV) 
and the EuropeAid Co-operation Office. 
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 Chapter 3 - Background: this chapter presents a brief overview of the international and EC back-
ground on the development aid to the health sector. 
 Chapter 4 - Inventory: this chapter presents a short résumé of EC financial contribution to the health 
sector between 2002 and 2010. 
 Chapter 5 - Answers to the Evaluation Questions: this chapter presents, for each of the seven Eval-
uation Questions, a summary box and the detailed answer. 
 Chapter 6 - Conclusions and recommendations: this chapter presents a full set of conclusions and 
recommendations (clustered in groups). 
2 Methodology 
2.1 Key steps of the evaluation process  
The methodology applied for this evaluation is based on the methodological guidelines developed by the DG 
DEVCO Evaluation Unit. The guidelines give precise indication on the design of the study, the structure the 
evaluation process in its different phases and provide an array of tools that can be used for evaluations.6 
The evaluation has been conducted in three main phases, as summarised in the figure below. It was man-
aged and supervised by the Evaluation Unit of DG DEVCO. Evaluation progress was closely followed by a 
Reference Group (RG) chaired by the Evaluation Unit and consisting of members of different DGs, in particu-
lar DG DEVCO and EEAS. The figure also lists the main tasks in each phase7, the RG meetings held and the 
deliverables for each phase. In line with the ToR, each phase has started after formal approval of the deliv-
erables of the previous phase by the Evaluation Unit. 
Figure 1: Evaluation process 
 
The evaluation process adopted a systematic approach that uses different building blocks to gradually con-
struct an answer to the Evaluation Questions (EQs) and to formulate conclusions and recommendations. The 
various phases and subsequent “stages” coincide with the different methodological steps undertaken within 
the framework of the evaluation and are described more in detail in the next paragraphs. 
                                                     
6
 General information on these guidelines can be found online at:  
http://ec.europa.eu/europeaid/how/evaluation/methodology/index_en.htm 
7
 The lists include some major tasks carried out in each phase, but they are not meant to be exhaustive. 
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It should be noted that this evaluation is a re-launch of an evaluation of EC support to the health sector, car-
ried out in 2008-2009. The final report of this former evaluation was rejected and it was decided to re-launch 
the evaluation, however with a reduced budget and excluding field visits.  
To avoid confusion, it is also important to note that the present re-launched evaluation had a different and 
narrowed-down scope, excluding in particular the discussion on PRDs. Moreover, it is based on completely 
new evaluation design which has been used to collect and analysis data. However, findings from the former 
evaluation have been included in the present evaluation report, whenever fitting in the new evaluation de-
sign. 
The methodology and tools used in each of the three phases as well as further details regarding the 
challenges can be found in Annex 22.  
2.1.1 Inception phase 
At the beginning of the evaluation it was essential to have a clear understanding and overview of the object 
of the evaluation, by producing an inventory and typology of EC support to the health sector falling within the 
scope of the evaluation (for more details on the inventory, see Annex 1 – Volume IIb). Moreover, the inter-
vention logic (see figure 3) underlying the rationale of EC support to the health sector was reconstructed. 
Once these two overviews were available, the team built the methodological framework for the entire exer-
cise during the inception stage.  
The evaluation is structured around seven evaluation questions (see Table 5) so as to shed light on some 
critical points of the intervention logic and provide more concrete content to the evaluation criteria and key 
issues. The EQs therefore cover the different evaluation criteria, including the five DAC criteria and EC spe-
cific criteria, such as ‘added value and ‘3Cs’.  
With a view to facilitate data collection as well as the responses to these questions at a later stage, each 
question has been further structured (evaluation matrix). To this end, appropriate Judgement Criteria (JC) 
and related indicators were defined. Furthermore, potential information sources were identified for each indi-
cator, as well as appropriate methods and techniques for collecting and analysing the information. Given the 
purpose and conditions of the evaluation, the most appropriate design for the evaluation was a multiple 
case study with literal replication based on the use of a mixed-methods approach.  
A sample of 25 countries was selected on which the in-depth data collection would be focused on. These 
countries should be regarded as representing and reflecting the broad range of EC support to health. The 
selection criteria used and final country selection can be found in Annex 24 which also provides an overview 
of priority interventions per country. Acknowledging that 38% of the total funds are going to regions or multi-
ple countries, the evaluation team addressed this characteristic of EC support through three thematic case 
studies (see Annex 17, 18, 19).  
2.1.2 Collecting Data (Desk study phase) 
On the basis of the established methodological framework, data collection could take place. It must be not-
ed that no field phase was foreseen for this evaluation. The report is based on an extensive and systematic 
documentary review, web-surveys, interviews and phone interviews with selected stakeholders (EC head-
quarter staff, person in charge of health in EUDs, Ministries of health and lead donors in the countries). 
The combination of data collection methods and techniques varies according to the different JCs. As a 
principle, data collected through different means was cross-checked. Moreover, where possible, the evalua-
tion team combined the use of qualitative and quantitative data and relied both on primary and secondary 
data sources while taking into account resources and time constraints. The overview of tools used during the 
evaluation is provided in Annex 22. 
However, as no field phase could be implemented only a limited amount of primary data could be gathered, 
e.g. through online surveys and various forms of interviews. The evaluation team checked that the final set of 
methods and techniques consisted in a sufficiently wide mix to ensure a high level of data reliability and va-
lidity of conclusions.  
2.1.3 Synthesis phase 
The synthesis phase was devoted to further fill gaps detected during the desk study phase, to validate pre-
liminary findings to the evaluation questions and formulating conclusions and recommendations on the 
basis of the data collected throughout the process. In order to do so, the evaluation team focused on select-
ed key issues and specific topics to study in detail through targeted further literature review and phone inter-
views with EUDs, MoHs and donors. 
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The combination of answers to the different EQs (see Chapter 5) in the main report allowed the team to for-
mulate more general judgements in the form of Conclusions (see Chapter 6.1) and, on that basis, to propose 
a set of Recommendations (see Chapter 6.2). This approach allowed for a clear linkage between EQs (find-
ings), conclusions and recommendations. 
2.1.4 Dissemination seminar, 
The final step will consist of a dissemination seminar, which gathers stakeholders and the interested public 
to discuss the evaluation results, conclusions and recommendations. 
2.2 Challenges and limitations 
2.2.1 Overall challenge of a strategy level evaluation 
A strategy-level evaluation of this kind is a challenge per se. It goes beyond a mere summation of evalua-
tions of multiple operations and tackles many high-level issues. It also covers different dimensions and areas 
of support, periods and countries and simultaneously focuses on individual interventions. This challenge has 
been tackled mainly through the specific structured methodological approach, based primarily on the defini-
tion of Evaluation Questions, Judgement Criteria and Indicators and the choice of countries and interventions 
for the data collection phase. 
2.2.2 Availability of primary sources 
This evaluation is unique because it is the follow-up to a rejected evaluation exercise. The approach of the 
team has been to start from scratch with a new inventory and set of EQs, Judgement Criteria and Indicators 
in order to avoid past mistakes. The existence of the previous evaluation provided both opportunities and 
constraints. As a direct consequence of the former exercise, the current Terms of Reference do not foresee 
any field visits. This fact automatically led to reduced availability of relevant primary information from the 
programme level and from national stakeholders. The team has strived to counterbalance this gap, by using 
tools such as the online survey to EUDs and MoHs or telephone interviews, which allow retrieving infor-
mation from the stakeholders at national level.  
The response rate of EUDs to the online survey was very high with all of the 25 targeted EUDs responding at 
least partially8 to the survey. They also showed considerable and highly appreciated willingness to collabo-
rate and to provide supplementary information or explanation where needed. Furthermore, all 12 EUDs 
commented the in-depth country case studies and provided supplementary documentation not accessible to 
the evaluation team before.  
The MoH survey did not yield the same high response rate as the EUD survey, with only eight MoH answer-
ing the questionnaire, out of 19 MoHs that were targeted.9 Due to this rather low response rate, information 
provided was used to complement and cross-check qualitative information collected from other sources, as 
the sample was too small for quantitative analysis. 
Unfortunately, as the scope of the evaluation has changed considerably from the scope of the former evalua-
tion, the information from the field visit reports of the previous exercise could only be used to a very limited 
extent in this evaluation.  
The phone interviews with selected EUDs, MoH and donors proved to be a rich source of information, espe-
cially to validate findings and highlight the specific focus of an in-country situation, a problem or a best prac-
tice. 18 persons have been interviewed by phone in eight countries. The list of people interviewed can be 
found in Annex 30. 
                                                     
8
 Due to the specific country situation and a low involvement of the EUD in the health sector, the EUDs of Tanzania and 
Ghana only completed certain parts of the survey, mainly related to financing modalities and co-ordination of donors.  
9
 The reason for not targeting all 25 MoH of the desk sample was that 1) EUDs did not recommend asking the MoH for a 
contribution; 2) no contact person was provided by the EUDs.  
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2.2.3 Heterogeneity of secondary data  
The data collection phase had the aim to screen the existing literature in order to answer the evaluation 
questions. The literature was mainly provided through the following sources: 
 Generally available statistics, such as from the Worldbank, the WHO databases; UN MDG Indicators 
database; 
 EC documentation from the European Commission’s Common RELEX Information System (CRIS) 
database; 
 EC documentation provided by the EUDs; 
 Literature from the web, including other donors and from the libraries of the individual team mem-
bers. 
To a considerable extent, the analysis of EC project documentation had to rely on documentation provided in 
the EC CRIS database. As the amount and types of documentation uploaded are under the responsibility of 
EC HQ and Delegation staff, the information retrieved by the team varies considerably from programme to 
programme and between countries. The feedback from the EUDs on the draft case studies also included 
new documentation, which was incorporated in the revised the country case studies, together with the com-
ments of the EUDs (see Annexes 5 to 16). A detailed list of available documentation per intervention can be 
found in the annex of each country case study.  
2.2.4 Building an inventory of EC support to the health sector 
Challenges and limits relating to the inventory are presented in detail in Volume IIb - Annex 2.  
One of the key challenges that had to be tackled in constructing the inventory and typology for this evalua-
tion is common to all mapping exercises for thematic evaluations and relates to the information source on 
which they are based. It is recognised and explicitly stated in the Terms of Reference and Launch Note for 
this evaluation that CRIS is deficient in a number of regards, in particular the non-systematic classification of 
interventions. In order to retrieve the interventions belonging to a specific sector a fuzzier, more subjective 
and more innovative approach, including tedious line-by-line review of interventions, s, was required to elab-
orate a comprehensive inventory of EC support to the health sector. The detailed methodology used is out-
lined in Annex 2. 
2.2.5 Assessment of EC contribution 
The scope of the evaluation includes health policies and their translation into results/impacts. Therefore, 
many indicators specifically investigated in the course of this evaluation refer to achievements at a global 
level. It also looked at specific country achievements, progress made and constraints encountered, through 
specific case studies at country level. At the country level, as well, it is difficult to isolate the EC impact in a 
multi-donor environment. None of the identifiable dynamics and effects at country level is solely dependent 
on EC contributions, but results of an interplay of various stakeholders and contextual factors. This makes it 
rather difficult to correlate a specific contribution of the EC directly to the current situation in the health 
sector in a given country, or at the regional or global level.  
The use of some aid modalities, especially GBS, adds to the complexity of assessing EC contributions. 
While there are often health-related indicators in governing agreements, approaches in terms of how to as-
sess this modality at a general level are still subject to discussions.  
In order to better assess possible EC contribution
10
 to progress related to a huge number of indicators, de-
pending on the EQ, a specific focus has been placed on: 
 Gathering information on output and impact indicators; 
 Completing quantitative data with qualitative assessments on the role played by the EC; 
 Cross-checking the information being gathered through different tools and from different actors. 
                                                     
10
 Keeping in mind the limitations of such an exercise concerning thematic evaluations and especially assessing effects 
and impact due to variety of donors, regional and national situations and availability of information. 
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3 Background and context of EC support to the health sector 
3.1 Current international development co-operation and health sector framework 
3.1.1 Development Co-operation context 
Aid effectiveness and MDG contracts 
After a lot of criticism from inside and outside, the international development aid system has witnessed a 
number of initiatives and changes, with the aim of increasing the effectiveness of aid. In terms of policy 
commitments, the international efforts to increase and assure financial support while at the same time im-
proving aid-effectiveness have led to different declarations, starting with the Monterrey accord in 2002, fol-
lowed by the declarations of Rome (2003), Paris (2005), Accra (2008) and Busan (2011). All these subse-
quent declarations aimed at enforcing the principles of ownership, harmonisation, alignment, results-based 
management and mutual accountability in development partnership in the aid delivery system.  
On a European level, the principle of harmonisation with other development partners is, highlighted in the 
2005 European Consensus on Development. The EU has recognised the challenges of, yet also opportuni-
ties for, harmonisation with (and between) Member States at policy and country operational levels by improv-
ing donor co-ordination practices. The development of protocols around the 3Cs (Co-ordination, Coherence 
and Complementarity) as principles for the development activities of the EU and Member States reflects this.  
Since 2000, the EC has become a proponent and leading actor in joint approaches towards increasing re-
sources and improving the processes to deliver development assistance, which has accelerated over recent 
years. In this sense, it has strongly committed itself to sector or general budget support as the financial mo-
dality that augurs best for country ownership, alignment with country priorities and accountability, reduce 
transaction costs and to improve harmonisation and coherence with other partners as well as reinforce the 
predictability of aid. With the MDG Contract, introduced in 2008 in ACP countries11, the EC intended to pro-
vide more long-term and predictable support.  
In many countries, the health sector has been at the forefront of these initiatives as well as a testing ground 
due to its specific characteristics, namely to be a service delivery sector with a huge budget and complex 
dependencies and in which there is usually many interested development partners, often with a tradition of 
fragmented support and strong donor suspicion of crowding out and/or lack of additionality.  
Poverty reduction strategies (PRS) 
The PRS initiative, introduced in World Bank (WB) and International Monetary Fund (IMF) operations in 
1999, has become a key element in the international development aid architecture.12 It requires a compre-
hensive country-based strategy for poverty reduction, the Poverty Reduction Strategy Paper (PRSP). These 
strategies should be genuinely country-owned and reflect the outcome of an open participatory process in-
volving governments, civil society and relevant international institutions and donors. PRS seeks to link and 
bridge national public actions and external support with development outcomes in order to meet the devel-
opment goals, such as the MDGs. PRSPs, as the reflexion of the partner country’s policy priorities are and 
will further be a major point of reference for EC co-operation with its partner countries, as highlighted in the 
2011 Communication Global Europe: A New Approach to financing EU external action13. Health is usually an 
element covered by a PRSP, especially in least developed countries. 
                                                     
11
 “The MDG Contract – An approach for longer-term and more predictable General Budget Support” (2008) 
12
 http://go.worldbank.org/OA7M2IKHL0. 
13
 COM(2011)865: Joint Communication to the European Parliament and the Council. Global Europe: A New Approach 
to financing EU external action.  
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3.1.2 International health commitments and initiatives 
Millennium Development Goals Initiative (MDGs) 
Adopted by world leaders in the year 2000 and set to be achieved by 2015, the MDGs provide concrete, 
numerical benchmarks for tackling extreme poverty in its many dimensions. They have set the policy priority 
for most donors and partner countries. The health related MDGs are: 
 MDG 4: Reduce Child Mortality 
 MDG 5: Improve Maternal Health 
 MDG 6: Combat HIV/AIDS, malaria and other diseases 
 MDG 8: Develop a global partnership for development, Target 8e: ‘In co-operation with pharmaceuti-
cal companies, provide access to affordable essential drugs in developing countries’ 
Both early and more recent reviews have concluded that the health MDGs are among those where there has 
been the least progress, in particular in Sub-Saharan Africa. Based on current trends, most human develop-
ment MDGs – especially for child and maternal mortality, but also for primary school completion, nutrition 
and sanitation – are unlikely to be met at the global level.  
Lacklustre progress on the health MDGs is closely related to the aid effectiveness issue. It is in this context 
that questions about the effectiveness of health spending and the integrity of the aid architecture in health 
have arisen.14 In addition to issues common to all sectors, such as aid predictability and the need for monitor-
ing, aid in the health sector is characterised by some specific problems. One is insufficient funding of holistic 
policy approaches; another is the fact that health is characterised by a multitude of stakeholders and inter-
ested agencies, raising the difficulty of adequate co-ordination. The multiplication of disease-specific initia-
tives has proven to be a double-edged sword as, for example, the increase in the share of health aid devoted 
to HIV/AIDS was accompanied by a decline in the share devoted to primary health. 
Major global initiatives 
The last decade has seen the growth and emergence of a number of major initiatives in the area of global 
health. Among these are (to quote only a selection, which will also be further analysed in the evaluation 
 GFATM - The Global Fund to Fight AIDS, Tuberculosis and Malaria, 
 GAVI – The Global Alliance for Vaccines and Immunisation, 
 The Global Polio Eradication Initiative, 
 International Heath Partnership HIP+. 
The next chapter describes more in detail how these international developments have contributed to shaping 
the EC support to the health sector. 
3.2 EC strategy and support to the health sector over the period 2002-2010 
This chapter sets out the main elements of EC policy related to health in communications, as spelled out in 
overarching policy documents that are of relevance for support to health in all partner countries. The EC 
policy statements in the heath sector are closely linked to the developments (global discussion on develop-
ment co-operation as well as sector specific developments) that have been briefly discussed above. The 
following figure gives an overview on the main strategic events in the evaluation period. 
                                                     
14
 Dodd, Rebecca, George Schieber Andrew Cassels, Lisa Fleisher and Pablo Gottret. 200z. Aid Effectiveness and 
Health. Geneva: Making Health Systems Work: Working Paper No.9, WHO/HSS/healthsystems/2007.2, World Health 
Organisation. 
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Figure 2:  Synthetic timeline of most important events/strategies at global and EC level  
 
Legend: Aid effectiveness conferences 
Annex 28 provides further information about some regional specificities relevant for supporting the health 
section, e.g. in the ACP countries; Annex 29 focuses on further details related to the consideration of cross-
cutting issues in EC policies related to supporting the health sector in partner countries.  
3.2.1 Overview on major EC policy statements in the health sector 
EU Communications and other policy pronouncements confirm that co-operation policy in health has reso-
nated both with the changing international co-operation framework and the global health and development 
landscape, sketched above. During the evaluation period of concern, the EC priorities for the health sector 
were defined through specific references that have successively focused on the links between health and 
poverty and between health and development; population issues; social protection; and financial and tech-
nical co-operation instruments.  
Landmark documents include:  
 Communication on “Health and Poverty Reduction in Developing Countries”, COM (2002)129; 
 Communication on “A European Program for Action to tackle the critical shortage of health workers in 
developing countries (2007-2013)”, (COM(2006)870; 
 Communication on “Thematic programmes for human and social development and the financial per-
spective”, COM(2006)18; 
 Communication on “The EU Role in Global Health”, COM (2010) 128. 
Furthermore, different communications related to poverty related diseases have been published15 and a sig-
nificant share of EC's external policy efforts in the area of health are concentrated on the fight against major 
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 The main communications are (list not exhaustive):  
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PRDs, HIV/AIDS, malaria and tuberculosis. However, as PRDs have been excluded from the scope of the 
evaluation, these communications have not been further analysed.  
The most relevant communications are described in more details in the next paragraphs. The evaluation 
team has given a special attention to the 2002 and 2010 Communications, as those more or less frame the 
evaluation period and as such the first served as baseline and policy framework against which EC action 
would be evaluated.  
Communication on Health and Poverty (COM 129 2002) 
The basis for all work in health over the evaluation period was the Communication from the Commission on 
Health and Poverty Reduction (COM 129 2002), which dealt with the new challenges for development and 
declared that “improving the health of the poor is both a vital contribution to efforts to reduce poverty and a 
moral imperative.” This communication established an EC policy framework to guide investment in health, 
AIDS and population for attaining the health MDGs. The framework had four strands:  
 To improve health, AIDS and population outcomes at country level, especially among the poorest 
countries; 
 To maximise health benefits and minimise the potential negative health effects of EC support for oth-
er sectors; 
 To protect the most vulnerable from poverty through support for equitable and fair health financing 
mechanisms; 
 To invest in the development of specific global public goods. 
Particular challenges identified were the implementation of pro-poor health policies, making health systems 
more equitable, assuring an environment compatible with a high standard of human health, expanding social 
protection, the operationalisation of new public/private partnerships for health, the need for greater invest-
ment in specific global public goods and the monitoring of performance, results and outcomes. 
Although there are no specific other communications explicitly addressing health and poverty, many of the 
other communications have included poverty reduction strategies on their agenda in order to tackle problems 
such as health workforce shortages and brain drain, poverty-related diseases and health systems finance in 
developing countries. 
Communication on health workers in developing countries (COM(2006) 870 final) 
On May 15 2006, the EU Council adopted the A European Program for Action to tackle the critical shortage 
of health workers in developing countries (2007-2013) (COM(2006) 870 final). This action programme con-
sisted of a package of action-oriented decisions which included 1) the incorporation of human resources 
issues into PRSs and health policy discussions and 2) the support and financing of national human re-
sources plans. The Council also adopted an EU Consensus Statement on the Crisis in Human Resources for 
Health, stating that: “Europe is committed to supporting international action to address the global shortage of 
health workers and the crisis in human resources for health in developing countries”:  
 At country level, emphasis was put on several issues, namely: policy dialogue and policy planning; 
capacity building, including human resources management training; developing south-south and 
north-south learning communities; linking programmes between professional bodies and regulatory 
agencies; and the support of research on this topic.  
 On a regional level, the EC committed itself to support the mapping, analysis and the technical and 
political dialogue on human resources necessary for effective advocacy and action.  
 At the global level, the internal EU action sought to develop a set of principles to guide recruitment of 
health workers within the EU and recruitment from third countries; develop guidelines and mecha-
nism for supporting ‘circular migration’ of health workers; and explore the feasibility of supporting 
partnerships between medical institutions in the EU and in the developing world, beside others. 
                                                                                                                                                                                
COM(2001) 612: Concerning the European Community contribution to the Global Fund to fight HIV/AIDS, Tuberculosis 
and Malaria 
COM(2003) 93: Update on the EC Programme for Action - Accelerated action on HIV/AIDS, malaria and tuberculosis in 
the context of poverty reduction - Outstanding policy issues and future challenges; COM (2004) 726: A Coherent Euro-
pean Policy Framework for External Action to Confront HIV/AIDS, Malaria and Tuberculosis; 
COM(2005) 179 final: European Program for Action to Confront HIV/AIDS, Malaria and Tuberculosis through External 
Action. 
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Communication “Investing in People” (COM(2006) 18) 
The communication on Investing in People (COM(2006) 18) focuses on six core themes. (1) good health for 
all, (2) knowledge and skills, (3) culture, (4) employment and social cohesion, (5) gender equality and (6) 
children and youth. It drew attention to the critical lack of personnel in many developing countries' health 
care systems and to the leading poverty-related diseases HIV/AIDS, malaria and tuberculosis. 56% of the 
budget of Investing in People goes to the pillar Good health for all, with a focus on the two afore mentioned 
topics as well as to neglected or emerging diseases and the promotion sexual and reproductive health and 
rights. In order to ensure access to health care for all, the programme sets out to: a) mobilise global public 
goods to combat and prevent diseases; b) support innovative health measures; c) improve the regulatory 
framework; d) increase political and public awareness and education; e) improve technical resources. 
Communication “The EU Role in Global Health” (COM(2010) 128) 
In the communication on The EU Role in Global Health of 2010 (COM(2010) 128), the EC emphasises again 
the need for a key position of health within the MDG framework. Taking into account the central role of 
health, a specific attention needs to be paid to multi-sectoral thinking and approaches, as health risks in de-
veloping countries are also depended on achievement of targets, not primarily health-related, such as the 
MDGs on nutrition (MDG 1), on gender equality (MDG 3), on environmental sustainability, including access 
to safe water and sanitation (MDG 7) and on the co-operation with the pharmaceutical industry concerning 
the provision of essential drugs (MDG 8). Five years before the targets of the MDGs are to be achieved, the 
EC recognised that many challenges had to be faced to reach these targets in a world of globalisation and 
global economic crisis. According to the Communication on Global Health, especially four challenges needs 
a specific attention. These are:  
 Global governance on health: The EU should defend a single position within UN agencies and work 
to reduce the multiplicity of health projects. 
 The challenge of universal coverage: The EU should ensure that development aid supports develop-
ing countries’ efforts to build sustainable health systems and should promote division of labour among 
all actors, public and private, bringing knowledge and funding to the health sector. 
 The challenge of policy coherence between EU internal and external policies: The EU will combine its 
leading role in trade and development to create a coherent approach to global health, including also 
issues such as migration, security, food security and climate change. 
 The challenge of global health knowledge: The EU will strive to ensure that research and innovation 
produce accessible and affordable products and services and that no diseases are neglected. 
Further, the communication recommended that the EC should: 
 concentrate its aid to serve the most fragile populations and countries; 
 strengthen the effectiveness and equity of health systems, as well as its functioning in terms of work-
force, access to medicines, infrastructure, logistics and decentralised management; 
 have recourse to global initiatives and existing international financial institutions, but also to innova-
tive funding sources and mechanisms. 
The Communication on Global Health is followed by three Commission staff working documents that draft 
response strategies for specific issues. 
The first staff working document, entitled Global health - responding to the challenges of globalisation16 out-
lines the seven pillars of the EU global health policy and strategy: coherence in development; promotion of 
Fundamental Rights and Public Goods; research and knowledge management; co-operation, co-ordination 
and export of experience and knowledge; foreign policy and governance; security; and Response to Globali-
sation (Market/Services).  
The second staff document with the title “European research and knowledge for global health”17 recognises 
medical knowledge as a global public good for health and focus strongly on supporting the research neces-
sary to achieve the health-related millennium development goals. Specific research foci are: Specific Interna-
tional Co-operation Actions (SICAs); international public health and health systems; HIV/AIDS, malaria, tu-
                                                     
16
 SEC(2010)380: Global health – responding to the challenges of globalization, accompanying document to the Com-
munication COM(2010)128 on the EU Role in Global Health. 
17
 SEC(2010) 381: European research and knowledge for global health; accompanying document to the Communication 
COM(2010)128 on the EU Role in Global Health. 
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berculosis; neglected infectious diseases; the European and Developing Countries Clinical Trials Partnership 
(EDCTP); and the Innovative Medicines Initiative.  
The third staff working document “Contributing to universal coverage of health services through developing 
policy”18 emphasised again the central role of health for poverty reduction and sustainable development. In 
particular, this communication calls for a better distribution of health aid across countries and health services, 
increased country ownership and better linking between poverty and health. 
3.2.2 Intervention logic of the EC support to the health sector for the period 2002-2010 
Based on analysis of the above policy documents, the intervention logic (IL) of the EC support to health has 
been reconstructed by the evaluation team; it is represented graphically in the impact diagram in Figure 3. 
It summarises, across five columns, the hierarchy of objectives, starting from clusters of expected outputs of 
the EC financed activities in the health sector and leading to the results and impacts that those activities 
should have on human health, health systems and health policy development as well on national, regional 
and international level and which should eventually lead to the global impact of enhanced development and 
poverty reduction. 
Further to the vertical reading, four horizontal strands, related to different EC policy, have been identified by 
the evaluation team. 
Strand 1: Institutional, policy and governance strengthening 
The EC had identified a strong need to improve policy making and governance and to strengthen public 
health institutions, notably Ministries of Health of aid-recipient countries. Better decision making, translating 
into improved resource allocation, was needed to ensure that drugs, vaccines and treatments were available 
and affordable. 
In this strand, the EC put emphasis on health care finance reform, improvement of health information sys-
tems, regulatory reform and general institution strengthening as key outputs of this cluster. The strand was 
grounded on the EC Communication “Health and Poverty Reduction in Developing Countries”19 which priori-
tised pro-poor health financing instruments, developing better indicators of health system performance and 
the need to include human resource strengthening as a metric of health system performance and budget 
support financing. The Communication ‘The EU Role in Global Health’20 re-iterated the role of health care 
finance, this time in the form of a call for improved social protection and universal coverage.  
Strand 2: Infrastructure, human resources and pharmaceuticals / equipment  
Since the oil crisis of the 1970s, multiple causes have led to resource crises in the heath sectors of poor 
countries and resulting in, what is called, the “implosion”. Fiscal pressures caused health ministries to forget 
needed investment causing the deterioration of physical infrastructure and resulting in outdated equipment. 
The growing need in developed countries for health care workers, gave rise to brain drain. Development co-
operation in health, as well as the explosion of HIV/AIDS programmes, attracted skilled health professionals 
into donor programmes, to the detriment of public health programmes. Trade-related aspects of intellectual 
property rights (TRIPS) requirements limited the ability of poor countries to produce generic drug equivalents 
and led to the poor being forced to pay higher prices, while continuing progress in pharmaceutical research 
produced entire new classes of pharmaceuticals that poor countries could not afford.  
Improved resourcing of the health system should result in improved health coverage, in particular including 
the poor living in remote areas. Coverage has to do with “availability” and in turn corresponds to the supply 
side. At the same time, the availability of good, accessible, affordable infrastructure, well endowed with hu-
man resources, equipment and needed drugs, will elicit more utilisation, i.e. the demand side. The EC ad-
dressed these topics in different, specific communications, e.g. in several Communications on health work-
ers21 or in the Communication related to the availability of key pharmaceuticals22. 
                                                     
18
 SEC(2010)382: Contributing to universal coverage of health services through developing policy, accompanying docu-
ment to the Communication COM(2010)128 on the EU Role in Global Health. 
19
 COM(2002) 129 (p.12) 
20
 COM(2010) 128 (p.4,5) 
21
 COM(2006) 870 
22
 COM(2000) 585 (p.19) “Accelerated action targeted at major communicable diseases within the context of poverty 
reduction” and COM (2001) 96 “Programme for Action: Accelerated action on HIV/AIDS, malaria and tuberculosis in the 
context of poverty reduction”. 
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Strand 3: Health behaviour 
The ‘health production approach’23, claims that health results are not only linked to the input of public health 
interventions, but are also influenced by a broad range of individual health behaviours linked in complex 
fashion to income, social relations, culture and values. Through support for Advocacy, Communication and 
Social Mobilisation (ACSM), EC has attempted to raise health awareness, leading not only directly to in-
creased health service utilisation but to improved health behaviours. ACSM is therefore a critical feature in 
HSS especially in disease control efforts but can also help mobilise communities and individual towards early 
health-seeking behaviour and treatment adherence. ACSM has gained momentum in recent years as the 
collaboration and interaction between the public sector and private health sector has risen and become more 
efficient and effective. Behavioural aspects are especially important in the complex nexus of gender, culture 
and sexual and reproductive health including MNCH, as recognised in the EC COM(2005) 17924. 
Strand 4: Regional and global added value 
The increased attention to public good aspects of health was another major trend in the years under consid-
eration, reasons being the globalisation of infectious disease and the increased pace in the emerging of new 
infectious diseases. The “Global Public Good” concept, covering notably health R&D and infectious disease 
control, is now accepted as a major rationale underpinning development aid in the area of health. The EC is 
traditionally a big supporter of global research (e.g. support to GAVI or the EC Framework Research Pro-
grammes). It is furthermore recognised as a high value-added partner, due to its experience with and promo-
tion of regional integration, an approach leading naturally to increased connectivity.  
In this strand, the EC aimed at focusing particularly on actions that increased global knowledge for health 
and developed new means of addressing communicable and emerging diseases. The EC commitments to 
these topics were found in several communications, such as the Communication “Accelerated action on 
HIV/AIDS, malaria and Tuberculosis (TB) in the context of poverty reduction” that called for a global action 
on affordability and investment in the development of public goods. 25 One of the four objectives of the Com-
munication “Health and Poverty” was “to invest in the development of specific global public goods” 26 and the 
Communication further highlighted the need to invest and to finance development and research The Com-
munication Investing in People27 reinforced the need for development and improvement of the availability of 
and equal access to global public goods.  
The following figure illustrates the different strands and the linkages between the different level of results and 
impacts. Furthermore, the impact diagram shows on which levels the Evaluation Questions are grounded. 
 
                                                     
23
 The World Bank (1993) World Development Report “Investing in Health”. 
24 COM(2005) 179 “A European Programme for Action to Confront HIV/AIDS, Malaria and Tuberculosis through External 
Action (2007-2011)” called for support to national authorities in collecting disaggregated data related to the three poverty-
related diseases through behavioural surveillance surveys (para.15) and supported social-behavioural research (para. 
28).  
25
 COM (2001) 96 “Programme for Action: Accelerated action on HIV/AIDS, malaria and tuberculosis in the context of 
poverty reduction, p.7. 
26
 COM(2002) 129 : “Health and Poverty Reduction in Developing Countries”, pp.2, 11, 12 and 15. 
27
 COM(2006) 18 “Investing in people”. 
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Figure 3: Impact diagram: Reconstructed intervention logic of the EC support to the health sector (2002-2010)  
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4 Inventory: Overview on EC resources to support health 
The inventory of the EC’s support to the health sector provides an overview of interventions financed 
by the EC in the countries covered by the evaluation during the period 2002 to 2010. The analysis of 
the captured interventions gives a grasp of the funding, in terms of temporal evolution of funds com-
mitted and disbursed, financial instruments applied, sectors, channels and aid modalities used, as well 
as the regional and country breakdown of EC support.  
The inventory is based on data from the EC’s CRIS database. The data was extracted in February 
2011 and processed to obtain the best possible overview of the EC’s support to the health sector dur-
ing the evaluation period. A number of challenges were faced by the evaluation team in compiling this 
data due to inherent limitations of the CRIS database. A specific and systematic methodology was 
therefore developed in order to ensure that all relevant interventions within the scope of this evaluation 
were identified. This methodology as well as the detailed results are presented in Annex 2.  
4.1 EC support to health between 2002 and 2010: Global overview  
EC supported the health sector through two different means: the first was what the evaluation team 
called “direct support”, which includes all types of interventions that are clearly earmarked to the 
health sector; the second type of support referred to General Budget Support, which was labelled as 
“indirect support”, as funds could not clearly and solely be attributed to the health sector. 
Figure 4:  Global overview of EC financial commitments to the health sector, 2002-2010 
 
*(1) GBS which refers to the health sectors among other sectors, through performance indicators or objectives 
stated in the Financing Agreements (FA). Taking into account the nature of GBS as un-earmarked funds, no 
statement can be made on the share of the 5 € billion that went effectively to the health sector. See for more detail 
Chapter 4.3 and Annex 2 
*(2) SSP: As defined by the EC under the sector approach but excluding SBS – “includes the modalities EC pro-
curement and grant award procedures” “Common Pool Funds” and “National Trust Funds” 
Source: CRIS and Particip GmbH analysis 
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The box below gives a brief overview of the key findings of the inventory. The following chapters pro-
vide further details. 
Box 1:  Key findings of the inventory  
Direct support 
Indirect support (GBS referring to the 
health sector) 
 The EC’s direct support to the health sector amounted to 
around EUR 4.1 billion during the period 2002-2010; 
 This EUR 4.1 billion represented 6% of the total support to all 
sectors over the same period; 
 Direct support shows a serrated pattern, but with a trend 
towards increase (from levels of EUR 128 million in 2002 to 
EUR 805 million in 2006 and EUR 414 million in 2010); 
 Basic health was the sub-sector supported most, receiving 
73% of the funds, of which 43% concern the delivery of basic 
health care and infrastructure and 27% the fight against the 
three PRDs. The second focus was on Health general (22%), 
out of which 70% concern the sub-sector policy and 
administrative management. Sexual and reproductive Health 
(SRH) received less attention, representing only 5% of the total 
funds; 
 The main beneficiary regions in absolute terms for direct 
support were the ACP states (46%), followed by Asia (18%) 
and European Neighbourhood Policy-South (ENP-South – 
13%); 
 The financing of individual projects (45%), followed by SBS 
(16%), were the main modalities used by the EC to deliver 
direct support to the health sector. Other modalities used were: 
support to sector programmes excluding SBS (18%)
28 
and the 
financing of Global Trust Funds such as the GFATM (21%). 
 The trend towards an increased use of SBS can clearly be 
seen during the evaluation period (from almost no funds at the 
beginning to EUR 180 million in 2010). In parallel, a decline in 
the use of the project modality can be noted.  
 The EC’s indirect support referring to the 
health sector (i.e. GBS with health 
related indicators) amounted to around 
EUR 5 billion over the period 2002-
2010. It is not possible to estimate how 
much of this was actually assigned to 
health; 
 This support represents 72% of the 
total GBS funds transferred to partner 
countries during the evaluation period; 
 The support concerned a total of 45 
countries, out of which 39 are located in 
the ACP region, four in Latin America, 
two in Asia, but none in the ENP region; 
 The six main beneficiary countries 
accounted for more than 50% of the 
GBS referring to health, among other 
sectors. 
4.2 Direct support to the health sector 
Although the evolution over the whole period shows considerable year-to-year variation, there is a 
global upward trend of amounts contracted for direct support to the health sector. Between 2002 and 
2010 the amounts evolved from EUR 128 million to EUR 414 million for the health sector. This reflects 
the EC commitment to provide increase health aid, such as reflected in the 2002 “Communication on 
health and poverty”.  
                                                     
28
 This is not an official category of EC aid delivery methods, but, as a clear categorisation of SPSPs was lacking 
in the CRIS database, the evaluation team used it as category for the analysis. See the methodology chapter of 
the inventory in Annex 2 for further details. 
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Figure 5:  Direct EC support to the health sector: Trend in the amount contracted between 2002 
and 2010 (EUR million) for the health sector 
 
Source: CRIS and Particip GmbH analysis 
4.2.1 Sector breakdown 
Based on the sector and sub-sector classification of the Organisation for Economic Co-operation and 
Development (OECD)-DAC, the interventions were classified in three main sectors: health general; 
basic health; sexual and reproductive health. 29 
Figure 6: EC support to the health sector: Breakdown of health sub-sector. 
 
Source: CRIS and Particip GmbH analysis 
The main focus over the period 2002-2010 was on “Basic Health”. The EC contracted an amount of 
EUR 3 billion which represented 73% of the total amount contracted. This sector included (as defined 
by the DAC sector classification) interventions for: basic health care and infrastructure, basic nutrition 
programmes and infectious diseases control including the three poverty related diseases HIV/AIDS, 
malaria and Tuberculosis. The figure below provides a detailed overview of the interventions financed 
in the sector ‘Basic Health Care’ 
                                                     
29
 A detailed description on how the interventions have been classified and the DAC sector codes in each of the 
three categories can be found in Annex 2.  
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Table 1: Direct EC support to the health sector: Breakdown of the subsector ‘primary health 
care’, 2002-2010 
Sector/Subsectors Contracted amount (€) 
Subsector Basic health 3,009,926,722 
3PRDs
30
:: Malaria/TB/HIV/AIDS  1,248,213,070 
Administrative, Evaluation, Audits, TA 29,029,768 
Basic health care 870,623,697 
Basic nutrition 138,458,935 
Essential drugs 33,528,663 
Infectious disease control (IDCs) 329,390,094 
Infrastructure 360,682,494 
Source: CRIS database, Particip analysis 
The second focus was on so-called “Health General”. The EC contracted EUR 895 million which 
represented 22% of the total contracted amount. This sector included (as defined by the DAC sector 
classification): support of policy and administrative management; medical education and training; 
health research and development; medical services such as mental health care or non-transmissible 
diseases.  
SRH received the smallest contribution, amounting to only 5% or EUR 219 million of the total direct 
support. However, these data have to be carefully interpreted, as SRH interventions are often “hidden” 
in larger basic health interventions. The SRH sector includes reproductive health interventions as well 
as interventions targeting STDs. 
The following figure shows the evolutions of sectors over the evaluation period. 
Figure 7:  Direct EC support to the health sector: Trend in the amounts contracted 
(EUR million) between 2002 and 2010 by main health sectors 
 
Source: CRIS and Particip GmbH analysis 
4.2.2 Regional breakdown 
The main regional focus of the EC support to the health sector was on the ACP region, which received 
46% (or EUR 1.9 billion) of the contracted amounts and Asia, which received 17% (or 
EUR 715 million). Equally large is the amount contracted for the category “all regions” which received 
EUR 681 million (17%) of the total funds contracted over the period 2002-2010. ENP South, ENP East 
                                                     
30
 This category includes support to the three poverty related diseases Malaria, TB and HIV/AIDS, either interven-
tions that targets these three diseases together, e.g. support to the GFATM or support to one specific of the three 
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and Latin America received the smallest share of EC support to the health sector (EUR 568 million; 
EUR 163 million and EUR 93 million). The following figure shows the distribution by region and sector. 
Figure 8:  Direct EC support to the health sector: Regional breakdown by main health sub-
sector, contracts (EUR million), 2002-2010 
 
Source: CRIS and Particip GmbH analysis 
4.2.3 Breakdown by modalities 
The EC delivered its “direct” support to the health sector through four main aid delivery methods: indi-
vidual projects, support to sector programmes (excluding SBS), SBS and co-financing of Global Trust 
Funds (e.g. GFATM, GAVI). The following figure shows the breakdown of these four modalities during 
the evaluation period.  
Figure 9: Direct EC support to the health sector: Breakdown of modalities used, contracts 
(EUR million), health sector, 2002-2010 
 
Source: CRIS and Particip GmbH analysis 
The analysis of the evolution of funds between the different modalities and throughout the evaluation 
period shows an increasing use of SBS from 2008 on. In total, the amounts contracted through SBS 
increased from about EUR 2 million in 2002 to EUR 200 million in 2009 and EUR 185million in 2010. 
The growing use of SBS goes in parallel with the decrease of project modality and support to sector 
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support programmes. However, compared to the education sector, the use of SBS and sector support 
in general is much less prominent (SBS 47% and support to sector programmes excluding SBS 
21%).31 
For SSP, the largest contracted amounts can be observed in 2004 and in 2008, They are due to large 
contracts with the private sector such as “Appui à la gestion du secteur de la santé” in Morocco and 
with UN bodies, e.g. in Bangladesh with the contribution to the national trust funds “National Health, 
Nutrition and Population Sector Programme (HNPSP)”.  
Global Trust Funds were quite steadily used over the evaluation period. Large contributions are ob-
served every three years, in 2003 (EUR 245 million), 2006 (EUR 267 million) and in 2009 
(EUR 201 million), the biggest share went to the GFATM.  
4.2.4 Breakdown by channels 
The EC channelled its support through different types of organisations. A breakdown of channels used 
is presented in the figure below32. It is interesting to note that multilateral organisations are the group 
receiving most of the contracted budget. This category includes contribution to the national trust funds, 
managed by World Bank and other development Banks, WHO or UN-Organisations, or contributions 
to global initiatives, such as GFATM and GAVI. These ratios are in some contrast to figures revealed 
in the EC’s support to basic and secondary education - one of the other main social sectors supported 
by the EC - where governments received 52% of EC funding, Development Banks (included in the 
category multilateral organisations, in the figure above) accounted for 17% and NGOs for 12%.33  
Moreover, the distribution of channels also provides an explanation why the project modality is the 
main aid modality used for direct support to health, as for support channelled through multi-lateral 
organisation the project modality is used. 
Figure 10:  Direct EC support to the health sector: Breakdown of support by main channel, con-
tracts (EUR million), health sector, 2002-201034 
 
Source: CRIS and Particip GmbH analysis 
The following figure gives more details on the distribution within the category “Multilateral organisa-
tions”. 
                                                     
31
 See See Particip GmbH (2011): Thematic global evaluation of European Commission support to the education 
sector in partner countries (including basic and secondary education). 
32
 Channels are defined based on the field “contracting party” in the CRIS database. Five categories have been 
retained: Public Sector, NGOs and Civil Society Organisations (CSOs), Public-Private-Partnership, Multilateral 
organisations, Other. An exact definition of each channel can be found in Annex 2. 
33
 For the period 2000 to 2007. See Particip GmbH (2011): Thematic global evaluation of European Commission 
support to the education sector in partner countries (including basic and secondary education). 
34
 Other included: Private companies-development agencies and Research and educational institutions. 
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Figure 11: EC support to multilateral organisations, (EUR million) health sector, 2002-2010 
 
Source: CRIS and Particip GmbH analysis 
The following figure shows a significant trend towards an increasing channelling of EC funds to the 
partner government (category: public sector). This coincided with an increased use of SBS as modali-
ty. It should be added that the considerable amount contracted with multinational organisations is part-
ly due to large financial contributions to global initiatives such as the GFATM.  
Figure 12:  Direct EC support to the health sector: Trend in the amounts contracted by main 
channel, contracts (EUR million), 2002-2010 
 
Source: CRIS and Particip GmbH analysis 
4.2.5 Breakdown by budget lines 
In terms of financial instruments used, the analysis shows that 74% of funds to the health sector were 
financed through geographical budget lines, i.e. EDF or DCI-ASIE/ALA or MED. 26% were funded 
through thematic budget lines, in which the SANTE/DCI-SANTE, with18 % of the total support to the 
health sector, accounts for the biggest share. The following table gives an overview of all budget lines.  
-
50.00 
100.00 
150.00 
200.00 
250.00 
300.00 
350.00 
400.00 
450.00 
500.00 
52% 
20% 
14% 14% 
1% 
M
ill
io
ns
Breakdown Multilateral organisations
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
Final Report Volume I August 2012 21 
Table 2: Total amounts contracted related to direct support to health sector through various 
budget lines (2002-2010) 
Domain (budget line) Contracted 
amount (EUR) 
Domain (budget line) Contracted 
amount (EUR) 
Geographic Budget Line Thematic Budget Line 
FED/EDF  
(European Development Fund) 1.553.787.876 
SANTE 
(Budget line for health, before 2007) 440.775.416 
ASIE  
(Budget Line for Asian countries until 2007) 397.453.332 
DCI-SANTE 
(Budget line for health, after 2007) 298.794.197 
MED 
(Budget Line for Mediterranean/ENP 
South countries, before 2007) 370.596.741 
ONG-PVD 
(Budget line for NGOs/NSA projects, 
before 2007) 120.989.780 
DCI-ASIE 
(Budget Line for Asian countries from 2007 on) 216.589.253 
DCI-NSAPVD 
(Budget line for NGOs/NSA projects, 
after 2007) 97.969.594 
ENPI 
(Budget Line for Neighbourhood countries) 210.400.242 
REH 
(Budget line for rehabilitation projects 
before 2007) 28.726.159 
AFS  
(Budget Line for South Africa) 123.558.244 
DCI-FOOD 
(Budget line for Food security projects, 
after 2007) 14.400.845 
TACIS 
(Budget Line for former ENP East countries, 
before 2007) 114.927.280 
DDH 
(Budget line for Human Rights projects 
before 2007) 8.231.908 
ALA 
(Budget Line for Latin American countries, 
before 2007) 57.291.705 
Other
35
 
39.981.045 
DCI-MED 
(Budget Line for Mediterranean/ENP South 
countries, from 2007) 22.277.767   
DCI-ALA 
(Budget Line for Latin American coun-
tries, from 007) 3.019.170   
Total 3.069.901.611 Grand Total 1.052.609.615EUR  
Source: CRIS and Particip GmbH analysis 
4.2.6 Breakdown by human development level 
When looking at the distribution of EC support according to the HDI, it appeared that the majority of 
EC funds go to countries with a low HDI (28%) or medium HDI (26%). Only 7% went to countries with 
high or very high HDI or to countries with no classification.36 The following picture gives an overview 
on the distribution of aid modality per HDI-classification. It appeared that SBS is preferably used in 
countries with a medium HDI, while in countries with a low HDI support via individual project support 
prevailed, followed by SSP. 
                                                     
35
 Other includes: EIDHR, DCI-MIGR, FOOD, PP-AP, DRG, DCI-HUM, IFS-RRM, ONG-ED, DCI-MULTI, RRM, NSI, ENV, 
CDC, BAN, EVA, INFCO, DCI-NSA.  
36
 38% of EC funds are not country specific, a classification according to HDI was thus not possible. 
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Figure 13:  Direct EC support to the health sector: Breakdown of financing modality by country 
according to the Human Development Index, 2002-2010 
 
Source: CRIS and Particip GmbH analysis 
Furthermore, 15% of EC support to the health sector is directed to so-called “fragile states”37. Almost 
half of all funds have been contracted to fragile states (48%) are used by only four countries. In their 
order of importance, these countries are: Afghanistan, Nigeria, DRC and Zimbabwe.  
4.3 EC ‘indirect’ support to the health sector: General Budget Support 
During the period 2002-2010, the EC has financed a total of 158 GBS programmes in 59 countries38 
falling within the geographical scope of this evaluation. Out of these 158 GBS programmes, 
93 programmes had a reference to the health sector expressed by health performance indicators or by 
objectives related to health in the Financing Agreements.  
These 93 programmes with a clear reference to the health sector were implemented in 45 countries 
and represented around EUR 5 billion, i.e. 72% of the total GBS funds transferred by the EC be-
tween 2002 and 2010. The following picture shows the geographical distribution of GBS during the 
evaluation period.  
It is important to underline that it cannot be stated which percentage of the EUR 5 billion actu-
ally went to the health sector. 
                                                     
37 It is to be noted that no “official list” of fragile states is available. Here we use the definition adopted by the 
OECD definition and its “list” of fragile countries, which it uses as the base for an annual report on resource flows 
to Fragile States (OECD-DAC Conflict and Fragility dossier at www.oecd.org/dac/incaf). These includes the fol-
lowing states: Afghanistan, Angola, Burundi, Cameroon, CAR, Chad, Comoros, Côte d'Ivoire, DRC, Djibouti, 
Equatorial Guinea, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Myan-
mar, Nepal, Niger, Nigeria, Pakistan, Papua New Guinea, Republic of Congo, Rwanda, São Tomé & Príncipe, 
Sierra Leone, Solomon Islands, Sudan, Tajikistan, Timor-Leste, Togo, Tonga, Uganda, Yemen, Zimbabwe. 
38
 The term “programme” in this inventory refers to a GBS decision, as found in the CRIS-database. One decision 
includes GBS funds, as well as the contracts related to technical assistance or other support, such as evaluation, 
audits or formulation mission. A country could have several GBS decisions during the evaluation period. 
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Figure 14: Indirect EC support to the health sector: Countries having benefited from GBS, both 
with and without health-related indicators (CSP periods 2002/3 to 2006 and 2007/8-
2010) 
Source: CRIS database, Particip GmbH analysis, created with StatPlanet 
The majority of GBS funds with a link to health went to Sub-Saharan countries, receiving 78%, fol-
lowed by ENP and Caribbean countries, with respectively 11% and 6%. The six main beneficiaries of 
EC-GBS account for themselves to 53.3% of the total GBS funds with a reference to the health sector.  
Table 3: GBS with reference to the health sector: The top-20 recipients (in million EUR 2002 – 
2010) 
Region/ 
Country 
Financial 
support 
committed 
% of total GBS 
amount 
(only financial 
support)
39 
Region/ 
Country 
Financial sup-
port committed 
% of total GBS 
amount 
(only financial 
support) 
Mozambique 644 9.13% Niger 162 2.30% 
Burkina Faso 508 7.20% Senegal 145 2.06% 
Tanzania 477 6.77% Sierra Leone 126 1.79% 
Zambia 445 6.31% Madagascar 123 1.75% 
Mali 321 4.56% Kenya 120 1.70% 
Ghana 306 4.34% Ethiopia 94 1.33% 
Uganda 276 3.91% 
Dominican Re-
public 92 1.30% 
Malawi 215 3.04% Jamaica 56 0.80% 
Benin 187 2.65% Nicaragua 68 0.96% 
Rwanda 180 2.55% Honduras 59 0.84% 
Source: Inventory data, Particip GmbH analysis 
                                                     
39
 Excluding funds committed under GBS decision but for TA or evaluation, etc.  
Countries with health-
GBSs
No. of 
countries
GBS in both periods 
(2002-2010)
19
Only period 2007/8-2010 5
Only period 2002-2006/7 21
Without health reference 14
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Table 4: Indirect EC support to the health sector: Regional breakdown of GBS health related 
GBS (in million EUR, 2002-2010) 
Region/ 
Country 
# of GBS 
decisions  
Financial support 
% of total amounts per 
region 
Sub-Saharan Africa 72 4,629 65.65% 
Caribbean 11 217 3.08% 
Pacific 2 2.4 0.03% 
Asia 4 51 0.73% 
Latin America 4 172 2.44% 
Total 93 5,072 71.93% 
Source: Inventory data, Particip GmbH analysis 
The figure below shows the trend in the amounts transferred through GBS between 2002 and 2010. It 
presents separately all GBS operations and those referring explicitly to the health sector. Health-
related GBS followed the overall trend of the GBS development which is slightly decreasing from 2002 
to 2008 before reaching a disbursement peak in 2009. The considerable increase in 2009 is due to the 
introduction of the MDG contracts. A budget of EUR 1.5 billion is foreseen for this type of GBS con-
tract and it amounts to 42% of the GBS provided though the 10
th
 EDF which target especially MDG-
relevant social sectors, such as health and education.  
Figure 15: Indirect EC support to the health sector: Trend in the amounts transferred through 
GBS (EUR million), 2002-2010  
 
Source: CRIS database; Particip GmbH analysis 
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5 Answers to the Evaluation Questions  
This part of the report presents a summary of the work in progress related to the seven evaluation 
questions listed below.  
The focus of the evaluation questions has been directed at the most relevant issues that became ap-
parent from desk work done during the production of the inception report and from the inventory. The 
EQs were discussed and agreed upon with the Evaluation Unit and the Reference Group.  
Table 5: Overview of evaluation questions  
Code EQ Evaluation question 
EQ1: Quality of health ser-
vices 
To what extent has EC support contributed to enhancing the quality of health 
services? 
EQ2: Affordability of health 
To what extent has EC support to health contributed to increasing affordability of 
health care, especially for the poor? 
EQ3: Health facilities availa-
bility 
To what extent has EC support contributed to improving geographical availability 
of health facilities especially for the poor? 
EQ4: Health service utilisa-
tion related to MNCH 
To what extent has EC support to health contributed to improving health service 
utilisation related to MNCH? 
EQ5: Management and Gov-
ernance 
To what extent has EC support to health contributed to strengthening the man-
agement and governance of the health system? 
EQ6: Co-ordination, com-
plementarity and synergy 
To what extent and how has the EC contributed to strengthening government-
led co-ordination, complementarity and synergies with Member States and other 
donors in the health sector, in line with the Paris Declaration? (national, regional 
and global levels) 
EQ7: Financing modalities, 
funding channels and in-
struments 
To what extent have the various financing modalities (GBS, SBS, other sector 
support, projects), funding channels and instruments and their combinations, 
been appropriate, thus contributing to improving access to, equity of and policy-
based resource allocation in health? 
The EQs can also be linked to one or several of the five DAC evaluation criteria (relevance, effective-
ness, efficiency, impact and sustainability) and/or to the visibility and value-added themes identified in 
the terms of reference of this evaluation. These linkages are illustrated in the following table. 
Table 6: Coverage of the evaluation criteria by the evaluation questions 
Criteria DAC criteria EC criteria 
Question 
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EQ1- Quality of health services          
EQ2- affordability of health          
EQ3- health facilities availability          
EQ4-health service utilisation 
related to Mother and Child 
Health (MNCH) 
         
EQ5- Governance and Manage-
ment 
         
EQ6- co-ordination & comple-
mentarity 
         
EQ7- Modalities          
 The criterion is largely covered by the EQ 
 The criterion is partially covered in the EQ 
Volume IIa provides detailed findings for each evaluation question. These findings were arrived at 
during the evaluation through the approach and with the tools described in Chapter 2 and in Annex 23. 
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5.1 EQ1: To what extent has EC support contributed to enhancing the quality 
of health services? 
The question focuses on the quality of health services. Quality in health care is a multi-dimensional 
attribute, but it concerns elements such as access to essential medicines, availability of good infra-
structure, being treated by well-trained health professionals  
The delivery of quality health services is central to improving the health status of the population not 
only because it results in decreased case fatality rates and complication rates, but also because it 
translates into health care-seeking behaviour, including preventive care, by those in need of it. Fur-
thermore, satisfied patients and clients are more likely to follow advice and prescribed treatments. This 
becomes increasingly important in situations where the prescribed therapy is complex and in settings 
where clients have to pay for services. Quality of care is linked to poverty, as well, as when public 
health care is perceived to be of low quality; even low-income households will seek expensive treat-
ment in the private sector.  
In recent years countries have begun to introduce comprehensive, continuous quality monitoring 
mechanisms. Quality Assurance Models or Total Quality Management Tools are increasingly used to 
assist organisations, such as hospitals and health centres to look at all aspects of performance and 
quality of services. The World Health Organisation has an important role in safeguarding quality in 
technical aspects, setting standards and ensuring patient safety. WHO develops guidelines and best 
practice recommendations based upon regional working contexts which Ministries of Health around 
the world can refer to for guidance.  
The question thus tries to capture to what extent the EC contributed to the amelioration of the quality 
of health service delivery. It has been addressed through four JCs: 
 JC 11 Availability of essential drugs improved due to EC support 
 JC 12 Improved availability of quality health infrastructure (physical structure of facilities, 
equipment) due to EC support 
 JC 13 Improved availability of qualified human resources for health due to EC support 
 JC 14 Increased or maintained quality of service provision due to EC support 
The answer to the question is based on several sources; a detailed list of sources used per indicator 
can be found in Annex 23.  
 Country Case Studies 
 Inventory 
 EUD survey 
 MoH survey 
 Selected Evaluations (CSEs not included in the case study countries, thematic evaluations) 
 International statistics 
 Interviews 
EQ1 on quality of health services 
– Summary Answer Box 
In general, evidence from the sources mentioned above suggests that there have been improvements 
in health care quality and that the EC has made a significant contribution in countries where it has 
provided support. This support and its impact on quality, takes many forms – from the virtual provision 
of primary health care in fragile states such as Afghanistan to the encouragement of family medicine in 
countries like Moldova and Egypt, to high-level technical assistance and capacity building in the con-
text of sector budget support in countries like the Philippines, to the difficult to nail down impact of 
GBS. 
In order to get a view of the overall situation it is useful to cite evidence from the EUD survey. Virtually 
all responding EUDs viewed the overall quality of health care as “unsatisfactory” or “completely unsat-
isfactory” in 2002-2004. Yet, only half of responding EUDs had the same negative view regarding 
2010. In that year, fully two-thirds of respondents believed that health care quality in urban areas was 
“satisfactory” or better. However, while most EUDs saw some improvement over the evaluation period 
in rural areas, they still cited wide rural-urban differences in quality. For instance, the EUD Philippines 
highlighted important geographical variation across provinces and EUD Moldova and EUD Ecuador 
commented that the differences in the quality of the health provision between rural and urban area are 
still an issue to be resolved. A theme that comes through strongly is that, in many countries, it is not 
merely the simple rural-urban dimension that must be considered, but the less tangible dimension of 
remoteness. The Philippines and Lao PDR are strong instances of this. In such countries, simply sup-
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EQ1 on quality of health services 
– Summary Answer Box 
plying health infrastructure and human resources may be prohibitively expensive and alternative strat-
egies such as road development and integrated rural livelihoods development may have strong spill-
over effects on access to health care. 
Ministries of Health who responded to the survey generally reported an improvement in the availability 
of infrastructure in both rural and urban areas. However, relating this to actual improvements in access 
by the poorest population has proven difficult even for in-depth investigations (e.g. the 2007 India 
Country Strategy Evaluation). 
While the EC has not had much impact on promoting essential medicine guarantees – these are 
often enshrined in national health policies and it they are frequently worthless – it has ensured essen-
tial medicine supply through provision of basic benefit packages in a number of settings. In settings 
such as Afghanistan (ten provinces), Egypt (pilot Governorates), Ecuador (three under-served prov-
inces) and Mindanao Province of the Philippines (including conflict zones) the EC has financed a full 
package of primary care. In Afghanistan, NGOs implemented; in the other cases, the Ministry of 
Health. EC support to the Global Fund and for the Global Alliance for Vaccines and Immunisation has 
also served to improve the availability of essential medicines. This said, it must be recognised that the 
EC can have significant direct impact only in very limited areas. Compared to the total amount of 
pharmaceuticals consumed in poor countries, the EC’s contribution is miniscule. In a number of coun-
tries, the EC’s possibly more significant contribution has been to support improved procurement of 
medicine and strengthen the supply chain. The EC supported an initiative with WHO to improve phar-
maceuticals policy in ACP states but, at least based on the mid-term review, results were less than 
expected. 
As with pharmaceuticals, the EC has nowhere near the financial resources to be a major player in the 
provision of health infrastructure. That said, in many countries, the EC has financed clinics in under-
served regions, either through NGO-supported projects (Lao PDR), sector support (Egypt and Ecua-
dor), NGO projects (Afghanistan), or multi-donor GBS (Ghana). In countries such as Moldova and the 
Philippines, EC sector support has been the vehicle for helping ministries of health to assess their 
infrastructure needs and re-tool as necessary. Much the same may be said for medical equipment. In 
limited settings, EC direct provision has improved the quality of health care; in other settings, EC sec-
tor support has helped countries to improve procurement and better analyse needs. Many rural clinics 
were equipped in India. Maintenance of infrastructure and medical equipment is an essential part 
health quality improvement and has received insufficient attention and support. 
We have noted that the human resource issue was ranked first by EUDs when asked what con-
strained progress on improving the quality of health care. We would expect the EC to pay particular 
attention to this issue, in part, as well, because the EU is a major destination of international health 
professional migrants and the problem of “diversion” of health professionals from the public health 
service to donor-supported projects is a perennial subject of discussion. A surprising lack of data was 
encountered in this area, but all qualitative evidence supported the view that the crisis in human re-
sources for health is still unresolved. This despite the fact that most Ministries of Health responding to 
the survey cited at least some improvement in the availability of staff. We identified perhaps surprising-
ly few EC interventions directly aimed at relieving the human resource crisis. Examples included re-
gional projects on better managing health professional migration and retention schemes. The barrier 
may well be that, ultimately, the human resource crisis is one of recurrent expenditure, which cannot 
be addressed directly by donors. Policy dialogue and indicators for GBS often mention human re-
sources, but we have often found that indicators are not measured. The EC has supported various 
training initiatives with significant impact; among the signal successes was increasing the availability 
of qualified female health workers in Afghanistan, with documented benefits to women and girls. We 
can also state with confidence that general support for the health sector, by contributing to better in-
frastructure, better availability of needed drugs and equipment, etc., improves the work environment 
and helps to diminish health worker attrition. The Global Fund, often accused of draining human re-
sources from the general health sector, has recently begun to take overall health sector strengthening 
more seriously, as has GAVI. 
When the EC supports facilities, it can generally be assumed that international clinical protocols will be 
followed and quality assurance mechanisms will be in place. In a few countries, we found, as well, 
that the EC directly supported quality assurance mechanisms. Data on client satisfaction are scarce. 
However, in two case study countries (Moldova and Egypt) we found solid evidence that EC support 
had improved client satisfaction. By contrast, in the Philippines, which has been the beneficiary of 
comprehensive EC support for health sector reform, large numbers of households insured by Phil-
Health continue to seek expensive private care, strong evidence of dissatisfaction with the EC-
supported public health programme. 
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EQ1 on quality of health services 
– Summary Answer Box 
To conclude, EC support has contributed to improved quality of health care in beneficiary countries. 
The modalities have been varied, from direct provision of basic health care in troubled settings to sup-
porting Ministry of Health reform design in less troubled ones. In all three main areas examined – es-
sential medicines, infrastructure and human resources – we have recognised that, while the EC’s im-
pact may be high at a micro-level, the total amount of money in play for pharmaceuticals, infrastructure 
and health worker salaries dwarfs the EC’s resources. 
5.1.1 JC 11 Availability of essential drugs improved due to EC support 
We assessed this JC based on two indicators, the first asking whether the EC had contributed to put-
ting in place national policies guaranteeing access to essential medicines and the second asking 
whether the EC had contributed to an actual improvement in availability of essential medicines in clin-
ics and pharmacies.  
The first indicator proved to be somewhat jejune, as in many countries constitutional and policy guar-
antees of access to essential medicines exist but are meaningless in practice. High prices and stock-
outs in public facilities remain major barriers to access to needed medication in many countries receiv-
ing EC support. The country case studies show that in some countries (e.g. Afghanistan and Egypt), 
by directly financing primary health care facilities, the EC has implicitly guaranteed access to some 
essential medications. EC support to the Global Fund, which has subsidised or guaranteed access to 
medications related to the diseases of poverty, has had the same impact. In only one case study 
country, the Philippines, did the EC directly contribute, through TA and policy advice, to legislation 
which significantly affected access to essential medicines. 
There is less ambiguity regarding the second indicator. Through a wide range of interventions, the EC 
has significantly contributed to improving availability of essential drugs. Evidences from the country 
cases studies highlights that, in Afghanistan and Egypt, as mentioned, the EC was involved in direct 
provision and similar impacts could be found in countries such as Ecuador and Lao PDR where pro-
jects, in the first case sector support in three underserved provinces and, in the second, NGO projects, 
supported primary health facilities where essential medicines were available. According to the health 
inventory, the EC contributed Euro 34 million (representing 0,8% of total direct EC support) to drug 
availability over the evaluation period, as shown in the table below. 
Table 7: Direct EC support to the health sector: Amounts (€ million) contracted for interven-
tions on essential drugs, infrastructure and Human Resources (HR), 2002 and 2010  
Interventions  Contracted amount 
(€ million) 
Essential drugs 34 
Infrastructure 361 
Human Resources for health 137 
Source: Particip inventory 
To this should be added the indirect contribution through support for the Global Fund. Support for 
health care finance reform, as in the Philippines and Moldova, can have the indirect effect of enhanc-
ing access to pharmaceuticals because it relives pressure on medical facilities to generate funds by 
the sale of drugs. 
In general, though, the evidence country case studies and interviews continues to be that essential 
medicine availability is much better in the private sector than the public sector and is one reason why 
even poor persons eligible for care in public health facilities often resort, at considerable expense, to 
the private sector. The direct support for medicines emanating from the EC is miniscule compared to 
total expenditure on medication.  
This JC has been reasonably well covered by evidence gathered from country case studies, inter-
views, EUD survey and the inventory. However, specific evidence on drugs related to the diseases of 
poverty has not been taken into account, nor has the EC’s support for vaccines and immunisation. A 
full understanding of the pharmaceutical sector at country level unfortunately requires a level of analy-
sis that is not practical given the constraints of this evaluation.  
5.1.2 JC 12 Improved availability of quality health infrastructure (physical structure of facili-
ties, equipment) due to EC support 
We assessed this JC based on two related Indicators, the mix of primary and secondary care facilities, 
the proportion of facilities with appropriate equipment and sufficient budget for maintenance and oper-
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ating expenses40. The efficiency of EC interventions providing infrastructure and equipment was often 
impaired by the inadequate attention paid to maintenance and operating costs. As a result, the use-life 
of EC-financed equipment is lower than could have been achieved. 
To put this in perspective, we can cite results of the EUD survey. As the following table makes clear, 
human resources, not infrastructure or budget, was regarded as the main factor constraining progress 
over the evaluation period.  
Table 8: Top four factors constraining quality most mentioned by EUDs 
Constraining factor Commented by: 
Lack of enough qualified human resources EUDs in Lao, Philippines, Bangladesh, Moldova, Syrian Arab 
Republic, Nigeria, Yemen, Egypt, Burkina Faso, Congo, Zim-
babwe, El Salvador, Zambia 
Governance and sector management issues EUDs in Barbados, Philippines, India, Moldova, Syrian Arab 
Republic, Burkina Faso, Nigeria, Yemen, Ecuador 
Lack of infrastructures and equipment EUDs in India, El Salvador, Moldova, Yemen, Zimbabwe, Zam-
bia 
Limited Public health financing EUDs in Vietnam, Lao, Philippines, Yemen, Nigeria, Burkina 
Faso 
Source: EUD survey 
Where infrastructure and equipment were mentioned, factors cited included population growth (EUD 
India) and the exacerbating factor of macroeconomic crisis (EUDs Zimbabwe and Zambia). In passing, 
inclusion of Moldova is surprising, since Moldova inherited an exceptionally dense health infrastructure 
from the Soviet era and has been the beneficiary of considerable EC support for rehabilitation, re-
furbishing and re-tooling. 
With hindsight, focusing on the mix of primary and secondary health care facilities may have been a 
mistake, since most of the information available dealt simply with number of facilities available, not the 
mix. This means that some caution must be applied in situations where infrastructure is imbalanced. In 
Moldova and many other post-Soviet states, for example, the problem was too many hospitals, often 
with low bed occupancy rates and not enough primary ambulatory facilities. So it is not surprising that 
one of the goals of EC support was to reduce the number of superfluous hospital beds.  
Over the evaluation period, according to the inventory, the EC contributed € 361 million directly to 
infrastructure (see Table 7). Note that this is not, in general, an EC focal area, as donors such as the 
World Bank, are in a stronger position to offer the major finance needed to finance infrastructure de-
velopment. However, in assessing Indicator I-121, country case studies shows a number of countries 
where the EC financed or supplied infrastructure – Afghanistan, Ecuador, Egypt, Philippines and Gha-
na among them. This was generally in under-served areas or serving a particular need (e.g. family 
clinics in Egypt). In the Philippines and Moldova, the EC also provided TA which aimed to improve 
health facility planning and rationalise infrastructure. Respondents to the EUD survey broadly support-
ed the view that the infrastructure situation had improved over the evaluation period. In India, accord-
ing to the 2007 Country Strategy Evaluation India (Volume 2, page 75), the EC supported the rehabili-
tation of dilapidated primary health care infrastructure and the provision of a basic package of health 
services. 
Some EC support to infrastructure should be seen in the context of support to decentralisation, in 
which case the recent thematic evaluation on decentralisation is relevant. It states that, in most of its 
support to decentralisation, the EC has contributed to some expansion of local infrastructures, not 
necessarily specifically in the health sector, but more broadly (e.g. roads), with the effect of improving 
access to services41. 
Related to the issue of provision of appropriate equipment, again, responding EUDs were generally of 
the view that the equipment situation has improved over the evaluation period, as shown in the next 
figures.  
                                                     
40
 Initially, the second part of the indicator had been separate, as I-123 Increased proportion of health facilities 
with adequate budget for maintenance and recurrent expenditures, Given that virtually no evidence was found 
relating to this Indicator, the two were merged, to be able to use, to a certain extent, the relevant information. 
41
 Particip (2012): Thematic global evaluation of the European Commission support to decentralisation processes, 
2012, p.48 
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
30 August 2012 Final Report – Volume I 
Box 2: Coverage with primary and secondary facilities having appropriate equipment and 
budget for maintenance and current expenditure; EUD survey 
: Primary health care facilities with appropriate equipment and budget for maintenance and 
expenditure 
 
Source: EUD Survey, 2011, Particip GmbH 
Explanation of the figure 
Rural primary. While 11 out of 24 EUDs regarded the situation as regards rural facilities as “completely unsatis-
factory” in 2002-04 and only 3 out of 24 in 2010, this must be tempered by the fact that most of the improvement 
was accounted for by movement into the “unsatisfactory” category, which rose from 6 (2002-04) to 12 (2010). 
Urban primary. Twice as many EUDs (9 as against 4) judged the situation in 2010 to be “satisfactory” as opposed 
to 2002-04. The increase was mirrored by a decrease in the “unsatisfactory” and “completely unsatisfactory” cat-
egories.  
Figure 16: Secondary health care facilities with appropriate equipment and budget for maintenance and 
expenditure 
 
Source: EUD Survey, 2011, Particip GmbH 
Explanation of the figure 
Rural secondary. 8 of 24 responding EUDs felt that the situation was “completely unsatisfactory” in 2002-04 but 
only 2 in 2010. Some of these EUDs felt that the situation has progressed to “unsatisfactory,” others felt that the 
situation had progressed all the way to “satisfactory.” 
Urban satisfactory. The trend was similar; there was a sharp drop in the “completely unsatisfactory” description, a 
slight drop in “unsatisfactory,” and compensating increases in “satisfactory and “good.”  
A number of EUDs pointed out that EC support targeted primary, not secondary, health care; only one (EUD In-
dia) cited any support to secondary health care at all.  
Reasons cited included GBS which loosened fiscal constraints, changed government priorities and 
direct EC support for the provision of infrastructure and equipment. The EC provided equipment direct-
ly in cases where it financed infrastructure development. While information related to the adequacy of 
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budget for maintenance and recurrent expenditures has remained scarce, it is possible that EC sup-
ported GBS, by means of the policy matrix and increasing budgetary resources, has helped making 
more current budget available to health facilities. EC support for improved health care finance would 
have similar results.  
5.1.3 JC 13 Improved availability of qualified human resources for health due to EC support  
An abundance of evidence from different sources was gathered on most of the indicators related to 
this JC but, surprisingly in view of the importance of the issue, relatively little consistent time-series 
statistical evidence were available. Before taking up the indicators, it is worth pointing out again that 
the lack of needed human resources was the single most-often cited constraint to improving health 
care quality cited by EUDs responding to the survey. 16 EUDs responded to the question “What are 
the top four factors constraining health care quality; of these, 13 mentioned human resources. Exac-
erbating factors included low salaries (EUD Burkina Faso), low skill levels (EUD DRC) and “brain 
drain.” Only one EUD – perhaps, not surprising, Zimbabwe, where macroeconomic collapse was se-
vere and opportunities for emigration of health professionals were high – cited the distortions in the 
labour market caused by donor interventions in health. Other EUDs cited the deterioration of training 
capacity to the unattractiveness of working in rural or remote regions.  
Figures from the inventory show that EUR 136 million was dedicated directly to interventions focusing 
on Human Resources for Health. The breakdown of this category is shown in the following table. 
Table 9: Human Resources for health – overview of EC support to the sub-sector: Inventory 
 Breakdown of the sub-sector: Human 
Resource for Health (EUR) 
% within the HRH 
sub-sector 
Health workers training 120,276,692 88% 
Retention Human Resources  12,030,019 9% 
Evaluation, Audits, TA 2,300,441 2% 
MoH capacity building 1,425,385 1% 
Total HRH 136,032,539 100% 
 Proportion of HRH within total EC support to health 
Total direct support to the health sector 4,118 million 3,3% 
Source: CRIS data base, Particip analysis 
We approached the JC through three Indicators; with hindsight, the last partly duplicated the first. The 
first was simply availability per capita of doctors and nurses. The second had to do with levels of train-
ing. The third had to do with attrition; which of course, is related to the first as a matter of mathematical 
logic and with health worker absenteeism. 
Despite the fact that there is a major global focus on human resources for health, the search for glob-
ally consistent data, e.g. from the WHO Global Observatory for Health, did not yield much. At the 
country level, as well, while country case studies found evidence in almost all countries of problems 
with human resources for health, consistent data comparing two points in time were scarce. This is 
perhaps less serious than it might appear, because it is clear that the problem is often not the number 
of health professionals itself, it is their geographical distribution. Rural areas are clearly disadvantaged 
and remote areas (e.g. in the Philippines or Lao PDR among the case study countries) are the most 
disadvantaged of all.  
Some EC interventions have directly targeted human resources, whether at the regional level (e.g. a 
Migration and Asylum budget line project on better managing migration of health professionals in Afri-
ca) or by supporting training institutions (e.g. Lao PDR, Ghana and Moldova). Direct training and pro-
vision of community health workers has occurred in a number of settings, most significantly in Afghan-
istan, where the EC’s impact has been especially important in increasing the number of female com-
munity health workers. Whether these improvements will be sustainable in the future is a question. 
EUDs acknowledge that attrition and absenteeism (on which we have little information) are major 
problems. In some countries (e.g. Zambia), the EC financed health worker retention schemes. They 
were implemented under the Human Resources for Health Strategic Plan adopted in 2006. The case 
study cites some evidence that this is resulting in a reduction in high attrition rates. EC sector budget 
support contributed significantly to financing retention schemes, but data available do not permit a 
precise statement of impact. Moreover, Zambia is the only ACP country for which hard evidence relat-
ed to absenteeism and the EC response was found. World Bank research has documented the scope 
and scale of the problem. Through its two programmes supporting public health service delivery (10
th
 
EDF) and Retention of human resources for health, the EC has contributed directly to reducing absen-
teeism. However, most EUDs responding to the survey regarded the availability of skilled health pro-
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fessionals in rural areas to be still “unsatisfactory” or “completely unsatisfactory” in 2010. Asked to 
describe the main reasons for shortages of human resources, the respondents to the MoH survey 
cited a familiar range of constraints: low status, salaries and incentives for health workers, poor work-
ing conditions encourage health personnel to remain in urban areas (Syria, Laos, Moldova, Burkina 
Faso) or the pay gap between public and private sector (Afghanistan). 
Following the intensified discussion on HRH within the donor community and with partner countries 
towards the end of the evaluation period42, the EC signed a contribution agreement for the 
WHO/GHWA-managed programme aiming at ‘Strengthening Health Work Force Development and 
Tackling the Critical Shortage of Health Workers’. According to the final evaluation report (May 2012), 
this programme has already “made an impressive contribution to implementation of the HRH Global 
Strategy and plan of action agreed at the First Global Forum in Kampala (2008)”.  
Box 3:  EC financed programme: Strengthening Health Workforce Development and Tack-
ling the Critical Shortage of Health Workers 
This programme has been launched in 2009 as an outcome of the 2008 Global Forum on Human Resources for 
Health held in Kampala and is managed jointly between the WHO and the Global Health Workforce Alliance 
(GHWA). The EC has signed a contribution agreement with the WHO in order to provide financial support. This 
ambitious 3.5-year programme (foreseen end: July 2012) targeted 29 countries
43
 addressing the global, regional 
and country level.  
 
Main objectives 
 Objective 1: Strengthening governance for heath workforce 
 Objective 2: Improvement of health workforce evidence and information: Global and Regional Health 
Workforce Observatories 
 Objective 3: Establishment of mechanisms for effective management of HW migration and retention 
 Objective 4: Scaling up health workforce production 
 Objective 5: Supporting countries in addressing their critical HRH bottlenecks for priority health service 
The overall objective of the programme was to promote a better knowledge, understanding and advocating of the 
HRH shortage issue. This was done by financing activities aiming at creating baseline data on the HRH situation 
and actual and upcoming needs (e.g. different Health Workforce Observatories; feasibility studies for financing of 
funds, assessments of investment requirements, support to the establishment of exchange platforms, etc.) as well 
as capacity building and awareness raising in HRH units of MoHs.  
In order to establish mechanisms for the management of HW migration and retention a ‘Code of Practise on 
health workforce migration’ was adopted in 2010.  
 
Results of the programme evaluation 
The final evaluation of the programme highlights the important role of the programme in creating a common plat-
form for joint action and, as such, can be regarded as a starting point to strengthen global health governance, 
thus reacting on the “plethora of parallel global heath institutions”
44
. However, it also mentions the problem of 
sustainability. It appears clearly that without further funding achievements of the 3-year period cannot be taken 
further. Furthermore, lack of clear distribution of roles between WHO and GHWA has hampered the effectiveness 
of implementation, just as discrepancies between countries with strong HRH leadership capacities (e.g. Came-
roon) and countries with less staff availabilities and competences.
45
 
Component number four ““Scaling up health workforce production“ addressed the issue of health worker availabil-
ity, especially better education condition for health workers for defined priority health services. The final evaluation 
report is in general very positive on the programme outcome; however, the specific objective targeting the in-
crease of health workforce has been assessed as being too ambitious and thus only partly reaching its initial 
objectives. Reasons for the limited success were the complexity of the issue and the inadequate allocation of 
funds and staff time to implement the programme components, according to the evaluation report. 
As a direct output the donor community developed a Code of Practise on health workforce migration; however, 
the evaluation report notes the continuing of international recruitment of HW. The introduction of a periodic volun-
tary reporting to the WHO planned for 2012 might offer ways to call on recruiting WHO member states. 
Source: Draft final evaluation report, Strengthening Health Workforce Development and Tackling the Critical 
Shortage of Health Workers, Sante/2008/153-644. May 2012.  
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In assessing the second indicator through country case studies, a number of examples of direct EC 
provision of health worker training were found. These ranged from training community health workers 
(e.g. Afghanistan, Lao PDR, South Africa) to arrangements that benefited national schools of public 
health (e.g. Lao PDR, Ghana, Moldova). Sometimes training was specifically oriented to family medi-
cine (Egypt, Moldova).  
Any action that improves working conditions in the health sector will tend to alleviate problems of attri-
tion. Where the EC has financed improved infrastructure and equipment, it will have simultaneously 
addressed issues of attrition and absenteeism (subject to the cautions above). Training is a double 
edged sword; on the one hand, EC training contributes to career prospects in the public health sector, 
but on the other hand, it may promote brain drain into donor-financed projects, into private practice, or 
abroad. Without better data and in the face of sometimes contradictory evidence from country case 
studies, it is hard to reach a strong conclusion regarding this JC. That the EC is trying to address the 
issue is without question, as evidenced by the 2006 Communication and the fact that human re-
sources are identified as one of the key foci of EC health sector strategy which has materialised in a 
EC contribution agreement with two main global stakeholders in this field (WHO and GHWA) aiming at 
Strengthening Health Workforce Development and tackling the critical shortage of health workers. Yet 
the situation remains serious, especially in rural areas, in many countries.  
Overall, judging from the persistence of the problem, EC interventions to relieve the human resource 
crisis in health do not appear to have been effective, making generalisations of the “What works?” type 
difficult to make. EC actions have improved the availability of data, increased the capacity of human 
resource planners in Ministries of Health, raised awareness and shared experiences at the regional 
level; however, there is no sign of tangible impact on the basic on-going problem. The reason for weak 
sustainable impact is that the gap between the salaries and working conditions in the public health 
sector and those available working in donor-financed projects, in the private sector, or emigrating 
abroad are so wide. Retention must be measured over a span of years and schemes that are effective 
in retaining young medical graduates for two to five years may still fail in the longer term. The globali-
sation of health training – many doctors and nurses from low-income countries will have received sig-
nificant education or professional training, including certification, abroad – eases the emigration pro-
cess. Also competing with effectiveness is the fact that, despite pledges and codes of good conduct, 
destination country health sectors continue to aggressively recruit needed health care workers from 
poor countries, especially those that are English or Romance language-speaking.  
5.1.4 JC 14 Increased or maintained quality of service provision due to EC support 
We assessed this JC based on indicators covering quality assurance mechanisms, clinical protocols 
and client satisfaction. The country case studies show that, where the EC has supported direct provi-
sion of health care, quality assurance mechanisms have been in place, usually implemented by 
NGOs. This was the case, for example, in Afghanistan, Egypt and Lao PDR. In a few countries such 
as Moldova and South Africa, quality assurance was a significant component of EC support imple-
mented (usually by NGOs). The EC was particularly active in this regard in the Philippines, where TA 
supported efforts to strengthen the capacity of decentralised local authorities to monitor the quality of 
care provided. A similar conclusion applies to Indicator I-142 on the dissemination and application of 
clinical protocols – if the EC provided the facility or support to the operation of the facility, such proto-
cols were implemented. However, it needs to be kept in mind that developing treatment protocols is 
typically the responsibility of agencies such as WHO. In a number of settings, such as Afghanistan, 
Egypt and Mindanao province of the Philippines, clinical protocols were implicitly disseminated 
through the development and provision of basic care packages. In two country case studies, Moldova 
and Egypt, strong evidence was found that there had been improvements in client satisfaction to 
which EC support contributed. However and despite strong EC support for health sector reform, it is 
not possible to document an improvement in client satisfaction in the Philippines. It was, however re-
ported in the Thematic Evaluation of Decentralisation that EC-supported public-private partnerships 
(PPPs) improved health care quality at local level46. In South Africa, by contrast, Public-private part-
nerships (PPPs) were less successful because national guidelines on PPPs were poorly suited to the 
needs of local governments and, to a large extent, PPPs were introduced as precondition for EC fund-
ing rather than fully appreciated by local stakeholders. 
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5.2 EQ2: To what extent has EC support to health contributed to increasing 
affordability of health care, especially for the poor? 
Experience has shown that addressing only addressing the supply side of health – the number of facil-
ities, doctors, etc. – is not sufficient to widen actual access and provision because there must be effec-
tive demand for health care, as well. Some of the barriers here are attitudinal and behavioural, or have 
to do with the quality of services availability. In some settings, geographical access is a limiting factor. 
Largely, though, the main constraint to increasing utilisation of the health system is financial; the poor 
do not have enough money to pay. The trend towards cost-recovery and tightening of health budgets 
has made the problem more serious. With salaries in the public health service being very low, many 
doctors have either set up private practices, where out-of-pocket charges are high, or have in some 
countries resorted to receiving under-the-table payments for services that should be provided free or 
at nominal cost. Affordability is linked to quality and the size of health budgets, as in countries where 
public health facilities and services have deteriorated drastically, even the poor may prefer to seek 
expensive private treatment. 
An especially serious aspect of affordability is the issue of catastrophic health expenditure – some-
times defined as spending in excess of 25% of income. General literature shows that catastrophic 
health spending is a common cause of poverty, either preventing poor families from advancing out of 
poverty or pushing the near-poor over the brink. In some settings, families sell assets and borrow 
money, entering a debt trap from which they have little likelihood of escape. The existence of a func-
tioning public health financing system, whether of the national health service variety or a variant on the 
insurance model, is a vital component of health development policy. 
This question thus tries to assess the extent to which policies adopted have tended to make health 
care more affordable, to the general population but most particularly to the poor. To this end, four 
Judgement criteria have been established: 
 JC 21: The cost of basic health care services are reduced for households due to EC support 
 JC 22 Increased development and sustainability of special schemes to ensure availability of 
health care to groups with special health care needs supported by the EC 
 JC 23 Improvements in health finance policies to enhance affordability of services supported 
by the EC  
 JC 24 Global research partnerships to develop new treatments and medicines relevant to poor 
countries supported by the EC  
The answer to this question is mainly based on the following sources: 
 Country Case Studies 
 EUD survey 
 Literature analysis (outside case study documentation) 
 Interviews 
 Thematic case study on EC financing of global public goods 
EQ2 on affordability of health 
 – Summary Answer Box  
We approached this question based on four JCs, the first having to do with the cost of basic health 
services and the second the existence of special schemes to ensure availability of health care ser-
vices to those with special needs, the third improvements in health care finance policies and finally, 
development and availability of medications and treatments. In considering the latter, we focused on 
the EC’s contribution to the production of global public goods for health. 
Increasing access and utilisation by reducing cost has been a central concern of all EC interventions 
in the field of health. There is evidence from many settings that high out-of-pocket costs for health 
care are one of the most important factors discouraging households from seeking needed health care. 
When, as is often the case, households are forced to pay high sums, the result may be indebtedness 
(common, for example, in India) or impoverishment. 
We found that, overall, the EC made some contribution to reducing the cost of basic health services to 
households in the countries where it provided support. In some cases such as Afghanistan and pilot 
Governorates of Egypt, this was in the context of direct financing of the provision of health care ser-
vices.  
The EC has contributed significantly in a range of settings to the reducing the cost of health care to 
those with special needs, with resulting increases (according to respondents to the EUD survey) in 
utilisation of health care services. A range of interventions that supported such schemes were identi-
fied, however, only about a third of EUDs responding to the survey felt that health finance policy over-
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EQ2 on affordability of health 
 – Summary Answer Box  
all was serving the needs of the poor “satisfactorily or “well.” The handful of responses to the MoH 
survey was mixed on this subject. There is evidence that EC support for special schemes led to addi-
tional utilisation of health care services in most countries, although precise estimates are not available. 
In most countries, the EC provided at least some TA and participated in policy dialogue related to 
health care finance. This included countries such as Afghanistan, where the clear focus was on provi-
sion, not on finance. In a few countries, such as the Philippines, Egypt and Lao PDR, health care fi-
nance was a focus area of sector policy support programmes. In general though, there appear to be 
few success stories in the area of health care finance. Even in Moldova, where the EC helped to sup-
port a sweeping reform, the results are not entirely satisfactory, as informal payments remain common 
and quality remains low. 
While we have identified impacts of EC support in most case study countries and while EUD survey 
results are broadly supportive of the view that EC assistance has had some impact, it is difficult to find 
systematic evidence of this. Probably the most looked-at statistical indicator of the affordability of 
health care is the proportion of total health expenditures that is out of pocket (often further decom-
posed into the share of the total that is private and the share of private that is out of pocket, i.e., not 
covered by private insurance). In some countries, such as Ghana and Burkina Faso, there were very 
significant reductions in the out-of-pocket share and EC GBS may have made some contribution by 
creating fiscal space. In others, such as Lao PDR and Philippines, the out-of-pocket share increased 
despite EC TA related to health care finance. A reverse causation factor can, however, also be cited; 
one reason for EC concern about health care finance, for example, in the Philippines is precisely the 
strong trend of rising out-of-pocket payments. Out-of-pocket payments also cannot be dissociated 
from other factors, especially the quality of health care available in the public sector. When this im-
proves, it can be expected that fewer patients will choose to seek more expensive private care. The 
answer to this EQ must be read together with the answer to EQ 1. 
We approached the last JC, on making affordable drugs and treatments available, in the global public 
goods dimension. We expressly left out the impact of the Global Fund, although EC support has signif-
icantly contributed to the availability of treatments and preventive measures for all three of the diseas-
es of poverty. We found that EC support to GAVI has significantly supported the availability of low-cost 
immunisation. The EC also supported the Global Polio Eradication Initiative and as well devoted bilat-
eral funds to polio control in countries experiencing resurgence or cross-border incursion of the dis-
ease. Through framework research programmes, the EC has contributed to the development of treat-
ments for and innovative approaches to malaria and it is active in a network co-ordinating malaria 
vaccine research. We found concrete example of EC participation in global health research networks, 
largely but not entirely through Framework Research Programmes, including at least some partner-
ships with the pharmaceutical industry. These contributions to the production of global public goods for 
health are solidly in line with the EC’s comparative advantage as a supranational organisation. 
5.2.1 JC 21: The cost of basic health care services are reduced for households due to EC 
support 
We assessed this Judgement Criterion based on five Indicators – change in the share of health spend-
ing that is out of pocket, change in the proportion covered by social security change in public / private 
health insurance contribution rates and change in the proportion of the population covered by public 
health insurance or enrolled in other public schemes. It can be said at the outset that we found virtual-
ly no reliable statistical and relatively complete information on the penultimate of these and dropped it, 
still considering that the other indicators were sufficient to provide reasonable answers the JC. 
Data point to different trends across countries in the share of total health spending that is out of pock-
et. Out-of-pocket payments discourage families from seeking needed health care and can be a major 
source of impoverishment. There is broad evidence especially from case studies that reducing the role 
of out of pocket payments has been a central EC policy goal in its project and sector support interven-
tions. TA was provided in countries such as Egypt and Philippines and, in the first case, direct support 
to provision of a basic family health package was provided in pilot provinces; in neither country case, 
however, can a significant downward trend in the importance of out-of-pocket payments be identified. 
Low quality of public services, the growing availability of non-essential medical services and rising 
incomes and expectations may all play a role. Very different are the examples of Ghana and Burkina 
Faso, which experienced major increases in the role of public finance of health care services over the 
evaluation period, changes that gave rise to striking reductions in the share of out-of-pocket spending 
in total health expenditure. Both countries benefited from EC-supported GBS and it is possible that 
policy dialogue and the fiscal space created played a role in encouraging this trend. Unfortunately, 
GBS documents consulted so far give little insight into precisely how GBS encouraged increased pub-
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lic improvement in health finance. An exception is Zambia, where there is stronger evidence that GBS 
resulted in better communications between social sector ministries and the Ministry of Finance, lead-
ing to increased social sector budgets. 
As stated in the country case studies, in a number of countries benefiting from EC support, such as 
Zambia and Afghanistan, there is no social security scheme covering health. Interpreting “social secu-
rity” loosely, the EC has provided support to strengthening and expanding national health insurance 
schemes in a number of countries. In Moldova, while the share of the national health system was un-
affected, EC policy advice and TA contributed significantly to putting the health insurance system on a 
more sustainable financial basis and generating additional resource that could be used in improving 
quality. However, there is widespread dissatisfaction with the compulsory health insurance programme 
because premiums are perceived to be high (and are rising) while the availability of diagnostics, 
treatments and drugs remains well below expectations. In Lao PDR, in the context of GBS, the EC has 
supported policy dialogue and policy advisory work on instituting health insurance, but despite expan-
sion in numbers, this remains in a nascent phase. In the Philippines, in addition to a broad and deep 
range of TA related to health care finance in general and the PhilHealth national insurance scheme in 
particular, public health insurance remains underutilised even by the covered population due to quality 
issues and problems of access, usually geographical in nature.  
The last indicator refers specifically to expansion in public health coverage. In Moldova, the goal of EC 
support was not expanding coverage which was already high) but improving finances and quality. 
Ghana saw a significant increase in membership of the national health Insurance Scheme, but it has 
not been possible to ascribe this to EC support in the context of GBS. In Egypt, there was also a sig-
nificant increase in membership of the public insurance scheme, for which the EC can probably take 
some of the credit, especially through its Health Sector Policy Support Programme (HSPSP-II). 
Finally, the case of Afghanistan deserves special mention. In that country, virtually all basic health 
care is provided through distribution of the Basic Health Services Package, which is financed in its 
entirety in ten provinces by the EC. Absent this intervention, the cost of basic health care in these 
provinces would be prohibitive. 
Under Indicator I-213, we present general EU Delegation survey evidence that the proportion of the 
population benefiting from some form of public health finance guarantee – whether direct access to 
free health care or an insurance scheme – has increased This is to some extent a result of EC support 
to health care reform. However, the EUD survey also shows that the effectiveness of such public 
schemes is low, as can be seen in the next figure. 
Figure 17: Results of the survey to EUDs: Effectiveness of the public health care financing 
scheme in financing needed care (in absolute figures - number of EUD respondents - 
and %) 
 
Source: EUD Survey, 2011, Particip GmbH  
Overall, from the information gathered, it appears that the EC has made some contribution to reducing 
the cost of basic health care services for households. In a few cases it has been via direct provision of 
health care, but that is somewhat outside the scope of this EQ. When it comes to health care financing 
systems, neither the EC nor any other donor has the resources, or the desire, to finance the large 
sums required. However, through TA and capacity building, the EC has focused policy makers on the 
financing issue and supported the strengthening of the range of financing approaches encountered. 
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5.2.2 JC 22 Increased development and sustainability of special schemes to ensure availabil-
ity of health care to groups with special health care needs supported by the EC  
We assessed this Judgement Criterion based on two Indicators: the putting in place with EC support 
of cost waiver and subsidy schemes for target groups with special needs and additional health care 
service consumption as a result of EC support for health care financing. 
A broad range of subsidy and cost-waiver schemes were identified in the country case studies, some 
directly supported by the EC, some indirectly supported and some which may be completely unrelated 
to EC support. The Egyptian Family Health Fund was supported both by TA and through direct finan-
cial input from the EC in pilot Governorates. In Afghanistan, free basic health services have been pro-
vided in ten provinces with EC support. In Ghana, nearly 70% of the population is theoretically exempt 
from fees in the compulsory National Health Insurance System; in fact, exempt populations are often 
denied care, but it is agreed that children, the elderly and pregnant women effectively benefit from 
exemptions. GBS in Ghana may have helped create fiscal space for these exemptions, just as EC 
GBS in Burkina Faso may have helped to create room to subsidise maternity services in supervised 
facilities. An important indirect support for subsidised or free services is EC support for the Global 
Fund, which provides services such as ARV therapy and TB testing / treatment in heavily AIDS-
affected countries. Most of the admittedly few respondents to the MoH survey reported that cost waiv-
er and subsidy schemes were in place and reasonably effective. However, there are countries such as 
Vietnam where it is clear from the 2009 CSE Vietnam that difficulties in identifying the poor and social 
stigma limit the effectiveness of health insurance subsidies. 
Despite EC contribution, in the EUD survey only a third of responding EUDs felt that health financing 
policy was addressing the needs of the poor “satisfactorily” or “well.” Responses from the MoH survey 
were mixed. 
Answering whether EC support resulted in additional consumption of health care by households is 
fraught with issues. While aggregate health expenditure data are widely available, data on actual 
household consumption are rare. Service utilisation data are more likely to be available. Here, too, 
there are ambiguities, for example, between needed health care and the non-essential care which is 
increasingly available. Improved access and reduced price must be set aside rising income as a cause 
of increased consumption of health care services.  
Despite these complications, a reasonable amount of evidence from country case documentation indi-
cates that EC support has resulted in additional utilisation of basic health services by households. This 
is clearly the case in Afghanistan where the EC finances distribution of a basic health benefit package 
in ten provinces and in Ecuador where, similarly, the EC supported provision of health care services in 
three under-served provinces. In Ghana, the introduction of compulsory health insurance resulted in 
an increase in service utilisation, which was one of the elements of the Multi-donor Budget Support 
programme; unfortunately, MDBS evaluation estimates are grossly lower than National Health Authori-
ty estimates. Moreover, in other countries evidence of EC impact is lacking. In Zambia, the increase in 
health care service utilisation when user fees were abolished was unrelated to EC support47.  
It should be added that findings from document analysis are largely confirmed by the EUD survey, 
where virtually all EUDs responding to the relevant question were of the view that public health 
schemes supported by the EC resulted in greater household consumption of health care services. 
 
Taken together, document analysis, the case studies and the EUD survey indicate that the EC has 
contributed significantly in a range of settings to the reducing the cost of health care to those with spe-
cial needs, with resulting increases in utilisation of health care services. 
5.2.3 JC 23 Improvements in health finance policies to enhance affordability of services sup-
ported by the EC  
We assessed this Judgement Criterion based on two Indicators, EC support for TA and the provision 
of expertise in health care finance and EC support for enhanced communication and co-operation 
between Ministries of Health and Finance.  
Regarding the first, evidence was found that, even in countries where health care finance was not a 
focus in the health sector, the EC supported TA did provide some expertise relevant to finance. For 
example, even in Afghanistan, where the focus was almost entirely on provision, the EC financed 
some studies (not TA strictly speaking) relevant to health care finance. In other countries, such as 
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 No relevant time series data were found for Moldova. 
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Egypt, the Philippines, Lao PDR and Moldova, TA on health care finance was a major contribution to 
health sector reform (source: country case studies). This is also corroborated by the findings from the 
EUD survey, where by far the majority of respondents identified TA along with capacity building as a 
major means of EC contribution in the area of health care finance (see following figure). The EUD 
Philippines reports greatly improved communications between MoH and MoF due to a united donor 
position, but while this has resulted in a larger budget for MoH, vertical communication remains poor 
and local budgets for health low. 
Figure 18: Results of the survey to EUDs: Means used by EC to support pro-poor health finance 
policies  
 
Source: EUD Survey, 2011, Particip GmbH 
Much less information was gathered on the specific question of whether EC support strengthened 
communication and co-ordination between the MoH and the MoF. Two countries where this impact 
was explicitly identified were Zambia and South Africa. For the Philippines, the EC supported better 
co-ordination in health finance generally, but especially given the complication decentralised context, 
this involved much more than simply improving communications between MoH and MoF. In general, 
the impression left by the country case studies and the interviews with EUDs and MoHs is that MoHs 
remain ineffective in their dialogue with MoFs, which is one reason why budgetary allocations for 
health remain weak in most countries. 
5.2.4 JC 24 Global research partnerships to develop new treatments and medicines relevant 
to poor countries supported by the EC  
The EC’s policy relating to research and development on global health issues is set out in the 2010 
Commission Staff Working Document “European Research and Knowledge for Global Health”48.  
We approached this JC based on two indicators, the first focusing on dialogue with the pharmaceutical 
industry and the second more generally on promoting North-South partnerships. A documentary re-
view yield little information on the first indicator, apart from DG Research contributions to, e.g. influen-
za research and pandemic preparedness (notably, contribution to the development of adjuvants which 
substantially increased global vaccine capacity). However, in the Working Document referenced 
above, it is described how the EC has participated in the Intergovernmental Working Group on Public 
Health, Innovation and Intellectual Property Rights and co-ordinated with major funders of health re-
search at the global level, all with a view to promoting access to pharmaceuticals and promoting re-
search of relevance to developing countries.  
Regarding the second indicator, our thematic case study on EC financing of global public goods for 
health has uncovered evidence of a broad and significant engagement, from framework research pro-
grammes to direct finance of initiatives related to immunisation, vaccine development, to pandemic 
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 http://ec.europa.eu/development/icenter/repository/SEC2010_381_EN.pdf  
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preparedness. Impact in science is typically long-term and unpredictable, but we can safely say that 
without EC support, there would be much less global research promoting access to drugs and treat-
ments related to malaria, tuberculosis, polio and the major infectious diseases. It is universally accept-
ed that health R&D in all forms, as well as infectious disease surveillance and control, are public 
goods which require collective action in order to ensure adequate supply. In the case of GAVI, a con-
crete estimate can be made of the EC’s contribution to the vaccination of an estimated 326 million 
persons in 2000-2010. The EC was also a major supporter of the Global Polio Eradication Initiative. As 
a supranational organisation, the EC is less susceptible to the free-riding incentive which gives rise to 
the public good problem. In addition, this is an area in which tangible benefits to European citizens, in 
the form of the reduction of global infectious disease risks, can be easily established. Much develop-
ment co-operation is based on altruism, but in the case of public goods for health, self-interest is a 
significant factor, as well. 
5.3 EQ3: To what extent has EC support contributed to improving geograph-
ical availability of health facilities especially for the poor? 
The question focuses on achieved coverage of health service delivery across the population. It specif-
ically looks at coverage of provision of primary health care and secondary (hospital) care.  
Health services can contribute to improved population health status provided they reach the great 
majority of the population, including the poor, with appropriate health interventions. Access to appro-
priate health services consists of several components: availability of primary and secondary health 
facilities within geographical reach, financial accessibility, quality of services offered and utilisation of 
the services by the population.  
This EQ looks specifically at the general geographical availability of health services - affordability and 
quality are dealt with elsewhere, although we recognise that all must be, in some sense, considered 
together in order to reach an overall assessment. 
We have addressed this EQ through two Judgement criteria: 
 Increase in availability of primary health care facilities 
 Increase in availability of secondary health care facilities 
The answer to this question is mainly based on the following sources: 
 Country Case Studies 
 EUD survey 
 MoH survey 
 International statistics 
 Selected further literature 
 Inventory 
EQ3 on Health facilities availability 
 – Summary Answer Box  
The strong emphasis on primary health care in the EC support can be seen in the distribution of finan-
cial volumes dedicated through the EC’s direct support to health. With regards to physical availability 
of health care, this is clearly reflected in the evidence found for the two judgement criteria.  
In general, access to both primary and secondary health care is not equitable within countries, not 
only in terms of affordability for different segments of populations, but also with regard to physical 
availability of health care units, which was the main focus of this EQ. Rural and remote areas are often 
underserved and geographical distance to care may result in inability to access care or access may be 
very costly in terms of time and money spent on transport. The EC has addressed this aspect of 
health care availability to some degree, more so on primary level than on secondary and in many cas-
es interventions were specifically targeted towards disadvantaged areas. 
There is evidence that the EC contributed to improved access to primary health care. Examples can 
be seen in countries such as Afghanistan, where the EC was active in 10 provinces and helped ex-
pand the heath care network through its co-operation with NGOs, or in Ecuador, where health units 
were built and improved in three provinces with high proportions of indigenous populations, or in the 
Philippines, where access was improved through extending the accreditation of health units to provide 
a larger array of services. However, it needs to be noted that the interventions to improve access to 
primary care facilities have not necessarily been translated into the improvement of indicators like 
number of units per capita and proportion of population living in certain radius of such facility. In some 
countries, potential gains in infrastructure can be offset by rapid population growth or by loss of exist-
ing units, such as in Burkina Faso, the Philippines and India. Moreover, EC support was not solely 
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EQ3 on Health facilities availability 
 – Summary Answer Box  
aiming at expanding the network of facilities, but in some cases reconstruction or equipment of exist-
ing ones, which has been relevant in for instance post-conflict countries such as the DRC. In some 
countries, mainly middle income countries, such as Moldova or Egypt, the physical availability of 
health facilities is not an issue, as sufficient numbers of health facilities exist. There, EC support was 
targeting other aspects of health care such as affordability and quality of care.  
In general, EC support for improved primary health care infrastructure targeted rural areas, a reason-
able strategy given that access is typically worse in rural areas than in urban ones. A consequence, 
however, which we have pointed out as well in answering EQ 1, is that EC interventions took little 
account of the increasing concentration of population and as a consequence health challenges, in 
urban areas. 
Related to increasing physical access to secondary care, evidence of EC contribution is much less 
available. This is ascribed not only to the fact that much smaller financial volumes have been dedicat-
ed to secondary health care compared to primary care, but also to the problem of obtaining reliable 
data on the indicator values in developing countries, especially with a time trend. Similarly as in prima-
ry care, differences in access persist between rural and urban areas. Some work on increasing func-
tional secondary care facilities has been done e.g. in DRC, where hospital rehabilitation has been 
supported as a part of the 9
th
 EDF health programme in the country. DRC has also seen the good 
improvements in road infrastructure made through the investments in the framework of the Support 
Programme for Rehabilitation, which is likely to have some spill-over effect into the accessibility of 
health units. Overall however, only little direct evidence has been found of the EC support towards 
alleviating the problem of insufficient availability of physical secondary care facilities, as most of the 
EC contributions favoured primary care access. 
5.3.1 JC 31 Increase in availability of primary health care facilities 
The JC of increase in the availability of primary health care facilities was assessed based on two Indi-
cators: change in number of primary care facilities per 10,000 population and change in the proportion 
of rural population living in a radius of 1 hour of a primary health care facility. The statistical data were 
not always readily available especially for the latter of the two.  
In general, access to primary care is not equitable within most countries and for many years rural pop-
ulations were typically the most disadvantaged. It was found in the inventory that primary health care 
has been emphasised strongly in the EC direct support to the health sector in the 2002-10 period, 
compared to secondary health care and that in many cases the EC support was preferably targeted to 
rural or poorer segments of population.  
Figure 19: Direct EC support to the health sector: Breakdown of direct support by primary health 
and secondary health care, 2002-2010 
 
N/A represents interventions which main focus is not health care but policy, 
administration, etc. 
Source: Particip Inventory 
Within the primary/basis health care sector, approximately 12% (€ 360 million) went to infrastructure 
projects (see Table 1 in the inventory section). 
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There is evidence from the country case studies that this has translated into improved access to 
health care facilities and in many cases disproportionately more so for poorer and disadvantaged pop-
ulations. Examples can be seen e.g. in Afghanistan, Timor Leste or Ecuador. However, it is important 
to note that the EC support to primary care facilities has not necessarily resulted in a positive change 
of the indicator (health facility per capita). This is because effort has also been given to the reconstruc-
tion of existing facilities, which is often necessary in post-conflict countries or fragile states, such as for 
example in the DRC. Moreover, even an increase in new health units can be offset by loss of existing 
ones or rapid population growth over the same period and the indicator remains unchanged or even 
deteriorates, such as in the Philippines or Burkina Faso. In some countries, e.g. Egypt or Moldova, the 
physical availability of health facilities is not an issue, as sufficient numbers of health facilities exists 
and contributions to primary care focus on quality and affordability of care, which would not have any 
impact on the indicators under this JC.  
Another aspect of the availability of primary care is the functionality of the health facilities, in its physi-
cal dimension described by appropriate equipment and budget for maintenance. While not specifically 
impacting on the trend in the indicators, there is evidence from the country case studies and the MoH 
survey that the discrepancy between rural and urban areas in this respect is even larger and might be 
growing. This underlines the challenge of sustainability of EC interventions aimed at increased primary 
care availability noted also by some of the EUDs.  
Time trend data on the “population within one hour of a primary care facility” were difficult to obtain. It 
can be noted that while one way of addressing the spatial availability of health care is to contribute to 
expanding the number of health care units and their equipment in underserved areas (first indicator), 
this indicator can also be tackled by investments in other types of infrastructure, such as roads im-
provements or provision of transport options in remote areas. In DRC, where distance to health facility 
was a problem in accessing health especially in rural areas, good improvements in access to facilities 
were made through the investments in road infrastructure, in the framework of the Support Program 
for Rehabilitation (PAR II) implemented between 2003 and 2007. It is thus likely that the EC interven-
tion has contributed to reducing the time needed by the rural population to access health care facili-
ties.  
It is remarkable that a basic indicator like “availability of primary health facilities” is so difficult to obtain 
from most countries. And if data are available, they are typically aggregate data, which may mean that 
the emphasis the EC put on increasing availability of primary care in the areas where the EC works, is 
not fully reflected in national data. 
Overall, country case studies, EUD survey and MoH survey indicate that the EC support to primary 
health care contributed moderately to increasing physical availability of care in many countries and 
often more so for rural and disadvantaged populations. However, sustainability of the interventions, 
together with lasting inequities between rural and urban populations, remains a challenge. While it is 
understandable that the EC has focused on access in underserved rural areas, one consequence is 
that there has been little account taken of urbanisation. Projects and interventions focusing on urban 
health were largely absent. 
5.3.2 JC 32 Increase in availability of secondary health care facilities 
The JC of increase in the availability of secondary health care facilities was assessed based on three 
Indicators: change in number of hospital beds per 10,000 population, change in the proportion of 
population living in a radius of 2 hour of a secondary health care facility and increased number of 
Caesarean sections in total deliveries. The statistical data were not always readily available especially 
for the latter two indicators.  
As discussed in JC31 above, the direct EC support to health care strongly prioritised primary care over 
secondary care and this is also reflected in much less evidence found of the EC contribution to the 
indicators in this JC.  
Some examples of the EC contribution have been found nevertheless in the country cases. In the 
DRC, the EC 9
th
 EDF health programme (PS9EDF) supported hospitals rehabilitation, which directly 
contributed to increasing the number of functioning secondary care facilities. It has been reported that 
hospitalisation rates have increased and rates of intra-hospital mortality as well as postoperative infec-
tions decreased during the programme implementation. Some countries experienced a decrease in 
the number of hospital beds per capita over the evaluation period, e.g. Moldova, Egypt, but it seems 
that quality of care or equitable access is of more concern in these countries. (I-321) 
Corresponding to the trends in primary care access, secondary health facilities are less available to 
rural populations and while the gap between rural and urban service delivery might have become nar-
rower according to the EUD survey, unsatisfactory scores made by EUDs were still quite high in 2010 
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
42 August 2012 Final Report – Volume I 
(see figure below). Again, availability of appropriate equipment and adequate maintenance budgets 
remains an issue for secondary care units and more so for those in rural areas. (I-322) 
Figure 20: Results of the EUD survey: Availability of secondary health care facilities 
  
Source: EUD Survey, 2011, Particip GmbH  
With regards to the number of Caesarean sections, some countries have already achieved or even 
surpassed the levels of international clinical good practice, which may be set at 15% – e.g. Ecuador 
26% in 2011, Egypt 28% in 2008, South Africa 20%. The contribution of the EC to increasing number 
of Caesarean sections has been difficult to find evidence for, partly due to the lack of time trends on 
the indicator and partly due to the fact that there were no interventions found that aimed at improving 
this particular indicator specifically. However, it is likely that some improvements might have occurred 
indirectly, through general support to maternal health and general quality of care. This could be the 
case for example in Bangladesh or Afghanistan, which both have had programmes with components 
on maternal health supported by the EC. Also in Egypt, which has seen the proportion of Caesarean 
deliveries rise from 7% in 1995 to 28% in 2008, the EC supported programmes to increase the use of 
health facilities and to reduce out-of-pocket payments, which could have contributed to increased ac-
cess to obstetric care. (I-321) 
Overall, only little direct evidence has been found of the EC support towards alleviating the problem of 
insufficient or inequitable availability of physical secondary care facilities, as most of the EC contribu-
tions favoured primary care access. 
5.4 EQ4: To what extent has EC support to health contributed to improving 
health service utilisation related to MNCH? 
This question focuses on those population behaviours that are particularly relevant to health seeking 
and health promotion with regard to maternal, neonatal and child care. Availability and access to 
health services is a necessary but insufficient condition to improve population health status. Another 
important aspect lays in health seeking behaviour and de facto utilisation of those health services. In 
relation to MDGs 4 and 5 it is of particular importance to assess if pregnant women and children make 
effective use of a number of key, largely preventive interventions with a well proven major impact on 
health outcomes. 
We have addressed this EQ through three Judgement criteria: 
 JC 41 Increased use of appropriate ante-natal and maternal health care supported by the EC 
 JC 42 Increased use of services and facilities to support health care for children supported by 
the EC 
 JC 43 Children better protected from key health threats as a result of EC support 
The answer to this question is mainly based on the following sources: 
 Country Case Studies 
 MoH survey 
 CSP analysis 
 Literature analysis (outside case study documentation), incl. ECA reports 
 Interviews 
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 Thematic case study on the GFATM 
 International statistics 
 Inventory 
EQ4 on Health service utilisation related to MNCH 
– Summary Answer Box  
During the last decade remarkable and constant progress has been made in the field of MNCH, how-
ever, the outcomes vary in terms of magnitude between countries, regions and especially between 
rural and urban areas. While some significant improvements in some aspects of MNHC can be ob-
served, such as in basic immunisation rates, slower progress has been recorded on many other indi-
cators, such as proportion of safe deliveries, use of modern family planning and child nutrition. Look-
ing at the regional distribution, it appears that major improvements have occurred in Asia and Northern 
Africa, less so in Sub-Saharan Africa.  
Nevertheless, MDGs 4 (maternal health) and 5 (child health) are acknowledged to be most off track of 
all MDGs. Some of this is because of the complexity of the problem area, which involves not only de-
livery of health services but also dissemination of health behavioural change, gender aspects, water 
and sanitation, transport, etc. 
Availability and, to a certain extent reliability, of statistical data on MNCH indicators is not good overall, 
especially regarding time trends, which limits the possibility to make sound statements on the change 
in the indicators. This is not an unknown fact and the claim for stronger accountability and transparen-
cy for women’s and children’s health has been reiterated in different international fora, such as recent-
ly in the Conference on Aid Effectiveness in Busan (2011).49  
Taking the inventory as an entry point, EC support to MNCH has been limited, financially speaking, 
with only 5% of all EC funds over the evaluation period being committed to the sector SRH. However, 
as MNCH interventions are rarely financed as self-standing interventions but rather included and “hid-
den” in more complex and comprehensive interventions labelled as ‘basic-health interventions’, EC 
support in the area of MNCH has in fact been higher, although the exact percentage is not identifiable. 
Although the EC emphasised in various Communications, the importance of sexual and reproductive 
health50 as well as its commitments to the MDGs, MNCH, including nutrition, rarely figures as a focal 
sector in the CSPs for the periods 2002-2007 and 2008-2013. 
The EC financed MNCH in the following ways. 
 Through including MNCH in programmes aiming directly at the provision of primary and basic 
health care, such as Basic Health Care Packages or indirectly via GBS or sector support; 
 Through individual projects targeting remote and underserved areas and excluded popula-
tions. These projects were either small NGO projects or larger-scale regional interventions, 
implemented by a partner organisation specialised in the area, such as UNPFA, UNICEF or 
International Planned Parenthood Federation (IPPF). 
 Through financial contributions to global initiatives, especially GAVI (immunisation) and 
GFATM (sexual and reproductive health and maternal health). 
An increased utilisation of health facilities by women and children is closely correlated with the availa-
bility and quality of the care provided. It appears from the analysis that EC financing of basic health 
care provision programmes (e.g. in Egypt, Afghanistan and South Africa) has been highly successful 
in improving maternal health and, to a lesser extent, in increasing the utilisation of health facilities by 
children, resulting in higher immunisation rates and better monitoring of the growth and nutrition sta-
tus. 
GBS programmes, especially in MDG contracts and PRS-based GBS, included in most of the cases 
one or several indicators related to maternal health (e.g. supervised delivery or antenatal care (ANC) 
visits) and child vaccination. The reviewed GBS (Ghana and Burkina Faso) show an overall good per-
formance and fulfilment of these indicators. Policy dialogue related to sector budget support was ex-
tremely successful in Egypt in promoting the primary health care model, with positive impacts on fami-
                                                     
49 
OECD, Commission on Information and Accountability for Women’s and Children’s Health (2011): Progress and 
Challenges in Aid Effectiveness, What can we learn from the Health sector? 4
th
 High Level Forum on Aid Effec-
tiveness (29.11.11-01.12.11, Busan Korea.  
50
 Official Journal of the European Union (2003): Regulation (EC) No 1567/2003 of the European Parliament and 
of the Council of 15 July 2003 on aid for policies and actions on reproductive and sexual health and rights in de-
veloping countries. 
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EQ4 on Health service utilisation related to MNCH 
– Summary Answer Box  
ly planning and MNCH. 
As considerable gaps remains between rural and urban areas for all MNCH indicators analysed in this 
evaluation, the EC approach in MNCH to prioritise underprivileged areas and communities can be 
seen as highly relevant. These projects, although mostly geographically too restricted to have an ob-
servable impact on national statistics, can however serve as innovative example how to address 
MNCH behaviour in different and difficult circumstances.  
Considerable EC support to SRH and vaccination was channelled through regional programmes or 
global initiatives in the ACP region and in Asia. Overall, these regional programmes have yielded good 
results and contributed to an increased number of woman and children being seeking appropriate 
health care, especially in remote areas or in cultural highly sensitive background on issues such as 
maternal health and sexual and reproductive rights. Problems highlighted in almost all regional inter-
ventions are those related to co-ordination and procedural differences, as regional programmes are 
mostly implemented by multi-lateral organisations. Especially for vaccination programmes these prob-
lems have considerably reduced the outcomes that could have been expected.  
While evidence of successful EC support to maternal health could be found, direct EC support ad-
dressing children’s health was much scarcer, especially related to children’s growth monitoring, use of 
bednets and fight against diarrheal diseases of children. The main EC contribution to children’s health 
can be found in the its support to primary health care interventions, such as the financing of basic 
health care packages (e.g. Afghanistan and Egypt) or sector programmes with a clear pro-poor focus 
(e.g. Ecuador, Bangladesh). Small project interventions contributed primarily to address specific geo-
graphical areas and to raise awareness on issues such as use of bednets, nutrition and treatment of 
child diarrhoea. 
In the area of child health, EC support to immunisation has a specific position. Immunisation has been 
funded by the EC either through contribution to large regional/worldwide vaccination campaigns 
(GAVI, Polio Eradication Campaign) or targeted country interventions (e.g. Nigeria, Ethiopia). Through 
its support, the EC has contributed, to a not negligible extent, to the raising rate of immunised children 
at a worldwide level.  
5.4.1 JC 41 Increased use of appropriate ante-natal and maternal health care supported by 
the EC 
MDG5 on maternal health is the most off track of all MDGs. With the exception of North Africa and 
some parts of Asia, overall progress in this area has been relatively slow. Although more and more 
women have access to modern family planning, receive ante-natal care during their pregnancy and 
deliver attended by skilled personnel, millions remain unprotected due to a lack of access to high-
quality care. 
The EC’s commitment to sexual and reproductive health (SRH) has been continuously strong since 
the 1990s, as set out in the 1994 International Conference on Population and Development (ICPD) 
Program of Action,51 the EC Regulation of 2003 on ‘Aid for policies and actions on reproductive and 
sexual health and rights in developing countries’52, the EU Agenda for Action on MDGs (2008), the 
‘Investing in People’ action programme 2007-201353 and in the 2010 Council conclusions on the EU 
Role in Global Health54.  
In contrast to these political commitments, SRHR does not figure prominently in the strategic planning 
of the EC, which is translated through the CSPs, as the analysis of the 25 sample CSPs shows. For 
example in Sub-Saharan-Africa, where maternal health is worst, none of the CSPs under the 10
th
 EDF 
have chosen SRH as a focal s or prioritised sector. 
Looking at the effective EC support to SRH during the evaluation period, the inventory shows that the 
sector sexual and reproductive health - which includes maternal and child health interventions - has 
received the smallest share of direct EC support, amounting to only 5% or EUR 219 million of the total 
                                                     
51 UN (1994): United Nations International Conference on Population and Development (ICPD). 
http://www.iisd.ca/cairo.html  
52 Official Journal of the European Union (2003): Regulation (EC) No 1567/2003 of the European Parliament and 
of the Council of 15 July 2003 on aid for policies and actions on reproductive and sexual health and rights in 
developing countries. 
53 European Commission: Investing in People. Strategy Paper for the Thematic Programme 2007-2013 
54 Council of the European Union (2010) Council conclusions on the EU role in Global Health 
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direct support during the period under evaluation. As can be seen in the figure below, the majority of 
funds within this subsector (84% of the funds of the SRH-sector) target reproductive health. 
Figure 21: Direct EC support to the heath sector: Sub-sector reproductive health breakdown, as 
a proportion of the total direct support to health sector, 2002-2010 
 
Source: CRIS database, analysis Particip 
Table 10: Direct EC support to the heath sector: Sub-sector reproductive health breakdown, 
2002-2010 (in EUR million and %) 
Sector categorisation 
Contracted amount 
(EUR million) 
% of the sub-
sector SRH 
Evaluation, Audits, TA 3 1% 
MNCH 25 11% 
Reproductive health  185 84% 
Sexually Transmitted Diseases (STDs) 8 4% 
Total SRH 221  
Total EC support during the period 4'118  
Source: CRIS database, Particip GmbH analysis  
However, as pointed out in the Inventory analysis, only those SRH interventions are detected which 
are primarily and solely aiming at reproductive health activities. It would be a mistake to judge the 
EC’s contribution in the area of maternal and child health purely on the amount of direct support clear-
ly labelled in the inventory as MNCH interventions, as they represent only part of actual amounts con-
tracted on reproductive health (RH).55 MNCH is often integrated in primary health care programmes, 
funded under big sector interventions (e.g. Provision of Basic Health Care Services or Sector Budget 
Support) or GBS programmes. Through these sector interventions, aiming at providing basic health 
care, access or quality of health care, the EC has certainly provided additional support for the im-
provement of maternal health, resources, although not directly quantifiable that must be added to the 
direct support to SRH. 
The JC has been assessed using three indicators: increased proportion of deliveries supervised by a 
skilled attendant; increased percentage of women receiving 4 or more ante-natal check-ups; and in-
crease in the use of modern family planning methods. 
The EC’s primary impact on the indicators related to utilisation of maternal health care services must 
be considered in the framework of its support to health sector reforms and health care delivery ap-
proaches that have been beneficial to improve access to basic services, including emergency obstetric 
services. Basic health care delivery usual includes many interventions related to reproductive health 
(such as antenatal and postnatal care and care during child birth). Good examples are EC basic 
health provision programmes in Egypt and Afghanistan, which seem to have been very successful to 
improve maternal health, according to documentation review, EUD and MoH interviews (I-411, I-412). 
Policy dialogue under sector support in Egypt was credited by the EUD as being the main factor be-
hind the increasingly primary health care orientation of MoH policy, with strongly beneficial implications 
for mother and child health. 
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GBS programmes often include performance indicators related to MNCH, such as the MDG indicator 
“Proportion of births attended by skilled health personnel”. In the reviewed GBS programmes in ACP 
countries (Ghana, Burkina Faso), supervised deliveries has been included as a performance indicator 
in the GBS triggers. The review of the tranche assessments show an overall good performance and a 
fulfilment of the indicator’s targets, although a slight trends toward a worsening of the situation can be 
seen towards the end of the evaluation period (I-411). 
A specificity of EC support to the SRH sub-sector is the high percentage of regional projects or world-
wide call for proposals.  
 71% of all SRH projects are directed to more than one country.  
 35% of SRH funds go to the ACP region, followed by Asian countries (25%), while 35% of 
funds are worldwide interventions. Examples of regional programmes are the ACP programme 
“Sexual and Reproductive Health EC/ACP/UNFPRA/IPPF Joint Programme” or, in Asia, the 
“Reproductive health initiative for youth in Asia (RHIYA)”, both with a component targeting 
ante-natal care, safe deliveries and, to some extent, also family planning.  
 A EUR 23.5 million worldwide call for proposal “Implementation of Cairo agenda on reproduc-
tive health” has been launched at the very end of the evaluation period, an assessment of its 
results is difficult at this stage  
Furthermore, it is interesting to note that 95% of EC support geared towards MNCH is channelled 
through individual projects, usually with rather small budget (less than EUR 2 million).56 In most cases, 
MNCH support is implemented by MNCH-specialised NGOs or multilateral organisations (e.g. UNFPA, 
IPPF, Marie Stopes International, or UNICEF). (I-411, 412, 413) 
Country case studies show that most of the individual MNCH projects target rural and remote area or 
conflict zones and aim at poor, underprivileged or indigenous population (e.g. Laos, Bangladesh). 
Bigger interventions, providing substantial support to maternal and child health, even financed through 
SBS, often show a similar pattern, as they target prioritised regions only (e.g. Programa de Apoyo al 
Sector Salud in Ecuador (PASSE), SBS to the Mindanao province, Philippines; HSPSP II in Egypt). 
The assessment of all three indicators of this JC shows that considerable MNCH support of the EC is 
targeted towards rural, remote and conflict areas and underprivileged communities. The gap between 
rural and urban areas is still pronounced, as evidenced by the national statistics and confirmed in by 
the responses of the MoH survey. In the intervention areas, the assessment shows that results have 
been achieved in relation to more frequent use of health facilities and services by women and children, 
resulting in an increase of almost all indicators assessed in this evaluation related to MNCH. In this 
sense, EC support to MNCH seems to have been highly relevant when specifically addressing geo-
graphical areas for which MNCH indicators were worse than the national average. (I-411, I-412, I-413) 
An increase of ante-natal visits of pregnant women is closely correlated with the availability and the 
quality of health care facilities and services. Statistics showing increasing ANC of pregnant women 
draw an encouraging picture. The EC interventions, including e.g. the increase of female health work-
ers in health care centres in Afghanistan, the provision of home based care focusing mainly on ante-
natal care in South Africa or the primary health care programme in rural areas in Egypt as well as the 
MNCH support in Burkina Faso have its share in this positive development I-412) 
In addition, GFATM programmes, although targeting primarily HIV, TB and Malaria, often include 
components aiming at improving maternal health in relation to these three diseases. The EC is one of 
GFATM’s biggest contributors. The GFATM interventions are likely to have some indirect impact on 
increasing the proportion of women using modern family planning through, for instance, awareness 
rising campaigns and condom distribution or through the new HSS component (I-413). 
Overall, EC supported to maternal health in most of the countries and this support has contributed to 
an amelioration of all three indicators – supervised deliveries, ante-natal-care visits and use of family 
planning, as shown in the country case studies. Maternal health has been supported by the EC in two 
different ways, thus allowing to targeting different country contexts and issues (e.g. neo-natal care, 
sexual rights and family planning, HIV/AIDS) adequately: 
 Support targeting in priority remote, underserved and conflict area and underprivileged popu-
lations: Targeting has been made either through low-budget NGO interventions or through 
large regional programmes implemented by specialised multi-lateral organisations. Both types 
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of interventions have yielded the expected results related to the improvement of maternal 
health. While regional support has achieved its targets, it must however been noted that prob-
lems related to the co-operation and administrative procedures between implementing partner 
organisations and the EC were frequent. Individual projects also have contributed to improved 
maternal health, although, due to their limited scope, the benefit of these projects can mainly 
be found in the awareness raising of women and communities on health behaviour related 
specifically to health behaviour during pregnancy and neo-natal care as well as sexual health 
rights. So the EC contributed locally to reduce the - still huge gap - between rural/poor/badly 
educated areas and the urban/wealthier and educated areas.  
 Support of basic health care and/or health system strengthening programmes, which often in-
cluded rather substantial targeting of maternal health, e.g. in sector programmes, SBS and, to 
some extent, also GBS. EC financing of basic health care packages (Afghanistan, Egypt) or 
support to primary health (Ecuador, South Africa, Philippines) has been most successful in 
improving maternal health (supervised deliveries as well as ANC visits) and family planning. 
Also in countries were the EC provided support via GBS (Burkina Faso, Ghana), the situation 
related to maternal health indicators, especially related to supervised deliveries, has improved. 
It must however be noted that indicators are again declining towards the end of the evaluation 
period, which might also be related to an increased population growth and a declining ratio in 
health facilities and health workers per inhabitant.  
5.4.2 JC 42 Increased use of services and facilities to support health care for children sup-
ported by the EC 
The assessment of this Judgement Criterion on increased use of services and facilities to support care 
for children is based on two indicators: percentage of children under 5 receiving regular growth moni-
toring and the child immunisation rate. 
Only very limited statistical figures are accessible for the first indicator on growth monitoring of children 
under-five. Therefore, the nutritional status of children has been used as a proxy. Globally, malnutri-
tion is the most important risk factor for illness and death, contributing to more than half of children’s 
deaths worldwide. The prevalence rate of children under five severely underweight is one indicator to 
measure the MDG target 1C “Halve, between 1990 and 2015, the proportion of people who suffer from 
hunger”, therefore the reliable data availability is better. 
As shown by the CSP analysis, nutrition is rarely included as a particular focus within the CSPs. Only 
for Bangladesh, the Philippines and Barbados evidence could be found for the CSP period for 2002-
2006. From the inventory, it is not possible to extract the exact financial amounts allocated to chil-
dren’s growth and nutrition, as those interventions will often be included in the basic health sector. 
However, 3% (EUR 138 million) of the total support health during the evaluation period went to inter-
ventions clearly labelled as “basic nutrition”, as can be seen in the figure below.  
Figure 22: Breakdown of EC committed funds within the Sector “Basic health” (contracts be-
tween 2002-2010) 
 
Source: CRIS database, Particip analysis 
With the exception of Bangladesh, where the EC supported child nutrition explicitly through the “Sup-
port to the national Health, Nutrition and Population Sector Programme,” none of the case study coun-
tries benefited from substantial interventions aimed specifically at child nutrition. Only small projects 
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related to food security and child nutrition can be found in DRC, Zimbabwe, Afghanistan, Myanmar, 
Vietnam and Yemen.  
Literature confirms that increased health service utilisation of children under the age of five has posi-
tive impacts on children’s growth monitoring. The evaluation’s analysis reveals encouraging records 
for Afghanistan (increases in child attendance to Basic Package of Health Services (BPHS) centres, 
especially an increase in girls’ attendance), Bangladesh (improved children’s nutrition status), Lao 
PDR (increased number of women consulting medical personnel with their children) and Ecuador (in-
creased number of children receiving annual check-ups in EC supported rural provinces, see box be-
low). In Egypt, as well, the promotion of the family health model through EC sector policy support has 
promoted primary health care, although child nutrition trends are discouraging (I-421). 
Box 4: Findings from the Country Case Studies: Example of the EC project PASSE in Ecua-
dor 
The situation in Ecuador highlights very well the relation between children’s health status and the population's 
overall socioeconomic status. Countrywide, 6.2% of children under-five were underweight in 2005. This figure is 
significantly higher for children of indigenous women (47%), for children of mothers with lower educational levels 
(38% in children of mothers with no education) and among the population living in the Sierra (32%) and rural 
areas (31%).  
The EC support within the PASSE project aimed at increasing the access to health care in three rural provinces. 
As can be seen in the evaluation reports of PASSE, the EC has likely contributed to the increased use of services 
and facilities by children and this situation translated into an increased number of children between 1 and 4 years 
receiving annual check-ups. The following graphics shows the ratio of annual check-ups of children between one 
and four years compared to the total of children in this age category in the three provinces of the PASSE imple-
mentation in the period 2004 to 2008. 
Figure 23:  Change in number of annual consultation per region for children aging between 1 and 4 years. 
(Ecuador) 
 
The number of annual check-ups for children between 1 and 4 years in the three provinces covered by the project 
shows a growing pattern, similar to the entire country. Notably, coverage in the province of Bolivar remains nearly 
four times that of the national average and the other two provinces. These data tend to suggest that the EC sup-
ported project had a positive impact on this indicator, at least during the mid-to-late years of the evaluation period. 
Source: Evaluación final del programa de apoyo al sector salud en Ecuador, PASSE, Final Report, 09/2010 
According to the inventory, the EC has supported vaccination interventions with EUR 180 million, 
which represents 4% of the total EC support to the health sector during the evaluation period. The 
majority of funds (EUR 100 million) went to global initiatives, such as GAVI (EUR 39.4 million)) and the 
Polio Eradication Campaign, implemented by the WHO (EUR 60 million). Remaining funds went to 
large scale country vaccination interventions in Nigeria and Ethiopia. However, evaluations of both 
global initiatives show a mitigated picture concerning the results of routine immunisation campaigns 
(funded by GAVI) or specific campaigns tackling measles (GAVI) or polio (WHO). While some signifi-
cant progress related to the vaccination coverage of children has been made in a number of countries 
related to polio and measles vaccination, shortfalls in vaccines, delayed vaccination activities or poor 
implementation of the immunisation campaigns have led to new outbreaks and failure to reach initial 
targets. Moreover, large donor-funded vaccination campaign, especially when it comes to routine vac-
cination, also implies a certain risk to substitute the government’s own activity. However and despite 
some negative points, it can be concluded that EC financed country wide immunisation programmes, 
helped considerably to raise awareness for the importance of children’s immunisation and made a 
concrete contribution towards higher immunisation rates. 
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Box 5: Findings from the Country Case Studies: EC support to immunisation: The Nigerian 
EC-PRIME57 programme as an example 
The EC-PRIME project 
The PRIME project was implemented from 2001 to 2009, starting at a time when immunisation state was very 
poor in Nigeria, with only 13% of children in the country fully immunised. Its primary aim was to facilitating change 
and behaviour regarding immunisation. The “Change agent programme” therefore exposed committed individuals 
to countries that had excelled in their immunisation programmes and Primary Health Care.  
Achievements of the PRIME project 
PRIME supported eight international study tours to Tanzania, Zambia, Egypt and Malaysia. Results of these study 
tours helped to resolve the polio rejection controversy in the country, as religious and traditional leaders publicly 
announced their support for Polio immunisation and withdrew previous statements that immunisation would be in 
conflict with Islamic law. 
The identification of targeted change agents or champions within government at all levels has institutionalised the 
commitment to Routine Immunisation (RI) as opposed to an emphasis on campaigns, national immunisation days 
(NIDs) or other one-off efforts to raise the level of immunisation coverage.  
These important achievements of EU-PRIME have enhanced the potential for sustained government-managed-
and-financed RI activities beyond the lifetime of the project. There seems to be a general agreement by all stake-
holders that the EC support has contributed to the greater immunisation coverage of the population. PRIME is 
considered as a success programme of EU assistance in Nigeria. 
At regional level within Nigeria, the EC-has supported six focal states. Cold chain systems have been in place in 
2010 and services continued even after the termination of PRIME in June 2009. However, only a few activities 
could be supported in the 17 additional States from 2008 onwards. The State-specific routine immunisation pro-
ject “Support to Routine Immunisation in Kano State” (SRIK) has not yet materialised, although it would be need-
ed, as Kano State is a hotspot for wild polio spread.  
Problematic aspects of the PRIME project 
There is the impression that PRIME was a substitute for the Government of Nigeria rather than a change facilita-
tor. This impression, according to the CSE, is evident both in government circles and also among other donors 
operating within the immunisation sector.  
There is, however, recognition that the project itself has adopted a resource mobilisation approach at level to 
encourage Government to put into practice mechanisms for supporting RI and also some evidence that certain 
States are beginning to adopt a resource mobilisation approach at Local government area (LGA) level. 
At state level, cost sharing between the Federal level, State and LGA levels remains problematic. As disease 
prevention is a public good, which benefits to the whole nation (and beyond, as in the case of polio eradication as 
a global goal), the increased reliance on individual federated states to prioritise routine immunisation cannot be 
considered a viable approach, so the conclusion of the CSE. 
Source: Country Strategy Evaluation (2010) 
In addition to direct and identifiable support to vaccination initiatives, the EC has contributed to pro-
gress related to immunisation of children through its support to basic health care and general health 
systems strengthening, as evidence from country case study confirms. In GBS and health sector sup-
port programmes, immunisation rates (three doses of the combined diphtheria/pertussis/tetanus vac-
cine (DPT 3) and measles) were a frequent performance indicator and the evaluation’s assessment of 
a selection of GBS programmes showed that the targets were reached in most of the cases. In coun-
tries where the EC financed health facilities and basic health care, which would include Afghanistan, 
DRC, Egypt, Lao PDR and Ecuador, the EC contributed to improved immunisation of children. Health 
sector programmes focusing essentially on pro-poor health, such as in Bangladesh and South Africa, 
contributed to an increased number of children receiving vaccination. These same programmes as 
well as more specific immunisation interventions contributed to strengthening national capacities to 
further develop their own national (routine) immunisation programme (e.g. Nigeria, Burkina Faso, 
Bangladesh, South Africa).  
To conclude, information on EC support to a better monitoring of children’s growth and nutrition status 
is scarce, although some positive developments in the numbers of children being regularly growth 
monitored (Afghanistan, Bangladesh, Ecuador) can be seen in a selection of EC financed interven-
tions which aim at increasing service utilisation by children and at the same time having an impact on 
growth monitoring of children. Discouragingly, in one country where the EC contributed substantially to 
primary health care through sector support, Egypt, child nutrition continues to be a major and worsen-
ing public health problem. In contrast to the first indicator, EC support to immunisation is much more 
pronounced and identifiable, either through contribution to large regional/worldwide vaccination cam-
paigns such as GAVI and polio eradication or targeted country interventions (e.g. Nigeria, Ethiopia). In 
the majority of EC supported countries results in terms of increased child vaccination coverage are 
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good. Furthermore, the EC also contributed, through its immunisation programmes, to an increased 
awareness on the importance and use of children’s immunisation. 
5.4.3 JC 43 Children better protected from key health threats as a result of EC support 
Thousands of child deaths could be averted through a combined prevention and treatment strategy 
implemented at household level – interventions such as improved mother and child nutrition; Oral Re-
hydration Therapy (ORT); new low-osmolarity formulations of oral rehydration salts (ORS); zinc sup-
plementation during diarrhoea episodes and improved personal and domestic hygiene, including keep-
ing food and water clean and washing hands before touching food and micronutrients.  
We assessed this Judgement Criterion on child health based on three indicators: Increased proportion 
of children sleeping under a bednet and reduction in rate of child deaths from diarrhoeal diseases and, 
closely related, an improved household management of diarrhoea based on ORS.  
International statistics indicate that over the evaluation period there has been a substantial increase in 
the proportion of children sleeping under insecticide-treated bednets (ITNs). Especially in the malaria 
risk zones of sub-Saharan Africa, data for 2009-2010 show that ITN coverage increased and, further, 
disparities in the use of bednets among population groups reduced58. This is largely due to nationwide 
campaigns aiming at the distribution of free nets with a specific focus on poor, rural areas as well as 
pregnant women and children, to which the EC has indirectly contributed through its GBS support , 
e.g. in Ghana and Burkina Faso. 
The GFATM, of which the EC is one of the largest supporters, is the biggest distributor of bednets in 
the developing world. Figures show that GFATM activities, financed by the EC, have contributed to 
considerably increase bednet coverage for children especially in high-risk zones and countries such 
as West- and Southern Africa (Ghana, Burkina Faso, Zambia), where figures increased from almost 
no use at of bednets for small children at the beginning of the evaluation period to a coverage of 
around 40% in 2009-2010. Furthermore evidence from the country case studies shows that the EC 
financed small self-standing projects in Afghanistan, Bangladesh and Laos which have resulted in an 
increased availability of ITNs as well as awareness raising on its use, especially for children and preg-
nant women. Two EC initiated projects on bednet distribution in Afghanistan and Laos (the latter in the 
context of a regional project which also covered Vietnam and Cambodia) have been continued by the 
GFATM after the project end. These examples, as well as the rather small amounts of EC funds direct-
ly targeting child health, highlight that the EC has chosen to channel its main support related to malar-
ia-control activities through other than bilateral support, i.e. mainly through the GFATM, as it has 
greater expertise and influence in this area. (I-431) 
According to UNICEF and WHO, diarrhoea remains the second leading cause of death among chil-
dren under five globally. Nearly one in five child deaths is due to diarrhoea. Diarrhoea is more preva-
lent in the developing world, in large parts due to the lack of safe drinking water, sanitation and hy-
giene, as well as poorer overall health and nutritional status. Diarrhoea deaths are concentrated in two 
regions (Africa 46% and South Asia 38%).59 The use of oral rehydration salt (ORS) therapy and con-
tinued feeding is an effective way to children to save children from death caused by diarrhoea and can 
be directly applied by the families. 
The evaluation did not find evidence, neither in the inventory nor in the country case studies, of single 
EC interventions specifically targeting the treatment of children affected by diarrhoea. The biggest 
impact of the EC on this indicator must to be seen in EC-financed primary health care interventions, 
which also target children’s health and are particularly effective in combating diarrhoeal diseases. 
Through increased availability of primary health care facilities, awareness and the treatment of diar-
rhoeal diseases have improved in countries such as DRC, Afghanistan or Bangladesh. General sector 
strengthening support, be it through GBS or support to sector wide programmes, had an impact on 
treatment of diarrhoeal diseases, such as in Ghana (GBS) or Bangladesh (Health, Nutrition and Popu-
lation Sector Programme (HNPSP)). Furthermore, individual NGO-implemented projects operating in 
remote areas or targeting vulnerable people, have locally have increased knowledge and awareness 
on the origin of diarrhoeal diseases and contributed to the promotion of better prevention and treat-
ment of diarrhoeal disease of young children (Laos, Philippines). (I-432; I-433) 
In sum, no direct interventions to both indicators could be found. However, the EC contributed indirect-
ly to increased availability of ITN through GBS and its impressive contribution to the GFATM activities. 
Concerning the treatment of diarrhoea through ORS, the EC has through its support to primary health 
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care, in some countries, contributed to reducing child mortality due to diarrhoea diseases, e.g. by fi-
nancing of basic health care packages in Afghanistan and DRC. Small projects have helped to spread 
the knowledge on water-borne diseases and increase the use of ORS, especially in remote and rural 
areas.  
It must however be noted that the fight against diarrhoea is closely linked to the water and sanitation 
sector, which was not included in the scope of the present evaluation. Through its support to the water 
and sanitation sector, the EC has certainly also further contributed to fighting diarrhoea. 
5.5 EQ5- To what extent has EC support to health contributed to strengthen-
ing the management and governance of the health system? 
This question aims to address the management and governance capacity – as well the policy making 
capacity of the health system. Governance in health is being increasingly regarded as a salient theme 
on the development agenda. Leadership and governance in building a health system involve ensuring 
that strategic policy frameworks exist and are combined with effective oversight, coalition-building, 
regulation, attention to system design and accountability. The need for greater accountability arises 
both from increased funding and a growing demand to demonstrate results.  
Accountability is therefore an intrinsic aspect of governance that concerns the management of rela-
tionships between various stakeholders in health, including individuals, households, communities, 
firms, governments, nongovernmental organisations, private firms and other entities that have the 
responsibility to finance, monitor, deliver and use health services. Accountability involves, in particular: 
(i) delegation or an understanding (either implicit or explicit) of how services are supplied; (ii) financing 
to ensure that adequate resources are available to deliver essential services; (iii) performance around 
the actual supply of services; (iv) receipt of relevant information to evaluate or monitor performance; 
(v) enforcement, such as imposition of sanctions or the provision of rewards for performance.  
Governance in health is a cross-cutting theme, intimately connected with issues surrounding account-
ability and transparency. In the context of health systems strengthening, it is an integral part of the 
health system components. Despite consensus on the importance of leadership and governance in 
improving health outcomes, they remain inadequately monitored and evaluated. 
The question is to consider how EC support has helped the partner government in these areas and 
the extent to which the EC practices contribute to improved sector governance and transparency. It 
has been addressed through two JCs: 
 JC 51 Improved availability of policy analysis and data for health sector management and 
governance due to EC support 
 JC 52 Strengthened and operational institutional and procedural system related to transparen-
cy and accountability issues at national and sub-national level due to EC support. 
The answer to this question is mainly based on the following sources: 
 Country Case Studies 
 EUD Survey 
 ECA reports 
 MoH survey 
 Selected further literature on Budget Support 
 Interviews 
 ECA reports 
EQ5 on Management and Governance 
– Summary Answer Box  
There is mixed evidence on the degree to which EC assistance has contributed to strengthening the 
management and governance of health systems. In some areas there has been a clear contribution 
such as in strengthening health policy strategy processes. This has been through improving the avail-
ability of policy analysis and data, supporting the preparation of national strategic health plans, the co-
ordination of performance monitoring, development of health indicators and assisting in the develop-
ment of sector co-ordination mechanisms. Key issues related to health sector management and gov-
ernance such as PFM, accountability and capacity have also been incorporated into policy dialogue in 
most cases. 
The EC has also made some contribution to strengthening institutional and procedural systems related 
to transparency and accountability in the countries in which it has implemented programmes. The 
majority of the EC’s work has been addressing public financial management and this has been the 
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EQ5 on Management and Governance 
– Summary Answer Box  
area where there has been most success. There has been some technical and capacity building sup-
port provided by the EC to assist Ministries of Health in establishing and monitoring Annual Work 
Plans and budgets, but this assistance has not been comprehensive as it was only been provided to a 
limited number of countries.  
Most of this support has been in the form of TA to support the drafting of health sector plans, Medium-
Term Expenditure Framework (MTEFs) and development of indicators, while EUDs in country have 
been active in establishing health co-ordination mechanisms. Evidence also indicates that there has 
been a good level of dialogue in health sector forums related to PFM, accountability and capacity 
building measures, in the majority of countries, although it is not always clear the extent to which this 
dialogue has resulted in strengthened capacity in these areas as a result. 
In some instances the development of plans and health policy related processes have been included 
as conditions in policy matrices to provide further leverage for these mechanisms to be established. 
There is however little evidence as to how successful the EC support was in strengthening health sec-
tor processes. Also, in some countries the EC has not made such a large contribution in these areas, 
mainly when there are few donors present to co-ordinate with or the government is not interested in 
dialogue, as aid does not represent a high percentage of the government budget. 
The EC has undertaken limited work on decentralised capacity building to strengthen health policy 
capabilities, but not in all countries, which is an issue as capacity at provincial and district levels re-
mains low. 
Procurement is the governance area where there had been the least contribution by the EC; there 
appears to be little focus in EC health programmes on this aspect. 
5.5.1 JC 51 - Improved availability of policy analysis and data for health sector management 
and governance due to EC support 
There is mixed evidence from country case-studies, CSPs, interviews and the EUD survey on the 
degree to which EC assistance has improved the availability of policy analysis and data to strengthen 
management and governance in the health sector. The EC has clearly contributed to strengthening 
health policy strategy processes and has incorporated key issues such as PFM, accountability and 
capacity into policy dialogue, but there is less evidence of these activities being sustainable. Moreo-
ver, little work has been undertaken by the EC at sub-national level.  
The EC has, however, made a contribution to strengthening overall health policy strategy processes in 
the countries in which it works by supporting the preparation of national strategic health plans, the co-
ordination of performance monitoring and preparation of indicators and has assisted in the develop-
ment of sector co-ordination mechanisms. The EC not only aligns its support to these plans, but also 
engages in co-ordination mechanisms related to health such as policy dialogue, joint sector analysis 
and reviews. 
Most of this support has been in the form of TA to assist in the drafting of health sector plans, MTEFs 
and development of indicators, while EUDs in country have been active in establishing health co-
ordination mechanisms. In some instances the development of plans and health policy related pro-
cesses have been included as conditions in policy matrices to provide further leverage for these 
mechanisms to be established. There is however little evidence given as to how successful the sup-
port given by the EC was in strengthening these processes. Also, in a few countries, the EC has not 
made such a large contribution in these areas, mainly when there are few donors present to co-
ordinate with or the government is not interested in dialogue, as aid does not represent a high per-
centage of the government budget. 
EC policy dialogue related to health in GBS/SPSP forums has incorporated PFM, accountability and 
capacity building measures, in the majority of countries, although it is not always clear the extent to 
which this dialogue has resulted in strengthened capacity in these areas. These issues were often 
introduced into this dialogue by the inclusion of indicators related to the three areas into policy matri-
ces or through the EC raising specific issues. The willingness of governments to engage with the EC 
in these areas was an important factor in the EC achieving successful dialogue. 
The EC has undertaken limited work on decentralised capacity building to strengthen health policy 
capabilities, but not in all countries and often the support undertaken has not been sufficient. This is 
probably due to the fact that most SBS/SWAps tend to focus more on upstream policy and monitoring 
processes, rather than the actual delivery of services. It is also notable that in the countries where 
decentralisation has been addressed, capacity building support was provided through projects. The 
activities that have been implemented ranged from TA to support and building capacity at local gov-
ernment level developing road maps to guide the decentralisation of health budgets, training in Inte-
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grated Financial Management Information Systems (IFMIS) at local level capacity building and sup-
porting planning. It is not clear in all cases from the information analysed, what tier of local govern-
ment this work was aimed at and the extent to which it was successful. This is an omission as it is 
pointed out by the European Court of Auditors (ECA) report on health services in Sub-Saharan Africa 
that low capacity at provincial and district level negatively affects the performance of EDF projects. 
Examples of where capacity building at local level has been successful include the Philippines, India, 
Ecuador, DRC, Afghanistan and South Africa (see box below): 
Box 6: Successful examples of support to strengthening health systems at the local level  
Afghanistan – Under the ‘Health Management Training to the General Directorate of Provincial Public Health, 
Ministry of Public Health’ (2006-2009), the EC strengthened the managerial and administrative capacity of the 
Afghan Ministry of Public Health for providing an efficient, accessible and equitable health services to the Afghan 
population at large and specifically in rural and remote areas.
60
 This was undertaken through a combination of 
national and international TA supply contracts and training. The programme has a positive impact on the capacity 
of the provincial public health and as an example, other donors started to replicate the same format late in 2007. 
India – The Health and Family Welfare Development Programme, 1998-2007 (HFWSD) programme’s support to 
the decentralisation process and to the planning and implementation capacity of State and District health authori-
ties has led to better-defined roles and responsibilities. The initiative also allowed State and District health authori-
ties to develop various initiatives to recruit and retain staff and to increase and maintain their skills and 
knowledge. These initiatives range from various training programmes to incentive schemes, including renovated 
staff houses for health workers.
61
 The HFWSD programme has also played a crucial role in the decentralisation 
process by providing budgets to participating Districts, based on plans developed by the District authorities in 
addition to the existing, rigid expenditure-based funding from State and national level. 
Ecuador – The TA attached to the main health sector programme (PAPES) had four different technical support 
and training programmes supervised by four national institutions. This has strengthened the PFM capacity of local 
governments where there have been interventions. 
DRC – EC support in capacity development have prioritised the decentralised level, especially targeting health 
facilities. The PS9FED has supported the provincial health departments by creating an expert team at provincial 
level, which has helped the DPS to better fulfil their new role in the context of devolution of responsibilities.
62
 
Philippines - The EC programme on health provided TA to support both the local government units and the DoH 
in systems strengthening (planning, procurement internal control, performance-based monitoring) and improving 
budget credibility and budget execution. This led to an improvement local health systems due to enhanced co-
ordination across local health systems, enhanced effective private-public partnership and improved national ca-
pacities to manage the health sector, in particular in the areas of PFM (e.g. procurement, finance, internal con-
trols) and information systems.  
South Africa - The Delivery of Primary Health Care including HIV and AIDS Programme (PDPHCP) I and II were 
successful in supporting decentralised capacity building to strengthen health policy capabilities at provincial, dis-
trict and local level. The 2009 MTR
63
 states that through PDPHCP II 1,264 non-profit organisations were funded 
to provide the primary health care packages to support the DoH in provide PHC to all communities. By 2009 the 
programme was operational in 40 of the 52 health districts in the country. 
Source: EUD Survey (Philippines), Country Case-study Afghanistan, DRC and South Africa 
5.5.2 JC 52 Strengthened and operational institutional and procedural system related to 
transparency and accountability issues at national and sub-national level due to EC 
support 
The EC has made some contribution to strengthening institutional and procedural systems related to 
transparency and accountability in the countries in which it has implemented programmes. The majori-
ty of the EC’s work has been addressing public financial management and this has been the area 
where there has been most success. There has been some technical and capacity building support 
provided by the EC to assist Ministries of Health in establishing and monitoring Annual Work Plans 
and budgets, but this assistance has not been comprehensive as it was only been provided to a lim-
ited number of countries. The area where there is least evidence of EC support is procurement as 
there appears to be little focus on this in EC health programmes. 
In terms of improving transparency and accountability, much of this work has been aimed at strength-
ening public financial management, planning, statistical strengthening and auditing, with less evidence 
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 Final Progress Report on Health Management Training to the General Directorate of Provincial Public Health, 
Ministry of Public Health 
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 India CSE 2007 
62
 Country Case-study 
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 Expanded Programme of Partnerships for the Delivery of Primary Health Care, HIV&Aids Services – PDPHCP 
II, Mid-Term Review, September 2009 
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of support aimed at the division of roles and responsibilities between the MoH and MoF. Most of this 
support was through TA or through actions related to PFM in health sector policy matrices and has 
included work at both national and sub-national level. This has resulted in improvements in most coun-
tries where the EC had provided this support (I-521) 
There has also been some technical and capacity building assistance given by the EC to assist Minis-
tries of Health in establishing and monitoring Annual Work Plans and budgets in a limited amount of 
countries. This has been reasonably successful in supporting Ministries of Health in strengthening 
their capacity for establishing and monitoring Annual Work Plan and Budgets linked to health sector 
plans and budgets. This support has not been comprehensive, however and it is notable that there 
has not been much assistance in this area to Sub-Saharan African countries. It is not clear why this is 
the case, but could well be due to the fact that and other development partners may be providing sup-
port in this area so the EC does not need to fund these activities. (I-522) 
EC support to the health sector has not focused very strongly on procurement reform. Where there 
has been support, it has mainly been in the form of (i) public financial assessments of the current sys-
tem and (ii) technical assistance to the government and there is little evidence provided of improve-
ments in accountability and transparency from these activities. 
5.6 EQ 6: To what extent and how has the EC contributed to strengthening 
government-led co-ordination, complementarity and synergies with Mem-
ber States and other donors in the health sector, in line with the Paris 
Declaration? (national, regional and global levels) 
This question focuses on how efforts in support of the health sector were co-ordinated – between the 
EC and the EU MSs and with other donors and funding agencies – and whether this led to comple-
mentary emphasis and approaches. With the increasing acceptance of programme and sector ap-
proaches to health sector support, donor co-ordination and complementarity have become increasing-
ly important. This is underpinned by the fact that these are crucial elements in the Paris Declaration. 
With the advancement of joint approaches of Development Partners and Development Banks towards 
budget support, donor co-ordination is even more essential.  
Policy documents and evaluations suggest that the EC is well placed to take a leading role in co-
ordination
64
, by way of the special position with regard to MS and through experience with and major 
involvement in the health sector worldwide. The EQ seeks to provide answers on EC’s leading role in 
that regard. 
Moreover, dialogue and co-ordination should not be confined to programme preparation. On-going 
dialogue and co-ordination efforts are necessary for monitoring implementation progress and for tak-
ing necessary corrective actions.  
By looking into all these aspects, the question aims at providing information on the EC’s value added 
in the health sector in relation to the benefits that would have resulted from Member States' interven-
tions only. 
Co-ordination and complementarity issues are very much related as well to the issues of alignment 
and harmonisation as spelled out for instance the Paris Declaration’s indicators related to these is-
sues. Grasping some aspects of alignment and harmonisation efforts under this EQ will complement 
the assessment. 
In addition to country co-operation, the EC uses financing channels such as World Bank, GFATM, 
GAVI, etc. This question will therefore also analyse the complementarity with them and possible syn-
ergies between such channels and other EC modes of supporting the health sector. 
The evaluation question is addressed through the following two JCs:  
 JC 61 Level of health sector-related co-ordination in place with active role/contribution of the 
EC 
 JC 62 Increased complementarity of EC support and between EC support and support of oth-
er donors 
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 See e.g. Midterm Review: “The EU’s Contribution to the Millennium Development Goals-Halfway to 2015”, 
report by Alliance 2015. The European Economic and Social Committee and the Committee of the Regions: 
“Keeping Europe’s promise on Financing for Development” Com (2007) 164final. See also: Treaty of Amsterdam, 
Article 180; and, for instance: Evaluation Services of the European Union (2004): The Treaty of Maastricht and 
Europe’s Development Co-operation. Triple C Evaluations, No. 1. 
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The answer to this question is mainly based on the following sources: 
 Literature analysis 
 EUD Survey 
 Paris Declaration Evaluation 
 CSP analysis 
 Thematic case studies: ‘Global public goods’ and ‘GFATM’ 
 Interviews 
 ECA reports 
EQ6 on Co-ordination, complementarity and synergy 
– Summary Answer Box 
Overall donor co-ordination in the health sector has considerably improved over the period under 
evaluation and can generally be judged as good in 2010. The EC usually participates actively in sector 
co-ordination and most EUDs have also been involved in one or several formal sector working groups. 
However, EUDs chaired only few co-ordination mechanisms including donors only. Specifically related 
to EU MS co-ordination, the EC has played a key role, most of the time chaired these groups and thus 
provided added value. The tool “Delegated Partnership Agreements” may, in the future, help to further 
simplify co-ordination among donors, just by reducing the number of players involved in these pro-
cesses, while at the same time ensuring that EC has adequate access to relevant information. 
Co-ordination mechanisms including partner governments have also been an important ingredient of 
co-ordination during the period under evaluation with an active participation of the EC. EC played a 
key role in a good number of countries in the health sector, e.g. by being increasingly involved in 
forms of sector support, including SWAp and channelling funds via common baskets (e.g. Zambia). 
Since 2003, there is a general trend towards more formal co-ordination, involving all donors working in 
the health sector and engaging the governments in the co-ordination tasks for the health sector. The 
move towards more sector support also requires closer co-ordination between MoH and Development 
Partners (DPs). The increasing role of partner governments in donor-government co-ordination mech-
anisms clearly demonstrates the improving capacity of governments to steer and co-ordinate donor 
assistance. However, some respondents of the MoH survey indicated that their weak capacity and low 
government leadership continue to be a major bottleneck. The main problems identified in these co-
ordination mechanisms are the difference in priorities, procurement policies and rules among donors. 
Increased government leadership is often a result of an emerging sector approach (e.g. Philippines, 
Tanzania). However, there is little evidence on EC support in the health sector affecting government’s 
capacity to steer and co-ordinate donor assistance.  
The use of parallel PIUs has decreased during the evaluation period. There is a clear will to phase out 
during these parallel units, thus showing progress of EC support to health in achieving Paris Declara-
tion indicators. It appeared that, where parallel PIUs in the framework of EC support in the health sec-
tor have existed over the evaluation period, problems such as creating parallel power structures, dis-
tortion of salaries and diversion of staff and difficulties in achieving sustainability tend to occur. 
Co-ordination can help achieving complementarity. Overall and especially for the second programming 
period within the evaluation period (i.e. from around 2007 onwards), there is further evidence of co-
ordination of the programming process with other donors, thus allowing for complementarity and syn-
ergies. In this context, an enhanced Division of Labour among EU MS became clear for this second 
period, most of the time in the EC programming process but also in implementation. In particular, the 
EU Code of Conduct and the Nordic Plus Initiative have contributed to limiting overlaps in EU donors’ 
sector support in partner countries. Within this framework, a Joint Action Plan has been agreed and a 
donor task force has established the comparative advantage of donors, in order to enhance Division of 
Labour in the implementation among EU donors. 
The Paris Declaration of 2005 has certainly further strengthened joint efforts between donors and 
governments. A number of JAS have been developed during the evaluation period. However, they are 
not necessarily complete nor applied in all areas of support. Moreover, too many separate strategies 
and initiatives are a major area of concern. Progress has also been made in increasing the number of 
joint field missions and shared analytical work. The driving forces to start using joint actions during the 
evaluation period are the improved capacity of the MoH, taking the lead on the sector approach or the 
introduction of a new sector-wide intervention.  
The EC has provided considerable financial contribution to global trust funds as well as trust funds at 
country level. While, across the board, complementarity of these funds with other EC support at coun-
try level can be assessed as rather good, co-ordination at country level between the participants of the 
trust funds has shown to be sometimes problematic (e.g. different administrative procedures, different 
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EQ6 on Co-ordination, complementarity and synergy 
– Summary Answer Box 
objectives and strategic goals). The main factor of success identified in the implementation phase of 
multi-donor trust funds are a regular and transparent dialogue between donors and partner govern-
ments, as well as an active participation of EUDs in the steering and co-ordination committees. With 
its support to global trust funds, the EC provides an important contribution to Global Public Goods for 
Health. In the case of GFATM, the significant role of EC headquarter has found to be in contrast to the 
limited role played by most EUDs in the partner countries. 
5.6.1 JC 61 Level of health sector-related co-ordination in place with active role/contribution 
of the EC 
Overall donor co-ordination in the health sector was judged by the EUDs as rather positive in 2010 
and communication and co-ordination between the Development Partners has considerably improved 
between 2002 and 2010. As for co-ordination between donors and related to EC support to the health 
sector, including the EU MS, findings reveal a rather positive picture. Since 2003, there is a general 
trend towards more formal co-ordination, specific to the health sector, involving all donors working in 
the health sector and engaging the governments in the co-ordination tasks for the health sector. Spe-
cifically related to EU MS co-ordination, the EC has played a key role, has chaired these groups and 
thus provided added value. 
The following figure depicts the main types of co-ordination mechanisms related to the health sector 
that the evaluation team could identify, from numerous sources like the EUD survey, the Paris Decla-
ration evaluation, CSEs and sector evaluations. 
Figure 24: Co-ordination mechanisms in the health sector 
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Source: Particip analysis 
According to the EUD survey, most EUDs have been involved in one or several formal sector working 
groups. The EC participated actively in sector co-ordination and only few EUDs (mostly when GBS 
was provided) reported no participation at all of the EC in sector-related co-ordination groups. Howev-
er, EUDs chaired only few co-ordination mechanisms including donors only and thus provided much 
less value added as compared to EU MS co-ordination. The tool “Delegated Partnership Agreements” 
may, in the future, help to further simplify co-ordination among donors, just by reducing the number of 
players involved in these processes, while at the same time ensuring that the EC has adequate ac-
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cess to relevant information. However, according to an EC mandated study on Development Partner-
ship in Action (DPA) in the health sector65 of June 2011, the only DPA to date can be found in Tanza-
nia. (I-611) 
Box 7: Tanzania: Example of a Delegated Co-operation Partnerships between EUD and EU MS 
in the health sector 
The German Embassy - through its bilateral co-operation (Deutsche Gesellschaft für Internationale Zusam-
menarbeit GmbH ) – and the European Union Delegation in Tanzania decided to co-operate strategically for de-
velopment assistance in the health sector of the Republic of Tanzania, in the spirit of greater donor co-operation 
and harmonisation. In accordance with the EU Code of Conduct of Complementarity and Division of Labour in 
Development Policy and the subsequent Division of Labour agreements in Tanzania, the EC under the 10
th
 EDF 
is no longer involved in the health sector. However, the EC is still following the developments in the sector, nota-
bly in the context of the MDG contract which includes a number of health indicators. In consultation with HQ, the 
Delegation has therefore signed a formal MoU empowering the German Embassy as the co-ordinator of the Ger-
man Development Co-operation in Tanzania – which is an active partner in the health sector – to engage strategi-
cally on health policy related matters on behalf of the EC. This arrangement should ensure to the EC access to 
health-related information required to inform the preparation of budget support payment files. The documents 
signed between the two parties - on the 15
th
 of December 2009 – detail the: (i) Scope and representation of the 
agreement; (ii) Responsibilities of the Lead and Silent partners and (iii) Monitoring, evaluation and reporting.  
Source: Study on DPAs in the health sector, 2011, EUD presentation workshop in Brussels 27-29th June 2011 
The move towards more and more sector support requires closer co-ordination between MoH and 
DPs, especially when programme implementation is not as smooth as hoped for (e.g. Bangladesh). 
EC also played a key role in a good number of countries in the health sector, e.g. by being increasing-
ly involved in forms of sector support, including SWAp and channelling funds via common baskets 
(e.g. Zambia). Health sector working groups (HSWG) in which governments usually participate, are 
more technical in nature and rather focus on operational (rather than strategic) information sharing. 
HSWG are sometimes underpinned by Task Forces or specialised sub-groups (e.g. Bangladesh), or 
specialised sub-groups work e.g. on Maternal Health (e.g. Morocco), HIV (e.g. Moldova), Tuberculosis 
and vaccination (e.g. Burkina Faso).  
Co-ordination mechanisms including partner governments have been an important ingredient of co-
ordination during both periods under evaluation. Overall, the EC was active in this type of co-
ordination mechanism, with almost two thirds of the EUDs participating actively and regularly or at 
least on specific occasion. Among the EUDs not participating in sector co-ordination groups, were, not 
surprisingly, GBS-countries (Ghana) and SBS-countries (South Africa). On the other hand, this pattern 
cannot be generalised, as EUDs in Laos, Mozambique and Vietnam claim to have participated actively 
or occasionally in technical health working groups gathering donors and partner governments. 
The increasing role of partner governments in donor-government co-ordination mechanisms clearly 
demonstrates the improving capacity of governments to steer and co-ordinate donor assistance. How-
ever, evidence on EC support in the health sector affecting government’s capacity to steer and co-
ordinate donor assistance has only been found in Afghanistan so far. Increased government leader-
ship is often a result of an emerging sector approach, federating donor and government around the 
same strategy or objectives (e.g. Philippines, Tanzania). A tool that was made available at the end of 
the evaluation period is joint assessment of national health strategies (JANS) in the framework of the 
International Health Partnership Initiative (IHP+). The EC is an active promoter of this initiative and 
EUDs highlight the positive contribution of the use of JANS in the overall co-ordination process for the 
health sector. (I-612) 
The use of parallel PIUs related to health has decreased during the evaluation period and a clear will 
to phase out during these parallel units can be seen, thus showing progress of EC support to health in 
achieving Paris Declaration indicators. According to more general findings of the survey on monitoring 
the Paris Declaration, most countries of the desk phase sample for which data was available even 
achieved to have no parallel PIU in 2010 (Afghanistan, Bangladesh, Ecuador, Moldova, Morocco, 
Mozambique, Philippines, Timor-Leste, Viet Nam, Zambia). Different interpretation of the concept of 
PIU leaves some room for interpretation of the actual number of PIU still running today in the desk 
sample countries. It should be noted that, where parallel PIUs in the framework of EC support in the 
health sector have existed over the evaluation period, problems such as creating parallel power struc-
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tures, distortion of salaries and diversion of staff and difficulties in achieving sustainability tend to oc-
cur. An example of the case of Afghanistan is described in the box below. (I-613) 
Box 8: Afghanistan: Grants and Contract Management Unit (GCMU) as separate PIU  
One issue of particular significance is the role of the (GCMU) as the central liaison between the MoPH, the three 
main health donors and the implementing NGOs and its effect on the management and administrative capacity of 
the MoPH overall.  
The central question is if it is preferable for the EC to work through the GCMU as a separate PIU or if, in the 
long run, it is better to work directly with the MoPH.  
One key concern is that the GCMU is being built up as a “ministry within the ministry” and thereby effectively 
hinders the build-up of capacity in the wider Ministry. It is feared that this development could eventually limit the 
sustainability of those interventions that currently are being managed by the GCMU. 
The substantial volume of funds managed by the GCMU, the better working conditions and higher salaries in the 
unit also have created tension within the MoPH and have limited the willingness of other departments to accept 
GCMU’s input. The Unit has responded to these dynamics by engaging in a capacity building strategy within 
MoPH and by seconding advisors to other MoPH departments. One challenge is, however, that these advisors 
receive an income that is many times higher than that of the department heads they are assisting and to whom 
they are reporting. Both GCMU and MoPH recognise this, but neither side has found a solution yet. 
 
A separate issue is the debate on the best approach for the EC to organise and manage its contracts with the 
NGOs. In principle, the choice of the EC to work as much as possible through existing institutions is coherent with 
its intention to build capacity in the MoPH and at the same time to expand the delivery of health services. In prac-
tice, however, the EC has yet to follow through with its commitment to decentralisation. At the time of the evalua-
tion, it had not yet decentralised the implementation and contracting of NGOs to the MoPH. 
Source: CSE Afghanistan, November 2007, p.465-468 
5.6.2 JC 62 Increased complementarity of EC support and between EC support and support 
of other donors 
According to the EU toolkit, “complementarity is a result of an optimal division of labour (DoL) between 
various actors in order to achieve optimum use of human and financial resources for enhanced aid 
effectiveness, i.e. to attain country strategy objectives and achieve better results in poverty reduction.” 
Co-ordination can help achieving complementarity. In EC support, one of the steps is ensuring, when 
drafting the CSPs that complementarity of support with the support of other donors is researched. The 
fact that donor matrices detailing donor interventions in all sectors, including health, have been pro-
duced in most CSPs reviewed is a first indication of reflection on the issue. Overall and especially for 
the second programming period under review, there is further evidence of co-ordination of the pro-
gramming process with other donors, thus allowing for and, as e.g. in Bangladesh, leading to, syner-
gies. In this context, an enhanced Division of Labour, at least in the EC programming process, among 
EU MS becomes apparent for this second period. (I-621) 
The Paris Declaration of 2005 has put significant pressure on both donors and governments to further 
strengthening their joint efforts, which had already partly started in the first period under evaluation. 
Evidence of joint efforts has been found ranging from a fully-fledged joint assistance strategies to 
punctual joint donor efforts (i.e. joint field mission or shared analytical work) has been found. It also 
appeared that joint efforts have helped enhancing co-ordination over the period under evaluation and 
improved co-ordination then has helped launching further joint efforts.  
A number of JAS have been developed during the evaluation period. However, they are not necessari-
ly complete nor applied in all areas of support, as indicated by several EUDs. Moreover, too many 
separate strategies and initiatives are a major area of concern. The JAS may complement CSP, their 
aim being to provide a joint response to the partner countries needs and priorities, each donor focus-
ing on specific sectors where it has a comparative advantage. However, these processes may not be 
synchronised in time. 
Progress has also been made in increasing the number of joint field missions and shared analytical 
work. The driving forces to start using joint actions during the evaluation period are the improved ca-
pacity of the MoH, taking the lead on the sector approach (Ecuador, Philippines) or the introduction of 
a new sector-wide intervention (e.g. Vietnam, Bangladesh). (I-622)  
EC contribution to global trust funds, including global initiatives, amounts to € 900.6 million for the 
evaluation period. Most of this amount was directed to the GFATM, the Avian Influenza Preparedness 
and GAVI. With its funds to global trust funds, the EC provides an important contribution to the realisa-
tion of Global Public Goods for Health.  
Moreover, the EC finances and is actively involved in several (multi-donor) trust funds at country level. 
Most of them can be found in Asian and ACP countries. They either support the entire health sector in 
fragile states (Timor Leste, Philippines-Mindanao province, Occupied Palestinian Territory, Angola) or 
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actions related to specific diseases (Myanmar, Nigeria, Ethiopia). This hints to the fact that trust funds 
at national level can take many forms when it comes to the geographical coverage (national level vs. 
provincial level), thematic focus (entire health sector, or specific areas, like immunisation, PRDs, 
health workers). In some countries, Task Forces at national level have been used as a pre-step to-
wards a full SWAp and possible SBS (Afghanistan); in one occasion they were purely used as a tool to 
speed up implementation (DRC). 
The following box shows the case of the Three Diseases Fund in Myanmar, which replaced the 
GFATM for a certain period in the country and to which the EC contributed substantially. It is a good 
example of how donors may effectively work together and the support of trust fund being an appropri-
ate way to jointly tackle challenges and reach specific aims. In the words of the EUD Myanmar, the 
Three Disease Fund in Myanmar is: “Good quality of partnership, efficiency, effectiveness, impacts, 
co-ordination.” 
Box 9: Myanmar - The Three Diseases Fund: A special case 
The Three-Diseases Fund (3DF) is a multi-donor consortium, which raised an initial USD 100 million to assist 
Myanmar in the control of three diseases over a five year period 2006-2011/12. It was set up with the donations of 
six countries and organisations -- the EC, the Department for International Development (DFID), the Australian 
Agency for International Development (AusAID), the Swedish International Development Co-operation Agency 
(SIDA), the Netherlands and Norway. The United Nations Office for Project Services (UNOPS) is the Fund Man-
ager on behalf of the Donor Consortium. In 2009, Denmark also joined the consortium. 
The core aim is to provide a simple and transparent instrument to finance a nationwide programme of activities to 
reduce the transmission of HIV and AIDS, TB and malaria and enhance care and treatment through access to 
essential drugs and related services. The target beneficiaries are the most vulnerable and under-served popula-
tions, especially those living in remote and inaccessible areas and those most at risk. 
By the end of 2010, 3DF had effectively supported 28 HIV projects, nine TB projects, ten malaria projects and four 
integrated projects. In addition, as part of its identified priorities, the 3DF has provided gap-filling support to the 
GFATM PRs until their programmes are fully-functioning.  
The EC contributed approximately 21% of the overall envelope over the five years period. If EU member states 
are considered the financial contribution to the fund exceed 80% of the total budget. 
 
The Mid Term Review finalised October 2009 concludes that the fund has performed well and has made signifi-
cant contribution to the containment of the three diseases epidemics. Major achievements and examples of im-
pact achieved: The 3DF MTR report concluded that the fund has been successful in adverting deaths and reduc-
ing illness due to the diseases. It notes that fund performance shows that 5-10% of needs met by services provid-
ed with Fund support. The Fund has contributed 30-50% of achievement towards the identified national targets 
and possibility even greater contribution to nationwide outputs. It noted that the level of effect is significant in the 
Myanmar context, especially given the level of need compared to available resources. The Fund has helped con-
tain but unlikely, on its own, to have contributed to reduced mortality and morbidity nationally. Among the indirect 
impacts of the 3DF it notes that the Fund has demonstrated that it is possible to successfully provide health ser-
vices to vulnerable groups in Myanmar. 
Longer term plans for 3DF are being reconsidered given the announced return of the GFTAM. It should start op-
erations in 2011. One option would be to widen the scope of the Fund to include mother and child health (MDG 4 
and 5). A scoping mission (framework contract (FWC) financed by the EC), to define various options to take place 
in March 2010. The EC is among the lead donors.  
Source: Thematic case study: The European Commission and the Global Fund, External Assistance Management 
Report n°17, 04.02.2010; External Assistance Management Report n°19, 31.01.2011 
By their very nature, trust funds can be a vehicle to enhancing complementarity in the health sector, 
as they bring together different donors and usually have a certain financial impact on the sector. This 
has been confirmed by the EUD survey giving clear indication that trust funds increase harmonisation 
and co-ordination efforts between donors (Vietnam, Bangladesh) and can facilitate the implementation 
of joint actions, such as joint needs assessments (Vietnam, Philippines) or a common and aligned 
donor-government strategy (Timor Leste, Zimbabwe). The majority of task force participants ranked 
them as satisfactory, the main issues of concerns being related to the day-to-day management, espe-
cially different donor procedures (Bangladesh, Philippines, Vietnam) and the lack of visibility of EC 
action within the trust funds (Vietnam, Zimbabwe). In most cases, the trust fund administrator at coun-
try level is the World Bank, with a total amount of € 129 million being trusted during the evaluation 
period (inventory). Not surprisingly, the main factor of success in the implementation phase of multi-
donor trust funds is a regular and transparent dialogue between the donor partners and the govern-
ment and the active participation of the EUD in the steering and co-ordination committees. (I-623) 
Classified as global goods for health, the following two initiatives are an example of the work towards 
complementarity between different EC budget lines and between different Directorates General of the 
EC (mostly DG Research and Health and Consumers).  
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Box 10: Global public goods for health: The role of the EC 
The Avian and Human Influenza Facility (AHIF)
66
 
The Avian and Human Influenza Facility (AHIF) is a multi-donor financing mechanism administered by the World 
Bank that helps developing countries to minimize the risk and socio-economic impact of avian influenza (H5N1) 
and other zoonoses and of possible human pandemic influenza), created following the Beijing conference. AHIF 
complements the World Bank supported Global Program for Avian Influenza Control and Human Pandemic Pre-
paredness and Response (GPAI) which has as its objective “to minimize the threat posed to humans by HPAI 
infection and other zoonoses to prepare for, control and respond to influenza pandemics and other infectious 
disease emergencies in humans”.
67
 
The AHIF is currently supported by ten donor agencies, led by the EC, which have collectively pledged more than 
USD 127 million. The EC is the largest donor to AHIF with total contribution of USD 80.73 million since inception 
to 2010 (figure below). EC funds are earmarked for East and South Asia, the Mediterranean, Central Asia and 
Eastern Europe. The other nine donors - Australia, China, Estonia, Iceland, India, Korea, the Russian Federation, 
Slovenia and the United Kingdom – contributed to AHIF which is not geographically restricted and can be used, 
notably, to assist countries in Africa and Latin America and the Caribbean regions. The EC played a leading role 
in responding to the highly pathogenic avian influenza (HPAI) crisis and policy preparations to combat a potential 
pandemic influenza outbreak. 
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EC funds under the Framework Research programmes 
For more than 10 years the EC has been supporting research on influenza in both humans and animals. Already 
under the 5
th
 Framework Programme for Research (1998-2002, FP5) about EUR 6 million was spent in 22 institu-
tions and national reference laboratories across 8 European countries. In FP6 (2002-2006) activities were ex-
tended and reinforced with a set of new projects launched with an almost tenfold increase in funding (more than 
EUR 50 million plus share in several larger projects dedicated to influenza as well as to other viral infections). In 
the FP7 (2007-2013) the pandemic influenza is addressed in the ‘Co-operation Programme’, Theme 1 ‘Health’ 
under the sub-heading ‘Emerging (Infectious) Epidemics’ and avian influenza in animals is dealt within the Theme 
2 ‘Food, Agriculture and Biotechnology Research’.
69
  
Source: Thematic case study on Global Public Goods for Health, Annex 19 
5.7 EQ7: To what extent have the various financing modalities (GBS, SBS, 
other sector support, projects), funding channels and instruments and 
their combinations, been appropriate, thus contributing to improving ac-
cess to, equity of and policy-based resource allocation in health? 
The EC uses various aid modalities, channels and instruments in order to achieve its objectives in the 
health sector. It is assumed that each of them should serve specific objectives and be selected and 
used based on specific national context requirements. The question analyses to what extent the re-
spective advantages of the different modalities and channels have been analysed and what specific 
contribution they had in improving access to, equity of and policy based resource allocation of support 
in health sector.  
The question will build upon an analysis of the modality specific findings of the EQs on access, service 
delivery and governance. Specific attention is given to SBS, GBS, trust funds and development banks, 
thematic instruments but also on the mix of these modalities and appropriateness of these channels in 
a given context.  
This question gives complementary insights into the selection of and process towards modality and 
channel implementation; contribution to policy related objectives, resource allocation and aid efficiency 
and effectiveness.  
This question seeks to address whether the choice of aid modalities has been based on a sound ana-
lytical basis, appropriate to the context and has contributed to the health outcomes and objectives as 
stated both globally and locally. To this end, three Judgement criteria have been established: 
 JC71 Aid delivery methods (incl. modalities and channels) adapted to national context 
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 AHI Facility, Avian & Human Influenza: A Partnership for Results. 
http://ec.europa.eu/europeaid/where/asia/regional-cooperation/animal-human-
health/documents/ahif_results_report.pdf  
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 Ibid. 
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 http://ec.europa.eu/world/avian_influenza/. A catalog of funded projects on avian influenza of the period 2001-
2007 is at: http://ec.europa.eu/research/health/poverty-diseases/doc/influenza-research_en.pdf; FP7 projects are 
at http://ec.europa.eu/research/health/infectious-diseases/emerging-epidemics/fp7projects_en.html  
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 JC72 Contribution of EC GBS and SBS to policy based resource allocations and inclusive ob-
jectives in the health sector 
 JC73 Increased cost-effectiveness and internal consistency of EC support 
The answer to this question is mainly based on the following sources: 
 Analysis of GBS /SBS documentation 
 Literature analysis, mainly evaluations, such as country level evaluations, sector evaluations, 
Paris Declaration evaluation, … 
 EUD survey 
 CSP analysis 
 Interviews 
 ECA report 
 Inventory 
 MoH Survey 
EQ7 on aid modalities, funding channels and instruments and their combination 
 – Summary Answer Box  
The selection by the EC of aid modalities and channels was made on the basis of a relatively good 
analysis of the health sector and of partner country needs and capacities, although this was weaker in 
the earlier period of the evaluation. EC aid delivery modalities were adapted well to the national con-
text in recipient countries and this trend has improved over the evaluation period and was accompa-
nied by an increasingly thorough analysis of the different dimensions of the health sector in partner 
countries. In terms of delivery modalities, this evolution has corresponded to more use being made of 
budget support especially sector budget support, although its use is still at a relatively low level com-
pared to other sectors.  
The EC in most countries analysed has had reasonably ambitious health-related indicators for both 
SBS and GBS programmes, although there are exceptions. Most programmes use outcome indicators 
focused on improving standards of health, which are linked to the health MDGs. The main problems 
have been finding sufficient data to assess whether these indicators have been achieved There are 
also indicators in most programmes aimed at improving the allocation of resources to health, either 
through GBS which tends to be focused on improving budgeting and planning at Ministry of Finance 
level or SBS working on planning and budgeting at the level of the MoH. Evidence tends to suggest 
that the achievement of indicators used by the EC varies, illustrating that not all have been easily 
achievable. In particular, the indicators used for the health performance indicators of GBS have tend-
ed to be overambitious, leading to low rates of disbursement.  
Although the EC, both on its own and in conjunction with other donors, has made a contribution 
through GBS and SBS to inclusive objectives in the health sector, this does not seem to have been 
translated into improved policy based resource allocations. There is no strong evidence on a signifi-
cant positive impact of budget support on national health expenditures and on budget processes at 
both central and decentralised levels. There is, however, evidence that SBS has resulted in increased 
levels of capacity building support for health, including all EC financed SBS and in some instances 
GBS. On the other hand, SBS or health-related GBS lending has not led to comprehensive improve-
ments in budgeting and policy processes, but there have been some notable contributions by the EC. 
Where there have been achievements, the development of MTEFs and sector strategies is the most 
common, but there is mixed evidence of consistent results in strengthening of policy processes or 
enhancing PFM. There was also limited success in improving policy based resource allocations, 
through SBS or GBS. 
There has been a move towards decreasing transaction costs for recipient governments through mov-
ing to SBS/GBS, reducing PIUs and increasing joint missions, the move to SBS/GBS has increased 
transaction costs for some EUDs, particularly as sufficient health PFM expertise was not always avail-
able in-house (a lack of health and PFM expertise has been an issue that has restricted the effective-
ness of the EC in dialogue related to GBS and SPSP as well). Also as projects still dominate EC port-
folios there is still a significant burden in terms of transaction costs for recipient governments. Fur-
thermore, the finding that SBS can reduce transaction costs is in contrast to the fact that it has a low 
rate of disbursement in comparison to other aid modalities such as projects. Much of EC’s health sup-
port is also implemented by other agencies and consistent problems are reported in projects run by 
UN agencies. These tend to suffer from protracted delays and large transaction costs for the EC.  
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5.7.1 JC71: Aid delivery methods (incl. modalities and channels) adapted to national context 
The selection of aid modalities and channels was made on the basis of a relatively good analysis of 
the health sector and of partner country needs and capacities. EC aid delivery modalities were 
adapted well to the national context in recipient countries and this trend has improved over the evalua-
tion period and was accompanied by an increasingly thorough analysis of the different dimensions of 
the health sector in partner countries. In terms of delivery modalities, this evolution has corresponded 
to an increasing use of budget support especially sector budget support. (I-7.1.1, I-7.1.2) The growth 
in SBS is perhaps the most notable increasing trend over the evaluation period. The amounts con-
tracted through SBS increased from about € 2 million in 2002 to € 200 million in 2009 and 
€ 185 million in 2010 (inventory). This progress was quite consistent over the years and accelerated 
from 2008. This rapid switch to a major use of SBS coincided with the signature of the last CSPs for 
the period 2008-2013 and resonates with the EC’s commitment in the context of aid effectiveness to 
make increased use of sector approaches. However, compared to other social sectors such as Educa-
tion, the EC made relatively little use of Sector Budget Support to directly assist the health sector. 
Only 16% of the total funds contracted to support the health sector were contracted for SBS opera-
tions, while for the education sector (basic and secondary education), SBS accounted for 47% during 
the period 2000 to 2007.
70
 This is mainly due to the fact that the health sector in recipient countries is 
often more fragmented than the education sector, which means that there is not always a coherent 
sector strategy to support, which is an EC eligibility criteria for SBS, while donor support is not harmo-
nised due to multiple funding channels used, such as vertical funds, which make it difficult to pool 
health financing. The EC supported also health sector policy programmes of beneficiary countries that 
are not delivered through SBS. This modality represented 15% of the total amount contracted by the 
EC. So overall, roughly a third of EC support to health has been given in various forms of support to 
the sector.  
This relatively small and late shift by the EC from a project approach to a sector approach has been in 
response to the preference stated by the EC for using budget support where possible, in acknowl-
edgement of commitments made by the EC under the Paris Declaration (2005) and Accra Agenda for 
Action (2008)71. This shift can be clearly seen over the evaluation period, with an increase in sector 
and budget support and the design and choice of these aid modalities benefitting from previous EC as 
well as other development partners experience in the sector. (I-7.1.1) 
This means that most analysis in documentation is focused on the suitability of moving towards a 
budget support approach or explaining why budget support has not been chosen. In nearly all cases, 
the discussion regarding alternative aid modalities is extremely limited. For example in financial pro-
posals where there is the most discussion of this issue, the focus is mainly on why a particular aid 
modality was chosen rather than an assessment of alternatives. (I-7.1.1) 
Support provided by the EU has become more aligned with national systems and procedures, given 
the shift from projects towards sector approaches and GBS, although this is not as large as it could 
have been, as there is still a considerable amount of EC support to the health sector which is not 
aligned. Despite this, the EU is still using fewer parallel aid delivery methods and making more use of 
national systems by channelling funds through national systems and supporting recipient government 
plans and strategies in the health sector. However, there are still countries where the EC had not been 
aligned with national systems and procurement is controlled by the EC, but this is due to concerns 
regarding the strength of government systems and fiduciary risk. (I-7.1.3) 
Aid delivery methods were reasonably well tailored to the capacity of implementing partners and the 
methods selected were generally appropriate to the context. Evidence of the EUD survey, CSPs and 
programme reviews in desk study countries shows that the capacity of organisations to implement 
programmes was often assessed with stakeholder institutional capacity assessments to analysis part-
ner readiness, capacity and potential structures for implementing health programmes. (I-7.1.2) 
5.7.2 JC72: Contribution of EC GBS and SBS to policy based resource allocations and inclu-
sive objectives in the health sector 
Findings reveal that, although the EC, both on its own and in conjunction with other donors, has made 
a contribution through GBS and SBS to inclusive objectives in the health sector, this does not seem to 
have been translated into improved policy based resource allocations. There is no strong evidence 
from numerous sources (interviews with EUDs, EC monitoring reports, Commission on Audit (CoA) 
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report 2008, on GBS and evaluations of GBS for Ghana and Zambia) on a significant positive impact 
of budget support on national health expenditures and on budget processes at both central and de-
centralised levels.  
It is clear that during the period assessed, the EC in nearly all countries analysed have had reasona-
bly ambitious indicators for both SBS and GBS programmes, although there are exceptions. Most 
programmes have used outcome indicators focused on improving standards of health, which are 
linked to the health MDGs.  
There are also indicators in most programmes, aimed at improving the allocation of resources to 
health, either through GBS which tends to be focused on improving budgeting and planning at Ministry 
of Finance level or SBS strengthening public financial management at the level of the Ministry of 
Health (MoH).  
In most cases, the indicators addressed well the core issues in the health sectors in the specific coun-
tries where the EC was giving support. Analysis of the country context in programme and other docu-
ments showed that the indicators chosen in nearly all cases were appropriate to the country context, 
although GBS variable tranche indicators have often proved to be over-ambitious. Another problem 
was that often there was not sufficient data available to judge progress on these indicators. Evidence 
from the Court of Auditors Report, Special Report, No 10, 2008 tends to suggest that the achievement 
of indicators used by the EC varies, showing that not all are achievable. Those related to GBS EC 
health performance tranches were least successful, with on average 50% achieved, whereas overall 
GBS indicators were achieved 70% of the time.  
Box 11: Sector Budget Support to Zambia: An example of indicators addressing core issues 
well 
In the Retention of Human Resources for Health Programme (2006- 2008) general conditions for 
tranche release were that PFM is transparent and effective and there is good macroeconomic and 
sector strategy. Conditions for the fixed tranche came from the health sector plan and were for 2006:  
 formal adoption of the national development Plan (2006-2010),  
 creation in the Government of Zambia budget items related to the retention of human resources.  
For 2007, they were:  
 creation of a human resources(HR) database;  
 M & E system for the HR plan 
 agreed and formalised mechanisms for providing incentives for Staff to go to underserved areas.  
For 2008 they were:  
 improvement in the ratio of health professionals to populations and  
 progress in the integration of the MoH payroll of staff. 
Source: Financing Agreement between the European Commission and the Republic of Zambia: Re-
tention of Human Resources for Health Programme, 2006. 
There were also increased levels of capacity building support normally being given as a result of 
health SBS, although support for health capacity building was not normally part of the GBS package. 
In SBS, capacity building was more frequently included as the aim of sector support programmes and 
was often focused on strengthening institutional capacity.  
Given this, it would be expected that as the design of programmes was appropriate, with indicators 
focusing on the right issues and significant capacity building components in the case of SBS, that this 
would result in improved health sector policies, processes and resource allocations. 
There is evidence (interviews, EC programme reviews and EUD survey) that GBS and SBS were able 
to enhance the framework for dialogue, particularly on PFM and capacity building issues. Also that 
good policy dialogue on health issues is more likely to result from SBS than GBS, which is logical giv-
en that financial support to the health ministry gives a good entry point and incentive for strengthening 
discussions.  
An assessment of the documentation indicated that neither SBS nor GBS led to comprehensive im-
provements in budgeting and policy processes, although there has been a contribution from EC and 
joint donor programmes of support. Where there have been achievements, the development of medi-
um-term expenditure frameworks (MTEFs) and sector strategies are the most common, but there is 
mixed evidence of consistent results in strengthening of policy processes or enhancing public financial 
management (PFM). Health sectors by their nature tend to be fragmented which makes it difficult to 
implement sector wide plans and processes. Additionally, political will to undertake reforms was lack-
ing in some cases. 
Another area that was not successfully addressed was improved policy based resource allocations, 
despite being tackled through both GBS and SBS indicators in many countries. There was only evi-
dence from Ghana and Zambia of budget allocations to health improving, while in Bangladesh funding 
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to the sector increased, but not as a percentage of the total budget. 72 This is probably as this is also 
an issue that needs to be tackled by the Ministry of Finance and as a result is out of the control of 
health ministries. However, there is the possibility to use GBS to try and enhance budget processes, 
but this does not appear to have been successful in most of the countries assessed. 
5.7.3 JC73 Increased cost-effectiveness and internal consistency of EC support 
There has been an increase in the cost effectiveness of EC support over the evaluation period, as 
there has been a clear reduction in transaction costs for recipient governments due to the change in 
aid modalities used by the EC and implementation of Paris Declaration commitments to harmonise 
and align support. This resulted in a reduction in the number of parallel project implementation units, a 
move towards more joint missions and analytical work and the shift towards using SBS and GBS (I-
733). This latter trend was highlighted in the results of the EUD survey and interviews with EUDs, 
while the reduction in transaction costs for recipient governments was reported to be the case when 
external evaluations were undertaken of GBS in Egypt, Vietnam, Lao, Ghana and the Philippines and 
in interviews with EUDs. 
On the other hand, the expected reduction in transaction costs for the EC and development partners 
has not always occurred, due to the time that has to be devoted to policy dialogue and co-ordination 
for SBS and GBS programmes and the fact the EC is still implementing projects, so two types of aid 
modalities need to be managed. This problem has been exacerbated by a lack of health sector and 
PFM expertise in some EUDs (see CoA Special Report No. 10, 2008). Also, as projects remain the 
dominant aid modality for the EC, transaction costs for both recipient governments and the EC are still 
higher than need be. This was reported to be the case in Mozambique, Vietnam, Zambia, Bangladesh, 
India and Barbados. Sources for this information came from interviews with EUDs, EUD survey and 
reviews and evaluations.  
There have been significant differences in disbursement rates over the evaluation period suggesting 
that some EC support is more effective at disbursing than others. The financing of trust funds has had 
the highest disbursement rate, with 100% disbursement on the amount committed followed by support 
to sector programmes (excluding SBS) at 86%, while the disbursement rate for individual projects is 
68% and SBS 48% (see figure below). In terms of channels for disbursement, multilateral organisa-
tions (World Bank and UN bodies, GFATM) have the highest disbursement rate (87%), while the se-
cond highest at 77% is “other channels” (private companies and development agencies) and funding 
for NGOs which also has a disbursement rate of 77%. Private-public partnerships (mainly GAVI) score 
lower with a disbursement rate of 75% and the public sector, mainly governments, scored the lowest 
at 63%  
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Figure 25: Direct EC support to the health sector: Disbursement levels by modality, health sec-
tor, 2002-2010  
 
Source: CRIS database; Particip GmbH analysis 
This interestingly indicates that, although SBS and GBS reduce transaction costs, SBS has the lowest 
disbursement rate, with the rate for projects significantly higher. This is due to the fact that indicators 
have to be achieved prior to disbursement for SBS, which are not always met - which means that not 
all funds are released. For projects this is not the case as funds are disbursed when project activities 
are undertaken. Similarly, disbursement through other bodies results in a high rate of disbursement, 
but there is evidence from interviews and EC programme reviews of dissatisfaction among EC re-
spondents when using both the World Bank and UN funding channels (I-731).  
Analysis of the internal consistency of EC support suggests that although the majority of EUDs 
thought that EC financial instruments to support the health sector were coherent, there were distinct 
problems related to thematic programmes, which indicates that they do not always add value to pro-
grammes of a geographic nature. This is mainly a result of the way that these programmes are man-
aged and implemented, as thematic programmes are subject to general multi-country guidelines so 
are not always tailored to a country’s needs. There also tends to be little communication or synergies 
between thematic and geographic programmes as the former are managed from Brussels and the 
latter at programme level (I-733). Evidence was also found by the ECA of a lack of coherence be-
tween EC instruments in health, as projects tend not always to be linked or complementary to SBS or 
GBS, while there are no links between Global Fund operations and EUD instruments, although this did 
not come cross strongly in this study. 
Standing a bit apart from the Indicator as stated but still relevant is the mixture of bilateral and regional 
geographical instruments. In a number of areas – human resources for health, sexual and reproduc-
tive health and infectious disease control – the EC used regional instruments. Specific examples from 
Southeast Asia include the regional malaria control programme in Vietnam, Cambodia and Lao PDR 
(antedating the evaluation period but extending into it), the Regional Health Initiative for Health in Asia 
and work related to cross-border animal health in the context of avian influenza. In Latin America and 
Africa, regional approaches financed by thematic instruments addressed human resource issues. In 
general, regional approaches were well supported by the two main aspects which call for a regional 
approach: either a genuine cross border or regional aspect to a problem, or the potential for sharing of 
experiences. Most, however, involved international agencies such as WHO, UNFPA and World Bank, 
with the dilution of effectiveness identified under EQ 4 above. 
Overall, the evidence on increased cost-effectiveness and internal consistency of EC support is mixed. 
Although there has been a move towards decreasing transaction costs for recipient governments 
through moving to SBS/GBS, reducing PIUs and increasing joint missions, the move to SBS/GBS has 
increased transaction costs for some EUDs (Egypt, Vietnam, Lao, Zambia, Ghana and the Philip-
pines). Also as projects still dominate EC portfolios there is still a significant burden in terms of trans-
action costs for recipient governments. Furthermore, the finding that SBS can reduce transaction costs 
is in contrast to the fact that it has a low rate of disbursement in comparison to other aid modalities 
such as projects, while evidence from interviews and the EUD survey on the relationship between 
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thematic and geographic programmes suggests there is not much coherence and consistency be-
tween them.  
5.8 Overall assessment of EC strategy 
Relevance: In view of the powerful links between health and poverty, EC co-operation in health was 
highly relevant to needs, as well as coherent with EC development policy. In general, the poverty fo-
cus of health co-operation was well maintained over the evaluation period Also in general, the theme 
of access to quality health care cut across all EC interventions, as would be expected. Issues of gen-
der, indigenous peoples, remote and disadvantaged regions, etc., were introduced as needed. EC 
assistance in health was also well in line with the observed fact that many countries are off track on 
the health MDGs, which have proven among the most difficult to achieve (especially MDG5 on mater-
nal mortality). In covering health care finance, human resources for health, improved governance in 
health, global public goods for health, the EC has been in line with the pillars of universal health care 
access stressed in the most recent EC global health policy.  
A few caveats are, however, in order. Human resources for health was ranked first by EUDs when 
asked what constrained progress on improving the quality of care. While the EU has taken a strong 
policy stance (through its 2006 Communication and has more recently committed itself to taking a 
global view that includes consultations with Member States on national policies, only few concrete 
interventions had sought directly to alleviate the human resource crisis. What was accomplished, by 
contrast, was strengthening of human resources planning, improved data and analysis and the sharing 
of regional experiences.  
While the concentration of projects on rural, as well as geographically remote and disadvantaged are-
as was appropriate for the poverty focus, the growing trend of urbanisation was little taken into ac-
count.  
TA and policy dialogue regarding finance were highly relevant and in line with the universal access 
goal, even if impact was limited. EC support in fragile states, such as provision of basic benefit pack-
ages in Afghanistan and DRC, was relevant but the overall small portion of EC co-operation going to 
fragile states is not in line with its recent policy commitment. The EC participation in various initiatives 
related to provision of global public goods for health, some related to pharmaceuticals and implement-
ed under DG Research Framework Programmes, was highly relevant to needs as well as coherent 
with the EC’s role as a supranational organisation. 
Efficiency: Overall, EC support to the health sector was no more or less efficient than support in 
comparable sectors such as education. The efficiency of EC interventions providing infrastructure and 
equipment was often impaired by the inadequate attention paid to maintenance and operating costs, 
either in the form of allocating budget directly or in assuring that beneficiaries had made adequate 
provision. As a result, the use-life of EC-financed equipment is lower than could be achieved. In an-
swering EQ4, it was found that in almost all regional interventions (implemented by partner organisa-
tions such as UN agencies and international NGOs, co-ordination weaknesses and differences in pro-
cedure limited efficiency. Much of EC’s health support is implemented by UN agencies and consistent 
problems of protracted delays and high transaction costs are reported in such projects. Similar prob-
lems were encountered with co-ordination of national multi-donor trust funds, where participants had 
different administrative procedures, different objectives and different strategic goals. In general, the 
EC has made progress on aligning with national systems and decreasing the use of parallel PIUs, in 
line with its Paris Declaration commitments. In answering EQ 7, it was found that there has been a 
move towards decreasing transaction costs for recipient governments through moving to SBS/GBS, 
reducing PIUs and increasing joint missions. However, the move to SBS/GBS increased transaction 
costs for some EUDs, particularly as sufficient health PFM expertise was not always available in-
house (a lack of health and PFM expertise has been an issue that has restricted the effectiveness of 
the EC in dialogue related to GBS and SPSP as well). To keep perspective, however, the EC has 
been slower to move to SBS than in comparable sectors, such as education. Projects still dominate 
EC health portfolios. The human resource crisis, leading to high turnover and staff shortages, impaired 
the efficiency of interventions across the board, from capacity building to direct provision of services.  
Effectiveness: EC co-operation in the health sector has been generally effective However, i such as 
health finance reform and human resources, these results have been found to be small compared to 
the scope of the challenges.  
A factor limiting effectiveness throughout has been the chronic shortage of technical expertise in 
EUDs. This weakens policy dialogue on health and PFM, co-ordination with other donors and partici-
pation in multi-donor trust funds and also the translation of EU global policy into country programmes 
via EU Delegation staff. 
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Impact: Impact is difficult to assess, but there is no doubt that overall, EC health assistance contribut-
ed to progress towards health MDGs, not only strictly speaking in the areas of maternal and child 
health and HIV/AIDS, but more broadly in terms of promoting better health outcomes, especially 
among the poor. By contrast, EC impact in health care finance and in human resources has been 
modest. Health care finance is ultimately the responsibility of governments and all the EC can do is to 
provide technical assistance and, through policy dialogue, encouragement. A disappointing finding of 
the evaluation is that, with a few exceptions, it is difficult to see hard evidence that EC SBS and GBS 
resulted in expanded resources for the health sector. Regarding the closely-related area of health 
sector PFM, there is evidence of EC capacity building, but less evidence of tangible improvements .  
In the area of human resources, the basic problem is the gap between salaries and working conditions 
in the public health sector and those available by emigration or by working in the private sector or a 
donor-financed project. Under such circumstances a significant share of capacity built is lost due to 
attrition. Some EC programmes and policies have sought to address this issue, but the scope of the 
problem has been too large to speak of substantial impact. General support for the health sector, by 
contributing to better infrastructure, better availability of needed drugs and equipment, etc., should 
improve the work environment and help to diminish health worker attrition, but the evaluation found no 
concrete examples of this. 
In answering EQ 2, it was found that most governments have in place schemes to improve health care 
access for the very poor or those with special needs. In some cases (e.g. ARV treatment financed by 
the EC-supported GFATM or GAVI vaccination campaigns), the EC had a significant impact. In other 
cases, general EC support may have had some impact. However, problems abound, either with tar-
geting the poor, or with enforcing the exemptions or subsidies that have been mandated at the clinic 
level. 
With a few exceptions, the share of out-of-pocket expenses in total health spending remained high or 
increased. This reflects a combination of limited impact on health sector finance and, closely related, 
the continuing low quality of public health service in many countries. EC programme providing direct 
provision of health services, as in Afghanistan and DRC have, not surprising, had a major impact, 
even if their sustainability is to be questioned. In a number of settings, EC support for improved MNCH 
has contributed to significant progress, even if the related MDGs are proving elusive. 
Apart from projects in disadvantaged areas, infrastructure supply is not a main focus of EC assistance, 
but in interventions that were geographically targeted the EC had significant impact on access via 
infrastructure and equipment. However, the problem of operations and maintenance has remained 
unresolved. 
There is mixed evidence on the degree to which EC assistance has contributed to strengthening the 
management and governance of health systems. In some areas there has been a clear contribution 
such as in strengthening health policy strategy, planning and processes. There is however little evi-
dence as to how successful the EC support was in strengthening health systems themselves, a priority 
goal of recent EC health strategy. The EC has also made some contribution to strengthening institu-
tional and procedural systems related to transparency and accountability. Evidence also indicates that 
there has been a good level of dialogue in health sector forums related to PFM, accountability and 
capacity building measures in the majority of countries, although it is not always clear the extent to 
which this dialogue has actually resulted in strengthened capacity in these areas. Procurement is the 
governance area where there had been the least contribution by the EC; there appears to be little 
focus in EC health programmes on this aspect. The EC has undertaken limited work on decentralised 
capacity building to strengthen health policy capabilities, but not in all countries, which is an issue as 
capacity at provincial and district levels remains low. 
The selection by the EC of aid modalities and channels was made on the basis of a relatively good 
analysis of the health sector and of partner country needs and capacities, although this was weaker in 
the earlier period of the evaluation. On the other hand, the indicators themselves have not always 
been achieved, while there have been problems experienced with finding sufficient data to assess 
whether indicators have been met. The EC, in most countries, analysed has had reasonably ambitious 
health-related indicators for both SBS and GBS programmes. Evidence tends to suggest that the 
achievement of indicators used by the EC varies, illustrating that not all have been easily achievable. 
In particular, the indicators used for the health performance indicators of GBS have tended to be over-
ambitious, leading to low rates of disbursement. Regional instruments and regional applications of 
thematic instruments were used when cross-border and regional aspects were prominent. 
There is no strong evidence on a significant positive impact of budget support on national health ex-
penditures and on budget processes at both central and decentralised levels. There is however, evi-
dence that SBS has resulted in increased levels of capacity building support for health, including all 
EC financed SBS and in some instances GBS. 
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Sustainability: Sustainability of EC health impacts has remained limited. A major theme to have 
emerged in the evaluation is the persistent and continuing under-resourcing of health sectors by bene-
ficiary governments. Related to the under-resourcing is the lack of clear evidence, with a very few 
exceptions, that SBS and GBS resulted in higher allocations of resource to the health sector. Health, 
even in very poor countries, represents a substantial proportion of GDP and it is ineluctable that, pro-
vided donors are not willing to underwrite the sector indefinitely (and they indeed are not) that re-
sources will need to be generated nationally. If the economic growth, good governance, sound public 
financial management and stability required for solid fiscal accounts are not present, combined with a 
policy commitment to provide reasonable health care, then it follows that the current situation will pre-
vail. In too many countries that situation is characterised by low access to quality health care, high out-
of-pocket costs and persistent health inequalities. EC assistance, like all donor assistance, can seek 
to break countries out of this low-level equilibrium trap, but this evaluation has found no clear exam-
ples of national health sector-wide success stories. While the evaluation has found some clear evi-
dence of successful impacts, it is not clear that many of these impacts will persist after donor support 
is withdrawn. 
EU added value: One way of approaching the valued added question is to ask what the EC was able 
to provide that other donors would have been incapable of, or worse at, providing. The EC, with its 
wide range of health policy styles in the Member States and close linguistic and historical ties with 
some developing regional, has a comparative advantage in TA and it provided a great deal in the 
health sector. . In part, this is because there are definable “styles” in health policy (the mix between 
public and private provision and the mix between public and private finance) and all of these (with the 
exception of the American private finance-private provision model) are to be found in the EU. The EU, 
through its member states, is effectively a “one-stop shop” for TA in the health policy area, giving the 
EC a comparative advantage. Adding to this is linguistic diversity (English, French, Spanish, Portu-
guese) Another area in which the EC clearly added value was in promoting global public goods for 
health, an area in which, virtually by definition, nation-states under-provide and joint action is required. 
In most other areas, it is hard to define a unique EC contribution, which is, of course, not to downplay 
the massive financial resources that it has supplied. 
Co-ordination, complementarity and coherence: Overall donor co-ordination in the health sector 
has considerably improved over the period under evaluation and can generally be judged as good in 
2010. The Paris Declaration of 2005 as well as health-sector specific initiatives such as the ‘Interna-
tional Health Partnership Initiative (IHP+) and Joint Assessments of National Health Strategies (JANS) 
have strengthened joint efforts between donors and governments. The EC has played a key role es-
pecially in MS co-ordination, most of the time chaired these groups and thus provided added value. 
The tool “Delegated Partnership Agreements” may, in the future, help to further simplify co-ordination 
among donors by reducing the number of players involved in these processes, while at the same time 
ensuring that EC has adequate access to relevant information. Co-ordination mechanisms including 
partner governments have also been an important ingredient of co-ordination during the period under 
evaluation with an active participation of the EC. The increasing role of partner governments in donor-
government co-ordination mechanisms demonstrates the improved capacity of governments to steer 
and co-ordinate donor assistance; however, weak capacity and low government leadership continue to 
be bottlenecks. Moreover, there is little evidence on EC support in the health sector affecting govern-
ment’s capacity to steer and co-ordinate donor assistance. The persistence of projects is testimony to 
governments’ continuing tendency, widely reported although not established by any specific findings in 
this evaluation, to accept whatever interventions are offered. 
In general, there could be better co-ordination and complementarity between the multiple interventions 
that are supported by the EC through multiple instruments, modalities and channels. The strategic 
relationship between thematic budget line projects (managed from Brussels and not tailored to country 
strategies), GFATM projects and bilateral geographical programmes was often not clear. While re-
gional projects were deployed effectively, there was no sign of co-ordination between regional and 
bilateral programmes. Under such circumstances, it is practically inevitable that there was overlap and 
lack of coherence. 
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6 Conclusions and recommendations  
6.1 Conclusions 
For analytical clarity we have grouped the conclusion into three clusters. 
6.1.1 Cluster 1: Strategic focus 
6.1.1.1 Despite policy statements from EC headquarters, the EC still lacks a clearly articulat-
ed and implemented global strategy for health co-operation with developing countries 
Conclusion 1: The evaluation has found that the EC was involved in essentially every aspect of 
health using a wide range of financing instruments, modalities and aid channels. While a 
strong anti-poverty focus was successfully maintained, it is difficult to identify any single, co-
herent and focused strategy in health with clearly defined priorities. At field level, CSPs aligned 
with national health priorities for the most part, but coherence with an overall EC vision was 
lacking. The absence of sufficient technical expertise in many EUDs worsened the situation. 
This conclusion is based on all the EQ answers 
The EC is a major health donor. In moving towards SBS and GBS, it has tried to align its aid more 
closely with national strategic priorities and decisions while reducing transaction costs and increasing 
predictability. CSPs / National Indicative Programmes (NIPs) over the evaluation period were generally 
linked to national health strategic plans and the alignment with national plans is set to increase signifi-
cantly under new programming guidelines. However, global health aid continues to be highly frag-
mented and outside government control. The EC continues to support a multiplicity of interventions 
with a multiplicity of instruments, each with its own support constituency – bilateral and regional pro-
jects, thematic budget line projects, Global Fund, GAVI, SBS, GBS, etc. Focus areas also each have 
each their own support base and constituency: MNCH, SRH, HIV/AIDS, infectious disease control, 
health system finance, etc. The result is that, apart from the poverty focus (which was well maintained 
over the evaluation period, there was no single, clearly articulated overall global EC health support 
strategy with clearly defined priorities for developing countries. The 2010 Communication The EU Role 
in Global Health and accompanying Staff Working Documents (especially Contributing to universal 
coverage of health services through development policy) made progress towards addressing this is-
sue, but came only at the end of the evaluation period and were themselves very broad. The disarticu-
lation had repercussions in the field, i.e., from the implementation, perspective. The EC sought to sup-
port essentially all aspects of health, from encouraging the production of global public goods to ad-
dressing the human resource crisis to providing technical advice and capacity building for health sec-
tor policy making and management, to concrete provision of clinics, staff, medicine and equipment. 
The result was an activity-driven approach rather than one that systematically incorporated major the-
matic or areas of concern such as human resources, operations and maintenance issues, health care 
finance, sustainability, global public good aspects, etc. Under-staffed EU Delegations, lacking in tech-
nical expertise, are trying to cope with a vast range of initiatives, each worthwhile in its own way, but 
failing to add up to a coherent and manageable whole. 
6.1.1.2 EC health strategies have tended to focus on the present, not the longer term over 
which health sector development takes place 
Conclusion 2: Because of its development co-operation cycle, the EC is in a weak position to 
take long-term trends such as urbanisation and the demographic and epidemiological transi-
tions, into account. Some health challenges are clear and present and EC co-operation has 
effectively addressed many of these (as detailed below in Cluster 2). Yet, others are closely 
linked to demographic, economic and social development, so they emerge and evolve over the 
long term. The EC’s global health strategy, to the extent that it can be identified, rather focused 
on near-term problems / solutions, paying insufficient attention to the longer at least one, if not 
several, decades)time frame over which health sector development occurs. 
This conclusion is based on all the EQ answers 
In part because of the lack of a unifying policy, EC global health strategies in health have taken insuf-
ficient account of long-run structural trends affecting health sector needs. Two of these are related to 
population: the ageing of populations, not evident in some of the poorest beneficiary countries (e.g. 
most of Africa) but acute in others (e.g. East Asia) and of growing concern in others (e.g. India) and 
urbanisation (of concern everywhere). Both of these trends are contributing to an epidemiological 
transition in which, despite continuing problems of poverty-related infectious disease, the burden of 
disease in poor countries is increasingly shifting towards non-communicable diseases (e.g. cancer), 
chronic conditions (e.g. diabetes and cardiovascular disease), trauma (especially road accidents) and 
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mental illness. The needed responses overlap with those traditionally financed by the EC, but not en-
tirely. While the burden of non-communicable disease was recognised in, e.g. the November 2008 
Programming Fiche, there was little evidence that much attention was paid to it over the evaluation 
period. More generally, as acknowledged in the Commission staff Working Document Contributing to 
universal coverage of health services through development policy (March 2010), global donors’ (and 
the EC’s) support for HIV/AIDS is greatly in excess, proportionally speaking, to the actual burden of 
that disease. 
Another long-term trend is the increased availability of more advanced medical technology, medication 
and procedures in many countries. These are being imported and made available thanks to rising 
income (in most developing countries), globalisation and increased expectations. Together with the 
epidemiological transition, this is accelerating growth in the demand for health care. Public health sys-
tems, under-resourced as they are, find themselves unable to meet expectations, as a result of which, 
even poor families incur large expenses as they seek care in the private sector. This helps to account 
for our finding (see the conclusion on health sector finance under Cluster 2) that, despite support to 
reforms, in a number of countries, out-of-pocket payments for health care continue to rise. 
The EC’s move towards sector budget support and general budget support (see Cluster 3 conclu-
sions) have been appropriate reactions to aligning better with government priorities for health sector 
development. It is, however, discouraging to report that the evidence found that budget support signifi-
cantly increases resource allocations for the health sector is thin. The move to sector budget support 
in health has also been slow relative to in other sectors, such as education. 
6.1.1.3 While the EC has made contributions to health system strengthening and had impact 
in the form of better health outcomes, the magnitude and sustainability of these im-
pacts are limited by the chronic under-resourcing of health systems in poor countries 
Conclusion 3: Despite the clear link with poverty, its prominent role in the MDGs and donor 
(including EC) pressure to pay more attention to the social sectors, health remains a low budg-
etary priority sector in most co-operation partner countries. In some of the poorest, the share 
of total health expenditure that is donor-financed is unsustainably high. Long-term progress 
towards better health in poor countries, which requires durable health sector reform, is de-
pendent on increasing national resource allocations to the sector. That requires economic 
growth, better governance, absence of conflict and stability, in addition to shift in policy atti-
tudes and priorities. 
This conclusion is based on all the EQ answers, but especially EQs 2 and 7. 
One of the most important conclusions to emerge is that the EC’s move towards SWAp / SBS / GBS 
cannot be shown to have resulted in a strong increase in allocations to the health sector save in iso-
lated cases (e.g. Zambia). Despite policy dialogue, policy matrices and capacity building, Ministries of 
Health remain in a weak position to assert and enforce claims on budgetary resources. In some set-
tings, aggressive decentralisation has complicated the picture. Health represents a significant propor-
tion of GDP even in very poor countries. Trends described above will increase it further, as will any 
meaningful attempt to deal with the human resource crisis in health. While donors often favour the 
health sector, their financial means are and should be, limited: eventually health sectors in develop-
ment co-operation partner countries will have to stand sustainably on their own. 
Health care finance reform is one approach to increasing resource availability. The EC has, as we 
describe below, made a contribution to designing needed reforms, but the record on outcomes is not 
very encouraging. Even in Ghana, a country where institution of mandatory health insurance went 
hand in hand with a reduction in out-of-pocket payments, targeted exemptions from fees are common-
ly not recognised at clinic level and threaten financial sustainability. In Philippines and Moldova, there 
is broad popular dissatisfaction with reformed health insurance systems and, in the latter, widespread 
informal payments for care have been reported. In China, pilot rural health insurance schemes have 
not been widely rolled out, meaning that health coverage is still essentially urban. In Vietnam, there 
remain gaping holes in health insurance coverage, now running about 40% with a putative goal of 
universality by 2014. 
While the EU has committed itself to supporting universal coverage, serious bottom-efforts to quantify 
the resource gap, based on a prescribed basic care package, unit costs, coverage targets and nation-
al revenue estimates, have not been systematically made at country level. The EC’s approach to esti-
mating the resource gap, namely the difference between the Abuja target of 15% of national budget 
resources for health and the Commission on Macroeconomics’ estimate of a minimum Euro 20 per 
capita per year, is top-down, ad hoc and not flexible to different country situations.  
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6.1.2 Cluster 2: EC support to specific thematic issues 
6.1.2.1 EC direct support to infrastructure / equipment contributed to improved access to 
health care in focused geographic areas, but failed to pay adequate attention to is-
sues of maintenance and operating costs 
Conclusion 4: EC direct support to infrastructure and equipment provision has significantly 
increased access to health care in specific geographical areas (essentially disadvantaged are-
as and essentially related to PHC) in some countries, but has been limited overall. While policy 
dialogue through SBS improved policy making, planning and management related to infra-
structure / equipment. Issues of maintenance and operating cost were neglected. These are 
most closely tied to the under-resourcing of public health systems, a problem against which 
there is little evidence that the EC made progress. 
This conclusion is based mainly on EQ1, EQ2, EQ 3, EQ 5 and EQ7 
The EC has supported improved health infrastructure via projects, often in disadvantaged and under-
served areas, often via projects implemented by NGOs (e.g. Ecuador, Afghanistan) and typically at the 
primary health care level. This has been appropriate in light of the EC’s poverty orientation as well as 
the fact that it does not have sufficient resources to finance large, national-level infrastructure projects. 
The EC has, however, participated in multi-donor trust funds which permitted it to contribute to nation-
al infrastructure development.  
While there has been some improvement in some countries, the issue of inadequate, broken, or out-
dated equipment remained serious in many. The issue of maintenance was generally neglected (i.e., 
there was generally no clear maintenance strategy / plan) resulting in deterioration of EC-supplied 
vehicles, cold chain equipment, medical technology, etc. While data on operating and maintenance 
budgets proved hard to find, it is broadly recognised that inadequate maintenance and operations 
problems such as lack of electricity, are tied to the overall under-resourcing of the public health sector, 
a theme that emerges repeatedly in these conclusions.  
While (see Cluster 3 conclusions) there is little evidence that EC-supported SBS contributed to in-
creased resource allocations to health, it did contribute to better planning, management and policy 
making, including in the area of infrastructure.  
6.1.2.2 While the EC has expressed strong policy commitment to addressing the human re-
source crisis in health, not much concrete impact has been found at country level 
Conclusion 5: Through its 2006 Communication, the EC has pledged to take actions to tackle 
the human resource crisis in health and EC project documents and SBS / GBS policy matrices 
regularly cite the human resource crisis, as called for by policy. However, the shortage and 
attrition of trained heath personnel remains serious in most countries and EC actions have 
been limited. 
This conclusion is based mainly on EQ1, EQ2, EQ 6 and EQ  
There have been some actions specifically devoted to addressing the human resource crisis in health, 
for example through the Thematic Budget Line on Migration and Asylum and the SANTE budget line, 
e.g. the programme “Strengthening Health Workforce Development and Tackling the Critical Shortage 
of Health Workers”. . The EC’s contribution to improved health sector policy making and management 
capacity covers human resource planning issues and human resource strategic and action plans have 
been developed with EC support (e.g. South Africa). However, in most countries affected by the crisis 
(particularly English-speaking ACP countries, but others such as in Asia such as Philippines, India and 
Bangladesh and in Latin America such as Ecuador, as well, the crisis remains unresolved. Two rea-
sons can be stated. The first is that the conditions that lead health professionals to migrate, whether 
internationally, to the private sector, or to donor-financed aid projects, are too great for the EC or any 
other donor to address. The failure of governments to significantly increase the allocation of resources 
to health despite SWAp / SBS / GBS is one reason for this. Human resource retention schemes and 
incentive schemes to encourage health professionals to live in rural areas have not succeeded, in 
large part because they are inadequate. The EC actively participates in health sector donor co-
ordination, which addresses human resources, but donors still compete to recruit health professionals. 
Another reason for human resource shortages is the persistence of vertical programmes financed 
through, e.g. GAVI and the Global Fund. This is despite the increased orientation of these pro-
grammes towards general health sector strengthening (due in large part to criticism over their impact 
on human resources for health). In some countries (e.g. Moldova and Egypt),-training or re-
certification schemes financed by the EC increased the supply of primary health care family physi-
cians, but these represent special cases and large areas remain under-served. While the EC pledged 
to consult with Member States in order to increase co-ordination between MS policies and EC policies, 
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no evidence that this was effectively been done has been found. At least some national schemes, e.g. 
a proposed scheme in the United Kingdom to encourage circular migration, have foundered on the 
shoals of domestic politics. 
6.1.2.3 The EC’s support to health care finance through TA, policy dialogue and support to 
better policy making has had only mixed success in reducing out of pocket payments 
as a share of total health care spending 
Conclusion 6: In a number of countries, EC technical assistance has supported overall health 
sector financial reform. Unsustainable financing policies have been addressed (e.g. Moldova), 
new strategies have been proposed and piloted (e.g. Egypt and Lao PDR) and existing health 
insurance schemes have been reformed e.g. in the Philippines). In many cases, despite policy 
changes, the key indicator of out-of-pocket payments as a share of total health expenditure has 
remained high or increased. Overall evidence for SBS / GBS contribution to increased public 
budgetary resources in health is thin; however, some countries that received GBS did experi-
ence significant declines in out-of-pocket payments.  
This conclusion is based mainly on EQ1, EQ2 and EQ 7 
In all its interventions, whether projects, or SBS / GBS the EC has sought directly or indirectly to re-
duce the burden of out-of-pocket payments, with their poverty, equity and access implications. There 
have been some successes. In Burkina Faso and Ghana, GBS may have helped to create fiscal 
space for health care finance reform and large declines in the share of out-of-pocket payments in total 
health care expenditure were observed in the context of instituting mandatory health insurance. In the 
latter case, the wide scope of exemptions and subsidies casts some doubt on long-run financial sus-
tainability. In Egypt, TA contributed to needed reform of the Health Insurance Organisation, but cover-
age is still only a bit over 50% and out-of-pocket payment remain at about 70% of total expenditure. In 
the Philippines, out-of-pockets continued to rise despite EC support for PhiHealth reform. In Moldova, 
where EC TA helped to address an unsustainable financial situation through mandatory health insur-
ance, there is widespread dissatisfaction with the system, families continue to pay informal fees for 
health care and doctors’ salaries and the quality of care available remain low. Vietnam is another 
country where, despite EC support for health sector reform, out of pocket payments show no sign of 
declining in absolute or relative terms. 
Several reasons for continuing problems in health finance reform have been found. One is the fact 
that, despite SBS / GBS, overall budgetary resource allocations for health remain low in most coun-
tries. Capacity has been built in Ministries of Health, but their ability to make and enforce claims on 
fiscal resources remains weak. As a result, the large quality differential between private and public 
facilities leads many families, even though poor, to seek expensive care in the private sector (e.g. 
Vietnam). We have found some countries where there is evidence that the EC contributed to an im-
provement in public sector care quality (e.g. PHC in Egypt). In others (e.g. Philippines), this has not 
happened. 
A third reason for the stubbornly high level of out-of-pocket payments is to be found in structural 
changes that do not reflect a failure of EC support, but rather secular trends. The EC has properly 
concentrated on essential medicines, Basic Benefit Packages and other hallmarks of the European 
public health model approach. Yet, higher incomes (in most countries), the availability of new or im-
proved drugs, tests and treatments due to globalisation and structural factors such as population age-
ing have led to a secular rise in the demand for health care. Much of this is at the secondary care lev-
el, or concentrated among middle- and upper income groups which are not the focus of EC assistance 
but who exercise strong claims on public resources. 
6.1.2.4 Geographically targeted interventions improved access to health care for the poorest 
populations, but innovative approaches to remote regions and interventions to ad-
dress the increasingly urban face of poverty were not in evidence 
Conclusion 7: When it was geographically targeted, EC assistance concentrated on rural re-
gions where health is poorest and access to quality health care is lowest. The EC scored some 
successes against health problems in remote and geographically disadvantaged regions, 
which are the worst-off of all. However, in concentrating its resources on rural areas – a strate-
gy in line with the broad-urban-rural gap in health – the EC did not take into account the fact 
that health challenges are gradually shifting from urban to rural areas because of urbanisation. 
This conclusion is based largely on EQ1, EQ3 and EQ4. 
Those EC health interventions that were geographically targeted (e.g. Philippines, Lao PDR, Egypt, 
Ecuador, South Africa, Afghanistan), were appropriately targeted. However, little evidence was found 
that the EC has taken into account the fact that, while the rural-urban divide in health is still striking, 
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the face of poverty is increasingly an urban one. There were many more rural health interventions than 
urban ones designed to address the health care needs of growing slums with high rates of poverty and 
poor health.  
In rural areas, geographical access to health care is increasingly an issue of remote or isolated re-
gions, often characterised by a large proportion of ethnic minority populations and sometimes affected 
by conflict. A number of EC projects (e.g. Philippines, Lao PDR, Ecuador and Afghanistan) addressed 
the needs of such regions and achieved significant impacts. NGO-implemented projects were espe-
cially effective in such settings. Document review suggests that traditional service provision approach-
es (financing clinics or supporting community health workers) tended to take precedence over innova-
tive interventions such as non-traditional outreach services (e.g. use of mobile telephone networks for 
community health workers or putting in place an adequate emergency referral and transport system). 
However, training of community workers was a key feature of many NGO-implemented projects.  
6.1.2.5 EC support to MNCH resulted in significant progress in many settings. In some of 
these, not only contribution to progress, but concrete impacts can be identified 
Conclusion 8: The EC has provided significant support to improved MNCH, mostly through its 
support to primary health care (the number of interventions exclusively devoted to MNCH has 
been low). In a wide range of settings, there has been progress against maternal mortality and 
under-five mortality, the two MDGs directly related to MNCH. That progress towards these 
MDGs has been slower than hoped for is due to the complex nature of the problem and the fact 
that ambitious goals have been set. 
This conclusion is based mainly on EQ1, EQ3 and EQ4 
The EC has contributed to better MNCH through its PHC interventions in many countries (notably 
Egypt, Afghanistan, Burkina Faso and Ecuador). MNCH has been improving over the long term in 
most countries, in part due to economic growth, cultural change including gender roles, increased use 
of family planning and the like. However, the EC’s strengthening of PHC systems has made a direct 
contribution. In particularly adverse circumstance (e.g. Afghanistan) concrete EC impacts through 
direct provision can be identified. That progress towards the related MDGs has been slower than ex-
pected is in part due to the high targets that have been set. Also contributing is the fact that MNCH is 
tied to many other factors, such as water and sanitation, gender, traditional cultural practices, geo-
graphical remoteness or isolation, income poverty and nutrition. Country case studies have uncovered 
many examples of this, particularly in the sharp rural-urban and income-level differences between 
basic MNCH indicators. Problems of remote and geographically disadvantaged areas have been es-
pecially serious. While the traditional provision of PHC as supported by the EC has contributed to im-
provements, a broader approach involving multiple sectors and innovative approaches would be nec-
essary to accelerate progress. EC support to the Global Fund (to prevent mother-to-child transmission 
(MTCT)) and GAVI (to promote vaccination) have made significant contributions. In the latter case, 
these have been quantitatively estimated.  
6.1.2.6 In the case of fragile states, only in the case of Afghanistan, can a more than modest 
contribution to health improvements be established 
Conclusion 9: One of the largest EC health programmes was that in Afghanistan, with a well-
documented impact on health status. Support to other fragile states has remained much more 
modest. The EC was also more bound by procedural constraints than other donors in such 
settings and would need to be more innovative to make a significant contribution to progress. 
This conclusion is based mainly on EQs 1-4. 
The EC spent around 15% of the total amount allocated to the health sector in fragile states, which 
have lagged seriously behind in achieving the health-related MDGs. Thirty-five countries, out of 40 
countries identified as fragile states, received support, but half of the total went to only a few countries 
Afghanistan, Nigeria, DRC, Zimbabwe and Angola, with by far the largest share (17%) going to Af-
ghanistan. A large proportion of this support was channelled through projects run by NGOs. The EC 
contribution to fragile states may have increased somewhat during the second half of the decade, but 
remained modest when compared to needs and the size of the EC’s health programme as a whole. As 
demonstrated in the inventory, significant amounts of EC assistance went to middle-income countries 
where overall fiscal reform and improved public financial management could generate significant addi-
tional resources for health from national sources. 
In an October 2007 Communication from the Commission “Towards an EU response to situations of 
fragility” and its ensuing “Conclusions of the Council,” a range of recommendations to ensure im-
proved EC policy and implementation in case of fragility were formulated, but steps to operationalise 
these recommendations have not yet been taken. Improved policy development for fragile states is 
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called for since traditional approaches may not be suitable. The EC’s approaches, however, as con-
firmed by the Afghanistan example, have been traditional, consisting in the main of direct provision of 
primary health care by NGOs. As documented in the Afghanistan case study, this is, in part, due to the 
inflexibility of the EC’s procedures as compared to other donors, which have generally been more 
innovative. That said, the substantial EC input in the health sector has definitely had positive impact 
on the health status of the population covered by EC programmes, including in remote and insecure 
areas. This resulted from sustained commitment to a programme with a clear focus aligned with gov-
ernment policy and other key donor policies.  
6.1.2.7 Through TA, capacity building and SBS / GBS-based policy dialogue, the EC has con-
tributed to improved health sector policy and management, however, impact on re-
source availability has been modest 
Conclusion 10: In most countries where the EC has been involved in health co-operation, es-
pecially SBS, EC support has led to improved health sector policy making capacities and im-
proved management practices. While capacity for better PFM has been built, the ultimate im-
pact on health sector PFM has often not been seen. 
This conclusion is based mainly on EQ 2, EQ 5 and EQ 7 
The EC, through policy dialogue, TA and capacity building, often in the context of SBS, strengthened 
health sector policy making and management, although this was been less evident at a decentralised 
level or in the area of procurement. There was, in a number of countries, improvement in transparency 
and accountability and, in general, the EC’s contribution to improved sector strategies and planning 
was significant (e.g. Moldova, Timor-Leste, Lao PDR, Philippines, Bangladesh, Egypt). The latter may 
be looked upon as one of the main achievements of budget support, particularly SBS, where TA to 
Ministries of Health made possible improvements in planning, reporting and monitoring. However, 
given that SBS only accounted for 16% of total health assistance, the width of impact of such 
measures, especially TA and capacity building, has remained limited. Moreover, increases in the ca-
pacity for better PFM were not always matched by actual improvements. 
Limiting the actual impact and sustainability, of improved policies and capacity was the overall short-
age of resources in the health sector. The human resource crisis limits the long-run impact of the EC’s 
contribution to capacity building, as persons trained often do not remain in post, leaving tools provided 
under-utilised.  
The human resource crisis is a symptom of financial resource shortages. We have found that there is 
little evidence that SWAp / SBS / GBS engagements have led to increased resource allocation to 
health (Ghana, Zambia and Burkina Faso being likely exceptions). There is no evidence that Ministries 
of Health strengthened their claim, or ability to defend it, on Ministries of Finance who typically hold 
the purse strings. The Philippines is a counter-example, but MoF resources support only a limited 
number of vertical MoH programmes, real health sector finance depends heavily on local budget deci-
sion makers. Health remains a low-priority sector in virtually all poor countries. 
The chronic under-resourcing of public health systems is a theme that has recurred throughout EQ 
answers and these conclusions: it slows progress against not only the human resource crisis, but 
shortages of infrastructure / equipment (including operations and maintenance issues) and, generally, 
the public-private quality gap in health care.  
6.1.2.8 The EC significantly contributed to the production of global and regional public goods 
for health, a contribution in line with its status as a supranational organisation 
Conclusion 11: Through support to research, infectious disease control (much of it through the 
Global Fund, GAVI and initiative to eliminate polio, but also in emerging areas such as cross-
border veterinary health and pandemic influenza), the EC made a significant contribution to the 
production of global and regional public goods for health. This is appropriate in view of its 
status as a supranational organisation. In the case of GFATM and GAVI, the significant role of 
EC headquarters is in contrast to the limited role played by most EU Delegations, meaning that 
co-ordination with other EC programmes is lacking. 
This conclusion is based mainly on EQ2, EQ4 and EQ6 
The EC headquarter has played an important role in setting up the GFATM, with considerable re-
sources allocated to it (the EC is the fourth largest contributor), as well as in agenda setting on 
HIV/AIDS, tuberculosis and malaria issues. However, EU Delegations are little involved in GFATM 
activities, which has given rise to overlap and poor co-ordination with other EC support to the health 
sector. The EC has also been one of the major donors to GAVI since 2003. Again, better co-
ordination, for example, between general EC support for health system strengthening (vehicles, cold 
chain, human resources, etc.) and GAVI immunisations campaigns might have improved results. Bet-
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ter co-ordination of both GFATM and GAVI with EC efforts in MNCH would also have been beneficial. 
However, estimates of the number of lives saved, based on number of immunisations provided, give 
evidence of a significant impact of EC assistance to GAVI. The EC has played a significant role in 
responding to the threat of emergent diseases (e.g. avian influenza) and pandemic influenza. None-
theless, the EC’s engagement with other emergent disease threats (Dengue, Chagas, etc.) has been 
limited. Where appropriate, the EC has been involved in some regional health initiatives, appropriately 
so when, as in the case of malaria and avian influenza, problems are inherently regional and cross-
border in nature. No evidence was found of EC development co-operation involvement in the area of 
antibiotic resistance (apart from GFATM involvement in work against multiple-drug resistant TB). 
6.1.3 Cluster 3: EC interaction with donors and partner governments in the health sector 
6.1.3.1 EC participation in co-ordination mechanisms has led to increased health aid effec-
tiveness, but has been limited by the lack of technical expertise in EU Delegations 
Conclusion 12: The EC, through its participation in co-ordination mechanisms, contributed 
significantly to improved co-ordination and complementarity, in line with the Paris Declaration. 
It has effectively exploited its role as a supranational organisation and its special relationship 
with the EU MSs. However, the shortage of technical expertise in EU Delegations placed it at a 
comparative disadvantage relative to other donors and governments. 
This conclusion is based mainly on EQ1, EQ4 and EQ6 
The health sector has been a lead sector for donor co-ordination, especially in view of the potential for 
geographic and thematic overlap. The EC has participated in health co-ordination mechanisms in all 
countries where it is s significant health donor and, in a number, has taken a leading role. Specifically 
related to EU MS co-ordination, the EC has played a key role, has chaired groups and thus provided 
added value. The EC’s co-ordination role has been strengthened by the fact that in some countries, it 
is a far larger health donor than the MSs. The EC has supported and respected the division of labour. 
The tendency of many governments to accept aid offers regardless of co-ordination concerns has 
been noted at a number of points, but in general the situation has improved over the evaluation period 
and the EC can claim some of the credit for that. 
Limiting the EC’s ability to co-ordinate effectively has been the under-capacity of EU Delegations in 
terms of health technical expertise. The health portfolio has often been found to be handled by gener-
alists who are balancing a number of sectors. Other multi-lateral donors and MS bilateral donors, 
when they choose to be involved in health, usually have a technically qualified specialist handling the 
portfolio. Government, it goes without saying, is represented by technically qualified staff. In countries 
where the EU Delegation is under-resourced, the imbalance of expertise gives rise to a credibility gap 
and limits the ability of the EC to co-ordinate effectively with other partners. 
6.1.3.2 The EC moved in the direction of honouring Paris Declaration commitments, but in-
teraction with MoHs and other partners would have been enhanced by more EUD ca-
pacity 
Conclusion 13: The EC has contributed to reducing health co-operation transaction costs for 
recipient governments through a reduction in PIUs and, despite the persistence of the project 
approach, moved towards sector support through SBS and GBS. However, one of the more 
recent instruments for this, Delegated Co-operation, was little utilised as of the end of the eval-
uation period. Moreover, EC effectiveness, as well as impact, is weakened by under-staffing in 
EUDs. 
This conclusion is based mainly on EQ 6 and EQ 7. 
In line with Paris Declaration commitments, the EC contributed to reducing transaction costs for recipi-
ent governments in the health sector through a reduction in reliance on Project Implementation Units 
(PIUs) and, as documented by the EUD survey, moving towards sector support through SBS and 
GBS. The move towards SBS has been slower that in some sectors such as education and it is fair to 
say that budget support is still under-utilised relative to the project approach. Transaction costs have 
often not fallen for EU Delegations (e.g. in Mozambique, Vietnam and Zambia). This has been due to 
a lack of health sector expertise in-country – most EUDs are under-staffed in terms of technical exper-
tise even when there is substantial health involvement - and the fact that EU Delegations must deal 
with a range of aid modalities. This reduced the quality of the interaction with other health stakehold-
ers, partners and MoHs, all of which are usually better resourced in terms of technical expertise and 
weakens EUDs’ impact in the overall health policy dialogue and health system implementation at the 
country level. 
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One of the recently promulgated tools meant to increase aid effectiveness is “Delegated Co-operation 
for HSPM and HSPD among EU MS and the EC, related to health.” Based on the country case stud-
ies, this approach was little utilised as of the end of the evaluation period. 
6.1.3.3 While EU Delegations’ participation in policy dialogue in the context of SWAp / SBS / 
GBS contributed to better health sector policies and management, there is little evi-
dence that it resulted in concrete increases in resources allocated to health 
Conclusion 14: As reported in Conclusion 10, despite capacity shortages, EU Delegation policy 
dialogue as part of the wider donor dialogue related to GBS and sector support has contribut-
ed to improved capacity. However, we have not found strong evidence that it has resulted in 
higher budget allocations for health. 
This conclusion is based largely on EQs 2, 5 and 7. 
The essential long-run challenge in addressing global health gaps is increasing the availability of fi-
nancial resources in the health sectors of poor countries. Repeatedly, whether in discussing the hu-
man resource crisis, problems of inadequate equipment and maintenance, the public-private health 
care quality gap and the heavy burden of out-of-pocket payments on families, we have cited the un-
der-resourcing of public health systems. Some, albeit not all, sectoral SBS and GBS policy dialogues, 
including policy matrices, was designed to increase the resources available to the traditionally under-
prioritised social sectors such as health. We have looked for evidence that budget support increased 
resources in health and generally not found it. 
The only evidence of budget allocations to health improving due to GBS was found in Ghana, Burkina 
Faso and especially Zambia, while in Bangladesh funding to the health sector increased, but not as a 
percentage of the total budget. In Vietnam it was specifically noted that efforts to increase sector fund-
ing through GBS, had not been as successful as in the education sector through SBS.  
Two reasons can be found in evidence considered. One is that decisions on budget allocations are 
made at Ministry of Finance. No evidence emerged that Ministries of Health, despite their improved 
capacity, have strengthened their claim on fiscal resources allocated by MoFs. Another is that dia-
logue has been constrained by a lack of capacity in EU Delegations to engage effectively, due to a 
lack of in-house PFM and health expertise and the fact that EU Delegations often do not have dia-
logue strategies which can help to focus EC efforts on a few key issues. Engaging in policy dialogue is 
time consuming, often frustrating and can considerably increase the transaction costs for the EUD. 
The skills required for participating in policy dialogue are very different to those needed for project 
management. Sufficient staff with the appropriate expertise is essential to ensure the effectiveness of 
policy dialogue and the management of GBS and sector support. 
6.1.3.4 Policy matrices focused on core health sector issues, but health sector progress has 
often been difficult to measure  
Conclusion 15: The indicators chosen to form the performance assessment frameworks for 
SBS and GBS were in most cases reasonably well specified and addressed the core issues in 
the health sector. In some instances however, a lack of data availability has made it difficult to 
track progress of indicators chosen.  
This conclusion is based on all EQ answers. 
SBS/GBS performance assessment has suffered from a lack of baseline data and the fact that statisti-
cal data are often not regularly collected and as a consequence can cause difficulties in making dis-
bursement decisions. Vague and inappropriate specification and inclusion of unrealistic indicators in 
policy matrices made the tracking of health sector progress and EC disbursement decisions hard at 
country level. In Laos, Uganda, Mali, Tanzania, South Africa, Burkina Faso and Paraguay, there was 
found to be a lack of data to assess if indicators had been achieved. Generally speaking, case studies 
and the ED Delegation survey revealed surprising difficulty in tracking health indicators having to do 
with infrastructure and equipment and maintenance budgets. 
Indicator targets were generally achievable, except in the case of EC health indicators for GBS which 
have an overall 50% achievement rate. An example of this is in Zambia where in 2010 it was noted 
that the performance in meeting health indicators had deteriorated over time and was not as good as 
in education. A similar comment was made relating to Burkina Faso’s second GBS operation. 
This is due to a number of possible reasons such as being over-ambitious as they are linked to 
achievement of the MDGs, the incentive of the small amount of funds attached to them not being 
enough, the fact that some are out of the government’s control and are difficult to measure. Non-
achievement reduces the amount of resources available to recipient governments and given this, it 
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would suggest a closer look needs to be taken at the design and incentive structure of these perfor-
mance targets. 
6.1.3.5 EC participation in multi-donor trust funds on country level served as a force magnifi-
er, permitting the EC to leverage its resources for greater impact as well as enhancing 
complementarity 
Conclusion 16: In many settings (e.g. Philippines, Vietnam), EC participation in multi-donor 
trust funds on country level has proven effective. The main factor of success in the implemen-
tation phase of multi-donor trust funds was a regular and transparent dialogue between donors 
and partner governments, as well as active participation of EU Delegations in the steering and 
co-ordination committees. Once more, however, limited technical capacity of Delegations was 
been a constraining factor. 
Multi-donor trust funds were effective vehicles for reaping economies of scale and scope, thereby 
increasing impact beyond what could have been achieved by donors acting separately. Some of this 
was due to enhanced complementarity in the health sector. The main issues of concern are related to 
daily management, especially with different donor procedures. Trust fund managers and other donors 
complain of rigid EC financial and reporting procedures, in particular citing the EC’s relatively heavy 
requirements. Also of concern is the lack of visibility of EC action within the trust funds. Greater capac-
ity at EU Delegations would increase the effectiveness of participation in joined-up approaches such 
as multi-donor trust funds. 
6.1.3.6 EC aid modalities are increasingly aligned with recipient government systems, but the 
mix of aid modalities could be more coherent and strategic 
Conclusion 17: The EC uses a wide range of aid modalities, which are increasingly aligned with 
recipient government systems, in the health sector. However, it is often not clear why alterna-
tive aid modalities and funding channels have been chosen and how they are intended to be 
complementary. This has led to a lack of coherence and consistency between programmes. 
This conclusion is based mainly on EQ 6 and EQ 7 
For example, co-ordination between thematic and geographic programmes is not as effective as it 
could be, as the former are run from Brussels and the latter in-country, while attention is not always 
paid to ensuring that projects are co-ordinated with other interventions (EUD Survey). The Global 
Fund, of which the EC is a major supporter, HIV/AIDS projects that are parallel to other EC-funded 
interventions. GBS and SBS on their own are unlikely to leverage results attained via policy matrices 
unless there are other targeted interventions, which is not always the case.  
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6.2 Recommendations  
The linkages between EQs (findings), conclusions and recommendation are illustrated in the following 
figure. 
Figure 26: Linkage between findings, conclusions and recommendations 
 
The table below provides an overview of the level of priority in terms of importance of the recommen-
dations and the urgency (agenda) of their realisation. This information is also provided schematically 
in the following figure. 
Table 11: Prioritisation of recommendations 
 Issue Importance* Urgency* 
1.  Comprehensive health co-operation strategy and operationalisation at field level 4 4 
2.  Shifting burden of diseases and long term structural trends 1 1 
3.  
Encourage move towards heath systems strengthening within global initiatives 
(GFATM, GAVI) 
2 2 
4.  Choices of instruments and modalities to improve coherence 3 3 
5.  Technical health capacities within EUDs 4 4 
6.  Human resources for health 4 4 
7.  Complementarities, synergies and inter-sectoral links 3 2 
8.  Systematic review of health system finance support 4 4 
9.  Health infrastructure and operation and maintenance requirements 1 1 
10.  Support to remote, isolated and vulnerable population and minorities 1 1 
11.  Needs assessment in designing budget support interventions 4 2 
* 1 = low, 4 = high 
C4
C2
C5
C6
C7
C12
C14
C15
R1
R2
R11
R7
R5
R3
R8
C1
Evaluation Questions Conclusions Recommendations
C13
R4
C3
C8
C9
C10
C11
C16
R6
R9
R10
EQ1: Quality of health services
EQ2: Affordability of health
EQ3: Health facilities 
availability
EQ4: Health service utilisation 
related to MCH
EQ5: Management and 
Governance
EQ6: Coordination, 
complementarity and synergy
EQ7: Financing modalities, 
funding channels and 
instruments
C17
Final version for word-file
Strategic
focus
Interaction with 
donors & partner 
government in 
the health sector
Support to 
specific 
thematic
issues
Strategic
level
Operational 
level and 
specific 
themes
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
Final Report Volume I August 2012 79 
The following figure depicts this assessment graphically. 
Figure 27: Prioritisation of recommendations, schematic overview  
 
The team has attached the highest importance and greatest urgency to consolidating EC health co-
operation policy and strategy, strengthening EUD technical capacity where needed and more effec-
tively addressing the key constraining issues of human resources and financing for health. Improving 
the availability, quality and timeliness of statistical data is also quite important, but can be addressed 
in the medium term. A number of other recommendations, while we consider them highly relevant and 
useful, are judged to be lower in importance, urgency, or both. 
Addressing these priorities requires interventions by different actors. Therefore, each recommendation 
includes suggestions for operational steps for putting it into practice and identifies implementation 
responsibilities.  
6.2.1 Strategic level recommendations 
6.2.1.1 Recommendation 1: Consolidate various global policy statements and approaches 
into a comprehensive health co-operation strategy that can be effectively operational-
ised at the field level in conformity with national sector development plans 
Based on conclusion 1 Main implementation responsibility:  
 EU HQ 
 Selected EUDs 
Conclusion 1 found that the EC’s global health strategy, trying to cover all fronts at once, does not 
result in sound country level strategies, especially since thin-stretched EUDs lack the capacity to ab-
sorb everything. In order to rise above the current activity-driven approach, the EU should review, 
consolidate and synthesise its health co-operation strategies, perhaps in the form of a White Paper. 
Major dimensions of a comprehensive approach should be identified, including the anti-poverty focus, 
PHC, health systems strengthening, health care finance, global public goods, human resources, etc. 
The goal should not be to devise a one-size-fits-all approach, but rather one sufficiently broad and 
well-articulated that components can be matched to country priorities and other donors’ activities to 
identify priority interventions while ensuring that the major issues are covered. In this way, e.g. capaci-
ty building will need to be matched with human resources policy; infrastructure and equipment needs 
with health care finance via maintenance and operating budgets; support for vertical programmes with 
health systems strengthening, etc. 
The persistent fragmentation of health aid and the need for improved co-ordination with national health 
sector plans and budget cycles argues for a continued strong role for both sector and general budget 
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support. In providing sector support of GBS, account needs to be taken of countries’ policy commit-
ments and resource allocation decisions related to social sector reform. Governments should be 
asked to do a credible case for additionally of how budget support has contributed to additional re-
sources being made available for inclusive and equitable health sector development, including health 
finance and social protection reform where needed. In addition to serving EU accountability, this will 
result in a stronger sense of country ownership.  
The hallmarks of the approach should be (i) identification, prioritisation and choice of interventions 
while maintaining enough breadth to allow consistency with national programmes and (ii) avoidance of 
overlap with other agencies such as GFATM, UNFOPA and UNICEF. It would distil overarching policy 
commitments into a menu of choices into which national strategic priorities could be mapped. 
Implementing this recommendation would include the following elements: 
 Create a Task Force (EC HQ and selected EUDs) to devise and design a comprehensive ap-
proach to health in developing countries. The emphasis should not be on process, already 
covered in recent documents relating to new programming procedures, but rather on how to 
prioritise health needs. 
 Strengthen EC/WHO collaboration as a means of promoting coherence with MoH objectives 
and approaches.  
 In countries receiving SBS for health, ensure that EUD capacity in health and PFM is ade-
quate to support effective policy dialogue. 
 Design a flexible and robust bottom-up methodology through which country needs can be 
quantified and matched with needs for donor assistance. This could focus on four-pillar ap-
proach: primary health care (covering inclusive and equitable coverage), health systems 
strengthening (particularly resilience to national, regional and global shocks), human re-
sources for health and health system finance. 
6.2.1.2 Recommendation 2: When defining the focus of support, take the shifting burden of 
disease and structural shifts such as urbanisation more carefully into account 
Based on conclusions 1 and 2 Main implementation responsibility:  
 EU HQ 
 EU Delegations 
The EC should take the shifting burden of disease and emerging problems into account in formulating 
global and country health strategies. The EC may be fighting yesterday’s battles in some settings – for 
example, HIV/AIDS receives a share of health assistance much greater than its estimated 3.8% con-
tribution to the global burden of disease in 2004 (a share projected by WHO to decline to 2.5% in 
2030). –At the same time, little notice has been taken of challenges associated with urbanisation and 
non-communicable diseases. Health and climate change is another area in need of consideration, less 
so issues such as heat stress and the shifting range of disease vectors than the problem of how to 
provide essential medical care in the wake of natural catastrophes, widely agreed to be rising in fre-
quency as a result of climate change (a health system resilience issue). The health-poverty focus has 
properly led the EC to concentrate on rural areas, but poverty is increasingly an urban phenomenon 
and the EC’s health strategy should be pro-active along this dimension. 
With its emphasis on primary health care and poverty focus, the EC is perhaps not in a strong position 
to directly address chronic conditions and non-communicable disease, which often require secondary-
and tertiary-level care. However, there are a number of areas where the EC can intervene. One is 
prevention, including behavioural change, widely agreed to be the most cost-effective response to 
non-communicable disease. Another is health care finance, which can stand as a cushion between 
catastrophic health events and poverty. Another is encouraging health planners to address road trau-
ma and mental disease squarely. Integrated PHC programmes, a clear and continuing focus of the 
EC, can be adapted to play an important role (e.g. health promotion, blood pressure monitoring, rou-
tine screening procedures, etc.) Addressing non-communicable disease does not compete with or 
crowd out primary health care, it leverages it. 
Implementing this recommendation would include the following elements: 
 EC HQ should provide clear approach guidelines to the EUDs in order to address and shifting 
burden of diseases. Basic training on the “burden of disease” concept may be needed and 
could be done in co-operation with WHO. 
 Strengthen EUDs health technical capacity. 
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 Undertake a systematic study of the relationship between EC health assistance and the bur-
den of disease, taking into account the support of other donors to ensure complementarity and 
coherence.  
6.2.1.3 Recommendation 3: While continuing to support global initiatives such as GFATM 
and GAVI, the EC should use its influence to encourage further moves towards the 
health systems strengthening components of such vertical programmes and in par-
ticular address the human resource consequences 
Based on conclusions 1, 5, 8 and 11 Main implementation responsibility:  
 EU HQ 
 Health working Groups 
 Country Co-ordinating Mechanism (CCM) 
The EC should continue its support to global initiatives such as the Global Fund (which has fallen 
somewhat outside this evaluation) and GAVI. However, the Health System Strengthening components 
of the GFATM and GAVI proposals (since Round 8) provide an entry point for HSS support and there-
fore should be prioritised. The EC’s considerable role in financing these initiatives gives it a strong 
governance voice for pushing them in the direction of systems strengthening. In addition to aligning 
more closely with country priorities, this will help to address the human resource crisis, which is in 
significant part due to health professionals having been absorbed by vertical programmes. The HSS 
approach is crosscutting and horizontal in addressing the weakest aspects of health system including 
service delivery and more in line with the goal to create a strong PHC framework. 
Implementing this recommendation would include the following elements: 
 EC HQ should use its voice in GFATM and GAVI governance to promote the Heath Systems 
Strengthening approach. 
 Health Systems Strengthening should, when appropriate (e.g., certainly in the case of vaccina-
tion and infectious disease control) be integrated with the EC’s work on global public goods for 
health.  
6.2.1.4 Recommendation 4: In order to improve coherence, the EC should be more strategic 
regarding the choice of instruments 
Based on Conclusions 1, 9, 13 and 17 Main implementation responsibility:  
 EU Delegations 
 EU HQ 
 Health working groups 
The EC needs to be more strategic regarding which aid instruments to use in which contexts, to en-
sure an appropriate mix and greater coherence between them. Thematic programmes need to be 
coherent with geographic programmes, while consideration needs to be given as to how GBS, 
SBS/other sector support and projects can be complementary. GBS is most likely to be successful in 
raising key health sector issues to a higher level of dialogue, with the achievement of objectives sup-
ported through a coherent series of interventions through sector support programmes and projects 
aimed at improving service delivery. SBS and other sector support can support dialogue aimed at 
better health sector management and strategic interventions related to this. More use of SBS should 
also be considered, with capacity building support given prior to SBS to ensure that the EC pre-
requisites are met.  
Fragile states present a special challenge. Relatively little EC assistance has gone to such countries, 
yet impacts have been substantial. In fragile states, emphasis should be put on strengthening basic 
service provision as a means of confidence building and, in situations of conflict or near-conflict, build-
ing bridges. Operations in fragile states should be innovative, flexible and adaptable, as situations may 
change rapidly.  
Implementing this recommendation would include the following elements: 
 EU HQ to revise the design of thematic programmes to make them more responsive to individ-
ual countries needs and complement geographic programmes more effectively. 
 CSPs should outline how different interventions link together and complement each other and 
the process of developing CSPs should be used to think this process through. 
 EUDs and health working groups to ensure that sector objectives/targets are supported 
through complementary interventions designed to support achievement of these objectives. 
 EUDs to develop a strategy to influence key EC health objectives through GBS dialogue and 
other interventions to ensure a joined up approach. 
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 EUDs to consider whether additional capacity building support can be provided to lay the 
groundwork for more SBS in health. 
6.2.1.5 Recommendation 5: The EC should strengthen the technical health capacity of EUDs 
or, in countries where this is impossible, consider either reducing its direct participa-
tion in the health sector, delegating to others by participating in pooled funding, or 
drawing on expertise in EU MS embassies 
Based on Conclusions 10, 12, 14 and 16 Main implementation responsibility:  
 EU Delegations 
 EU HQ 
 EU Member States  
A theme that has emerged repeatedly in conclusions is that most EU Delegations, even in countries 
with significant health engagement, are short of technical capacity. In order for policy dialogue related 
to sector SPSP and budget support to be effective, EUDs should have sufficient in-house expertise 
and capacity in health and PFM and there should be a dialogue strategy developed focused on key 
issues which the EC is interested in influencing. Participation in co-ordination exercises and multi-
donor trust funds also requires that the EU Delegation be credibly represented and input into policy 
dialogue and visibility suffer from a lack of credible expertise. The planned tightening of focus on only 
three focal areas per country is a golden opportunity for doing an inventory of needs and formulating a 
staffing plan. Where needed technical expertise cannot be mobilised, delegated co-operation may be 
employed to use the skilled staff of EU MS embassies. 
Implementing this recommendation would include the following elements: 
 This point is crosscutting and it is valid for all recommendations. If the EC wants to play a 
greater role in health, the capacity of EUDs is a fundamental starting point. 
 EU HQ to provide training in key skills for staff engaged in sector dialogue (negotiation, influ-
encing, etc.). 
 EUDs to develop a strategy to influence key EC health objectives through GBS. 
 EU HQ to recruit health and PFM specialists to EUDs where expertise is lacking. 
6.2.1.6 Recommendation 6: More explicit actions are called for in favour of human resources 
for health 
Based on conclusion 5 Main implementation responsibility:  
 EU  
 EUDs 
 Health working groups 
 CCM of the GFATM 
We have found that, in many developing countries, Ministries of Health struggle to attract and retain 
sufficient numbers and types of human resources for health to provide quality services, especially in 
rural and remote areas. The EC should give more attention to this burning issue, e.g. in human re-
sources planning in consultation with key stakeholders to provide a framework and strategic directions 
to guide the development of an effective workforce that can meet the challenges facing in countries’ 
health systems. The aim is to ensure that the health system has health professionals in the required 
quantity and quality at leadership, managerial and technical levels, deployed where and when needed 
and motivated to perform their functions. One of the key pillars of the strategy is to ensure appropriate 
incentives for health workers based on the national policy and legal frameworks. Guidelines describing 
various strategies a country can pursue to increase access to health workers in remote and rural are-
as through a range of retention interventions covering four main categories: education, regulation, 
financial incentives and personal and professional support mechanisms were released by WHO in 
2010.  
Moreover, the EC should ensure that HRH are taken into account in SBS / GBS policy matrices. 
Through its participation in co-ordination, it should act in concert with other donors and government to 
reduce poaching from the public health system.  
The EC should also explore the links between problems experienced in Third Countries and the bur-
geoning demand for health worker immigrants in EU MS. In so doing, co-ordination and liaison with 
the MS and WHO would be especially valuable. 
Implementing this recommendation would include the following elements: 
 All national health sector development policies supported should be subjected to a human re-
sources sustainability audit.  
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 EU HQ should take advantage of its unique role to engage in co-ordinated policy dialogue with 
MSs on their policies towards immigration of health professions, with the goal of establishing 
an EU policy / programme to support circular migration as opposed to brain drain. 
 Actions/indicators related to HR attrition should be included in SBS/GBS policy matrices to 
complement and reinforce EC and other donor programmes aimed at directly tackling the 
problem. 
6.2.2 Operational and level recommendations - specific themes 
6.2.2.1 Recommendation 7: Take greater account of complementarities, synergies and inter-
sectoral links 
Based on conclusion 4 and 7 Main implementation responsibility:  
 EUDs 
 EC HQ 
The EC’s country programmes should take into greater account the synergies, as well as the comple-
mentarities and cost-efficiency considerations that exist between different sectors – e.g. health, rural 
development, food security, water / sanitation, transport, etc. Policies seemingly diverse but in reality 
closely tied, such as provision of effective community-level health care, a referral system based on 
mobile telephony and emergency transport availability, deserve consideration in many settings. Par-
ticularly in the area of MNCH and in dealing with remote regions, integrated approaches may be espe-
cially important in accelerating progress. In addition, EUDs should ensure that, in aligning with national 
sector development plans, co-operation is aligned with EU policies on climate change, migration and 
environment. 
As education, health and social protection are priority sectors and as the new approach is to limit as-
sistance to three priority sectors, if one of these is selected, then aspects of the other two should be 
mainstreamed into the support package. 
Implementing this recommendation would include the following elements: 
 Strengthen EUD technical capacity in the health sector. 
 Systematically include linkages with the health sector in the project formulation process in re-
lated sectors. 
6.2.2.2 Recommendation 8: The EC should undertake a systematic review of its health sys-
tem finance support to identify lessons learned and directions for further action 
Based on conclusion 2, 3 and 6 Main implementation responsibility:  
 EC HQ 
In view of the generally weak record of the EC (and other donors) in effectively, sustainably and equi-
tably reforming health system finance and the crucial importance of increasing resources available to 
the health sector, the EC should conduct a thematic review specifically devoted to this area in order to 
identify lessons learned and identify new strategic directions. The EU Member States, having suc-
ceeded in delivering reasonably affordable health care in a financially sustainable manner using a 
range of approaches, are in a unique position to serve as a one-stop shop for policy advice in this 
central area. The role of the private sector – which accounts for more than half of health spending in 
many developing countries – should be given more attention than in the past. Where out-of-pocket 
payments remain high despite health system finance reform, reasons should be identified and shared 
with partners and stakeholders. The actuarial sustainability of mandatory public health insurance 
should be analysed in a selection of partner countries and income distribution and poverty conse-
quences of health system finance should be explored. 
Implementing this recommendation would include the following elements: 
 In aligning with national health sector development plans, the EU should (in co-ordination with 
MS donors) impose a mandatory financial sustainability audit.  
 Regarding the uses of funds, a bottom up “costing” methodology, in which basic interventions 
are identified, unit intervention costs are estimated, the target population is estimated and cov-
erage rates are assumed, should be used to estimate the cost of attaining reasonable inclu-
siveness and equity.  
 Regarding the sources of funds, the straightforward WHO approach of looking at public re-
sources, insurance, the public sector, donor finance and out-of-pocket should be used. 
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6.2.2.3 Recommendation 9: Regardless of the modality chosen, EC support to health infra-
structure 
Based on conclusions 3, 4 and 15 Main implementation responsibility:  
 EU Delegations 
While infrastructure and equipment are not and should not be EC priorities, in those cases where the 
EC does provide these, it should more carefully assess the operations and maintenance requirements 
that arise. Whenever the EC is involved in support to infrastructure and equipment (cars, medical 
equipment, cold chain, etc.) an amount of the project/programme budget should be mandatory includ-
ed and allocated to a simple and hoc maintenance strategy and plan. From the effectiveness, efficien-
cy and sustainability perspectives, the EC needs to tighten the link between facilities and health sys-
tem finance. The EC clearly cannot itself finance operations and maintenance. However, through sec-
tor support and to the extent possible, general budget support, it should provide support to strengthen 
ad hoc maintenance strategy in the health sector following WHO guidelines on performance inspec-
tions, preventive maintenance and corrective maintenance. Monitoring and data collection regarding 
the state of infrastructure and equipment need to be drastically strengthened, as evidence by the diffi-
culties that the evaluators had in collecting data in this area.  
Implementing this recommendation would include the following elements: 
 Clear guidelines are provided from EC HQ to the different EUDs and partners. It will be a con-
ditionality in/of the SBS and GBS. 
 The costs of infrastructure and equipment maintenance and operation should be fully reflected 
in project documents and the sources of such finance made explicit. 
6.2.2.4 Recommendation 10: Pay greater attention to innovative approaches to target remote, 
isolated and vulnerable population and minorities 
Based on conclusions 7 and, to lesser ex-
tent, 4, 5 and 8 
Main implementation responsibility:  
 EUDs 
 Health working groups 
It is clear that the worst health outcomes are increasingly concentrated among remote, geographically 
isolated, more often than not ethnic minority populations and frequently affected by conflict. These are 
inherently difficult areas to work in, with typically high costs of operations. Therefore, the EC should 
help to develop comprehensive strategies at country level that are tailored to local circumstances. 
Where needed, the EC should support data gathering and mapping exercises in MoHs. In some cas-
es, traditional provision of infrastructure and equipment, typically through NGO projects, will be appro-
priate. In others, supporting government in putting in place a human resources policy that relieves staff 
shortages will be more effective. In other cases, innovative approaches involving mobile telephony 
and community health workers, bush ambulance services, medical evacuation, etc. may be more cost 
effective. Addressing the human resources issue will, whatever the strategy developed, probably be 
necessary. Improving health system performance in remote and disadvantaged regions can be added 
to SBS / GBS policy matrices. Moreover, the EC should consider the role of health in some of its other 
activities in these areas, such as rural development, roads and water and sanitation. Geographical 
division of labour may be called for in some countries. 
6.2.2.5 Recommendation 11: Pay increased attention to data needs, particularly in designing 
sector and GBS interventions 
Based on all conclusions, especially con-
clusion 15. 
Main implementation responsibility:  
 EUDs,  
 Health working groups 
There exists almost everywhere a solid core of data availability regarding key indicators such as mor-
tality and vaccination. However, data needed to guide government policy, donor policy dialogue and 
resource allocation now cover a much wider range: infrastructure, budgets and health outcomes and 
expenditure data disaggregated by income, poverty status, household structure, sex, age, etc., as well 
as geographical disaggregation. In the context of its sector support, the EC should continue to 
strengthen data collection, stressing not only disaggregation, but timeliness, as data five or more 
years old are of little use. This may require co-operation with statistical agencies as well as the EC’s 
traditional MoH partners. 
Implementing this recommendation would include the following elements: 
 Consultation with partner governments to agree on indicators to be used in measuring health 
interventions. 
Particip GmbH 
Thematic evaluation of the European Commission support to the health sector 
 
Final Report Volume I August 2012 85 
 Ensure that indicators used are SMART (specific, measurable, attainable, relevant, timely). 
 EUDs and health working groups ensure that indicators chosen for SBS/GBS policy matrices 
are measurable and collected on a timely basis. 
 EC support to statistical offices in recipient countries to strengthen capacity to collect data or 
funding by the EC of key surveys and data collection activities. 
 EC support to the MoH to enhance capacity to collect data and monitor results. 
 
